"Rank","Title","Status","Study Results","Conditions","Interventions","Gender","Age","Phases","Enrollment","Completion Date","Locations","URL"
1,"Retrospective Postoperative ARDS Study at Vanderbilt University","Completed","No Results Available","ARDS",,"All","11 Years and older   (Child, Adult, Older Adult)",,"89","August 2008","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00656071"
2,"The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol","Completed","No Results Available","Acute Respiratory Distress Syndrome (ARDS)",,"All","18 Years and older   (Adult, Older Adult)",,"367","September 2012","Yale University, School of Medicine, Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT01714583"
3,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset","Completed","No Results Available","ARDS, Human|Covid19","Other: ARDS and COVID19 treatments","All","Child, Adult, Older Adult",,"1800","January 19, 2021","Feinstein Institutes for Medical Research, Manhasset, New York, United States","https://ClinicalTrials.gov/show/NCT04729075"
4,"Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients Recovery","Completed","No Results Available","ARDS, Human","Procedure: upright bed","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","5","January 1, 2022","University of Kentucky, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT04612608"
5,"Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)","Completed","Has Results","SARS-CoV 2|ARDS","Drug: Dornase Alfa Inhalation Solution","All","18 Years and older   (Adult, Older Adult)","Phase 3","30","December 31, 2020","University of Missouri Hospital and Clinics, Columbia, Missouri, United States","https://ClinicalTrials.gov/show/NCT04402970"
6,"A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients","Completed","No Results Available","Covid19|ARDS","Other: Lung Ultrasound (LUS)","All","18 Years and older   (Adult, Older Adult)",,"60","January 31, 2022","Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04692779"
7,"Treprostinil Sodium Inhalation for Patients At High Risk for ARDS","Terminated","Has Results","Respiratory Distress Syndrome, Adult","Drug: Treprostinil Inhalation Solution|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","14","November 7, 2017","University of North Carolina Hospitals, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02370095"
8,"Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS","Completed","Has Results","Acute Lung Injury (ALI)|ARDS","Device: Electrical Impedance Tomography monitoring","All","18 Years and older   (Adult, Older Adult)","Not Applicable","13","March 2011","Christiana Hospital, Newark, Delaware, United States","https://ClinicalTrials.gov/show/NCT01272882"
9,"Viral-Related Neutrophil Response and Condition Severity in People With ARDS","Completed","No Results Available","Respiratory Distress Syndrome, Adult",,"All","18 Years and older   (Adult, Older Adult)",,"132","July 2012","University of Colorado Health Sciences Center, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT00548795"
10,"The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)","Terminated","Has Results","Acute Respiratory Distress Syndrome","Drug: ClinOleic 20%|Drug: Intralipid 20%","All","18 Years to 90 Years   (Adult, Older Adult)","Phase 2","14","November 2012","Methodist Hospital, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT01096771"
11,"Stress Index to Individualize Mechanical Ventilation in ARDS","Terminated","No Results Available","Acute Respiratory Distress Syndrome","Procedure: Recruitment Maneuver with PEEP and Tidal Volume Optimization","All","18 Years and older   (Adult, Older Adult)","Not Applicable","4","December 2017","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT02871102"
12,"ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Extracorporeal Membrane Oxygenation","Device: ECMO support|Other: PROSpect protocolized therapies","All","14 Days to 17 Years   (Child)",,"550","June 2026","University of Michigan - Mott Children's Hospital, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT05388708"
13,"Mild Hypothermia for COVID-19 ARDS","Withdrawn","No Results Available","COVID19 ARDS","Other: Hypothermia Via Cooling Machine- Arctic Sun 5000","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","0","December 31, 2020","North Shore University Hospital, Manhasset, New York, United States","https://ClinicalTrials.gov/show/NCT04570462"
14,"Trial of Steroids in Pediatric Acute Lung Injury/ARDS","Unknown status","No Results Available","Acute Respiratory Distress Syndrome (ARDS)|Acute Lung Injury (ALI)","Drug: methylprednisolone|Drug: Normal Saline (0.9%)","All","1 Month to 18 Years   (Child, Adult)","Phase 2","100","December 2014","Le Bonheur Children's Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01274260"
15,"Electrical Impedance Tomography for Optimization of Positive End-Expiratory Pressure: Acute Respiratory Distress Syndrome","Completed","No Results Available","Acute Respiratory Distress Syndrome|ARDS","Other: Usual care|Device: PEEP titration by EIT","All","18 Years and older   (Adult, Older Adult)","Not Applicable","16","June 24, 2022","The University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT03793842"
16,"Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS","Withdrawn","No Results Available","Respiratory Distress Syndrome, Adult|Sars-CoV2","Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of Care","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","0","April 27, 2021","University of Maryland Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03376854"
17,"Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)","Completed","Has Results","ARDS|Covid19|Acute Hypoxemic Respiratory Failure","Other: Prolonged Proned Positioning|Other: Traditional Proning Arm","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","52","March 20, 2021","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT04581811"
18,"A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)","Recruiting","No Results Available","Respiratory Distress Syndrome, Acute","Drug: GEn-1124|Drug: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","52","July 2024","Ocean Springs Hospital, Ocean Springs, Mississippi, United States","https://ClinicalTrials.gov/show/NCT05795465"
19,"Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)","Completed","No Results Available","Acute Respiratory Distress Syndrome|Coronavirus Infection","Drug: vadadustat|Drug: placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","449","March 7, 2022","The University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04478071"
20,"ARDSnet Protocol vs. Open Lung Approach in ARDS","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Other: Different Mechanical Ventilation Protocols","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","224","March 2013","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00431158"
21,"Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDS","Completed","Has Results","Acute Respiratory Distress Syndrome|Acute Respiratory Failure","Device: Ultrasound","All","18 Years and older   (Adult, Older Adult)","Not Applicable","14","July 2016","Hennepin County Medical Center, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02463773"
22,"Provider Perceptions of Neuromuscular Blockade in ARDS","Completed","No Results Available","Neuromuscular Blockade|Acute Respiratory Distress Syndrome","Behavioral: Interview","All","18 Years and older   (Adult, Older Adult)",,"35","March 18, 2018","University of Pittburgh Medical Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03179709"
23,"Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)","Withdrawn","No Results Available","Respiratory Distress Syndrome, Adult",,"All","18 Years and older   (Adult, Older Adult)",,"0","January 2017","Weill Medical College of Cornell University, New York City, New York, United States","https://ClinicalTrials.gov/show/NCT00319631"
24,"Clinical Decision Support for Mechanical Ventilation of Patients With ARDS","Recruiting","No Results Available","Acute Respiratory Distress Syndrome","Procedure: Implementation of Processes","All","18 Years and older   (Adult, Older Adult)","Not Applicable","350","December 23, 2022","Intermountain Medical Center, Murray, Utah, United States","https://ClinicalTrials.gov/show/NCT03984175"
25,"Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)","Recruiting","No Results Available","COVID-19 Acute Respiratory Distress Syndrome|Respiratory Distress Syndrome","Drug: EV-Pure™ and WJ-Pure™|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","20","December 2023","Kit Bartalos, Liberty, Missouri, United States","https://ClinicalTrials.gov/show/NCT05387278"
26,"Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS","Unknown status","No Results Available","Acute Respiratory Distress Syndrome|Neuromyopathies",,"All","18 Years and older   (Adult, Older Adult)",,"290","September 2020","University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03038906"
27,"Estimation of Intrinsic Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome (ARDS)","Completed","No Results Available","Acute Respiratory Distress Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"6","April 2007","Thomason Hospital (Now University Medical Center), El Paso, Texas, United States","https://ClinicalTrials.gov/show/NCT00446706"
28,"KL₄Surfactant Treatment in Patients With ARDS","Terminated","Has Results","Acute Respiratory Distress Syndrome","Drug: A.1 Lucinactant|Other: B.3 SoC|Drug: A.2 Lucinactant|Drug: A.3 Lucinactant|Drug: A.4 Lucinactant|Drug: B.1 Lucinactant|Drug: B.2 Lucinactant","All","16 Years to 75 Years   (Child, Adult, Older Adult)","Phase 2","124","February 2006","Discovery Laboratories, Inc., Warrington, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00215553"
29,"Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)","Completed","No Results Available","Acute Respiratory Distress Syndrome|COVID-19","Procedure: Stellate Ganglion Block","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","5","December 31, 2020","West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT04402840"
30,"ARDS Esophageal Balloon Pressure Changes With Positioning Study","Terminated","No Results Available","ARDS|Respiratory Failure","Device: Esophageal balloon catheter","All","18 Years and older   (Adult, Older Adult)",,"2","March 1, 2020","University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03120793"
31,"Alveolar Macrophage Programming Following Endotoxin Exposure","Recruiting","No Results Available","ARDS, Human","Other: bronchoscopy with intrabronchial administration of lipopolysaccharide","All","18 Years to 50 Years   (Adult)","Not Applicable","25","March 2024","National Jewish Health, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT03859050"
32,"A Strategy to Improve Implementation of LTVV for Patients w/ ARDS","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome","Behavioral: Multi-component LTVV implementation strategy","All","18 Years and older   (Adult, Older Adult)","Not Applicable","0","August 31, 2017","Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03051139"
33,"Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)","Withdrawn","No Results Available","Severe Sepsis|Acute Respiratory Distress Syndrome","Drug: Bevacizumab|Drug: Placebo","All","18 Years to 99 Years   (Adult, Older Adult)","Phase 2","0","February 2016","Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01314066"
34,"Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome","Active, not recruiting","No Results Available","Covid19|SARS-CoV Infection|ARDS|ARDS, Human","Drug: Instilled T3|Other: Placebo Therapy","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","250","July 2024","University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04725110"
35,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection","No longer available","No Results Available","Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19","Drug: Remestemcel-L","All","18 Years and older   (Adult, Older Adult)",,,,"Mount Sinai Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04366830"
36,"Nitric Oxide Administration for Acute Respiratory Distress Syndrome","Completed","Has Results","Acute Respiratory Distress Syndrome","Drug: Nitric Oxide|Other: No Intervention","All","1 Month to 18 Years   (Child, Adult)","Phase 3","52","September 2008","The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00240487"
37,"Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome","Completed","Has Results","Respiratory Distress Syndrome","Drug: Poractant alfa|Drug: calfactant","All","22 Weeks to 35 Weeks   (Child)","Not Applicable","30","July 2015","University of Missouri, Women's and Children's Hospital, Columbia, Missouri, United States","https://ClinicalTrials.gov/show/NCT02834624"
38,"The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)","Completed","No Results Available","Acute Lung Injury|Acute Respiratory Distress Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"8","March 12, 2021","University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT03654352"
39,"Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome","Completed","No Results Available","Pulmonary Contusion|Respiratory Failure|ARDS",,"All","16 Years and older   (Child, Adult, Older Adult)",,"10","March 2015","Wake Forest Baptist Health, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02265198"
40,"Adaptive Support Ventilation in Acute Respiratory Distress Syndrome","Completed","No Results Available","Acute Respiratory Distress Syndrome","Other: ASV|Other: Lung Protective Ventilation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","January 31, 2021","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03715751"
41,"Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS","Completed","Has Results","Prone Positioning|High Flow Nasal Cannula|Acute Respiratory Distress Syndrome|Corona Virus Infection","Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","224","February 21, 2021","Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04325906"
42,"Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)","Terminated","No Results Available","Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV","Biological: Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","4","March 2, 2022","University of North Carolina, Chapel Hill, North Carolina, United States|The Ohio State University, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT05027815"
43,"Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients","Recruiting","No Results Available","ARDS, Human|Lung Injury, Acute|Respiratory Distress Syndrome|Mechanical Ventilation Complication|Alveolar Edema|Right Heart Failure|Right Ventricular Dysfunction","Procedure: PEEP ARDSnet|Procedure: PEEP LRM","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","50","August 2024","Massachussets General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03202641"
44,"Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)","Completed","Has Results","COVID|Sars-CoV2|COVID-19|Acute Respiratory Distress Syndrome","Drug: Defibrotide","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","13","April 9, 2021","University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT04530604"
45,"Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome","Terminated","Has Results","Acute Respiratory Distress Syndrome","Drug: Budesonide|Drug: Placebo|Device: Nebulizer","All","30 Days to 18 Years   (Child, Adult)","Phase 2","2","March 30, 2020","The University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04064684"
46,"High Flow Nasal Cannula in Comparison With Nasal Continuous Positive Airway Pressure in the Management of Respiratory Distress Syndrome","Completed","No Results Available","Respiratory Distress Syndrome","Device: HHHFNC|Device: NCPAP","All","Child, Adult, Older Adult","Not Applicable","60","April 2012","Akron Children's Hospital, Akron, Ohio, United States","https://ClinicalTrials.gov/show/NCT02587832"
47,"Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome","Completed","Has Results","Respiratory Distress Syndrome, Newborn","Drug: PS Group|Device: NCPAP Group|Drug: ISX Group","All","26 Weeks to 29 Weeks   (Child)","Phase 3","648","June 2011","Vermont Oxford Network, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT00244101"
48,"Early Insulin and Development of ARDS","Completed","Has Results","Respiratory Distress Syndrome, Adult|Sepsis|Hyperglycemia","Drug: Insulin","All","18 Years and older   (Adult, Older Adult)","Phase 2","18","September 2013","Montefiore Medical Center, Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT00605696"
49,"Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome","Withdrawn","No Results Available","Respiratory Distress Syndrome","Drug: Curosurf®|Drug: Survanta®","All","15 Minutes to 12 Hours   (Child)","Not Applicable","0",,"University of Michigan C & W Mott Children's Hospital, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT01537354"
50,"Molecular Epidemiology of ARDS","Active, not recruiting","No Results Available","Acute Respiratory Distress Syndrome|Lung Diseases",,"All","18 Years to 80 Years   (Adult, Older Adult)",,"4000","December 2023","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00006496"
51,"Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome|Covid19","Biological: T regulatory cells","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","0","September 2022","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT04737161"
52,"Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies","Completed","No Results Available","Blood And Marrow Transplantation|Adult Respiratory Distress Syndrome","Biological: Mesenchymal Stem Cells (MSCs)","All","18 Years and older   (Adult, Older Adult)","Phase 1","20","June 13, 2019","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02804945"
53,"Titration of PEEP During Mechanical Ventilation in Patients With ARDS Using Electrical Impedance Tomography.","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome","Device: Electrical Impedance Tomography","All","2 Years to 35 Years   (Child, Adult)","Not Applicable","0","July 1, 2020","Boston Children's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02596178"
54,"Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome","Unknown status","No Results Available","Respiratory Distress Syndrome, Newborn","Device: Endotracheal intubation|Device: Laryngeal mask airway|Drug: remifentanil","All","2 Hours to 48 Hours   (Child)","Phase 4","130","March 2020","Albany Medical Center, Albany, New York, United States","https://ClinicalTrials.gov/show/NCT02164734"
55,"Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants","Terminated","Has Results","Respiratory Distress Syndrome","Drug: Aerosolized lucinactant","All","15 Minutes to 30 Minutes   (Child)","Phase 2","17","September 2005","University of California, San Diego Medical Center - Hillcrest, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT00807235"
56,"N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome","Drug: N-acetyl cysteine","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","0","January 30, 2021","Palmetto Health Richland, Columbia, South Carolina, United States","https://ClinicalTrials.gov/show/NCT03346681"
57,"Non-invasive Fluid Management","Unknown status","No Results Available","Respiratory Distress Syndrome, Adult","Other: NICOM-Guided Diuresis|Other: Standard of Care","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","December 2020","Intermountain Medical Center, Murray, Utah, United States","https://ClinicalTrials.gov/show/NCT02892799"
58,"Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome","Drug: Tenecteplase","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","0","December 2008","Medical Center of Central GA, Macon, Georgia, United States","https://ClinicalTrials.gov/show/NCT00431379"
59,"Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)","Active, not recruiting","No Results Available","ARDS, Human|Covid19","Biological: Longeveron Mesenchymal Stem Cells (LMSCs)|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1","70","July 2025","Miami VA Healthcare System, Miami, Florida, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04629105"
60,"Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress","Withdrawn","No Results Available","Covid19|ARDS","Drug: COVI-MSC|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","0","September 2021","Fresno Community Hospital, Fresno, California, United States","https://ClinicalTrials.gov/show/NCT04728698"
61,"Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment","Recruiting","No Results Available","SARS-CoV-2|Hypoxia|ARDS","Drug: Dapsone 100 MG","All","18 Years to 100 Years   (Adult, Older Adult)","Early Phase 1","100","December 31, 2021","Hunt Regional Medical Center, Greenville, Texas, United States","https://ClinicalTrials.gov/show/NCT04918914"
62,"Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS","Withdrawn","No Results Available","Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Respiratory Failure|Sars-CoV2","Drug: Rapamycin|Drug: Placebo","All","60 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","0","January 2023","University Hospital System, San Antonio, Texas, United States|Audie L Murphy Memorial Veterans Hospital, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04482712"
63,"Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS","Active, not recruiting","No Results Available","Covid19|Corona Virus Infection|SARS-CoV Infection|ARDS|Coronavirus","Biological: Umbilical Cord Lining Stem Cells (ULSC)|Other: Placebo (carrier control)","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","17","July 31, 2023","Miami Baptist Hospital, Miami, Florida, United States|Sanford Research, Sioux Falls, South Dakota, United States","https://ClinicalTrials.gov/show/NCT04494386"
64,"Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)","Active, not recruiting","No Results Available","Acute Respiratory Distress Syndrome|ARDS (Moderate or Severe)|COVID-19 Pneumonia","Biological: Mesenchymal stromal cells|Other: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","9","December 2023","University of Minnesota, Minneapolis, Minnesota, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04466098"
65,"RAPA-501-Allo Therapy of COVID-19-ARDS","Terminated","No Results Available","Severe COVID-19 Disease","Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","1","September 13, 2021","Hackensack University Medical Center, Hackensack, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04482699"
66,"Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)","Withdrawn","No Results Available","Adult Respiratory Distress Syndrome|Acute Lung Injury","Drug: Simvastatin|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Not Applicable","0","October 2011","OU Medical Center, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01195428"
67,"Identifying PARDS Endotypes","Recruiting","No Results Available","Respiratory Distress Syndrome|Respiratory Distress Syndrome, Adult","Diagnostic Test: Respiratory epithelial cell brushing","All","1 Month to 18 Years   (Child, Adult)",,"60","March 31, 2025","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT03539783"
68,"The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome","Completed","No Results Available","Neonatal Respiratory Distress Syndrome",,"Female","18 Years and older   (Adult, Older Adult)",,"160","June 30, 2017","Eskenazi Hospital, Indianapolis, Indiana, United States|Methodist Hospital, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT02112513"
69,"SP16 as a Therapeutic for COVID-19 Induced ARDS","Recruiting","No Results Available","SARS CoV 2 Infection|Pneumonia","Drug: SP16 (6mg)|Other: Placebo|Drug: SP16 (12 mg)","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","20","March 2024","UVA Health Center, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT05135624"
70,"Ketamine Infusion as Sedative Analgesic in Severe ARDS","Completed","No Results Available","Intensive Care Unit Syndrome|Mechanical Ventilation Complication|Sedatives and Hypnotics Causing Adverse Effects in Therapeutic Use|Delirium",,"All","18 Years to 90 Years   (Adult, Older Adult)",,"124","February 14, 2021","Interfaith Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04818827"
71,"Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation","Completed","Has Results","Respiratory Distress Syndrome, Newborn","Device: Endotracheal tube insertion|Device: Laryngeal mask airway insertion","All","4 Hours to 48 Hours   (Child)","Phase 4","61","November 2012","Albany Medical Center, Albany, New York, United States","https://ClinicalTrials.gov/show/NCT01042600"
72,"Feasibility of Upright Bed Position in ARDS Patients","Completed","No Results Available","Critical Illness|Acute Respiratory Failure|Adult Syndrome","Other: Intervention Arm","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","June 2015","Wake Forest Baptist Health, Medical Intensive Care Unit, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02160561"
73,"Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial","Active, not recruiting","No Results Available","COVID-19","Drug: Decitabine|Other: Placebo Saline","All","18 Years and older   (Adult, Older Adult)","Phase 2","33","September 2023","Johns Hopkins University, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04482621"
74,"A Randomized Trial of GM-CSF in Patients With ALI/ARDS","Completed","Has Results","Respiratory Distress Syndrome, Adult","Drug: Placebo|Drug: GM-CSF","All","18 Years to 90 Years   (Adult, Older Adult)","Phase 2","132","June 2009","University of Colorado Health Sciences Center, Denver, Colorado, United States|Emory University, Atlanta, Georgia, United States|University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT00201409"
75,"Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Procedure: Conventional Pressure Controlled SIMV|Other: Mid-frequency Ventilation","All","1 Hour to 7 Days   (Child)","Phase 1|Phase 2","12","May 2013","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT01242462"
76,"Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Procedure: Bronchoscopy","All","18 Years to 95 Years   (Adult, Older Adult)","Not Applicable","40","June 2009","Emory University, Atlanta, Georgia, United States|University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT00217880"
77,"COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19","Terminated","Has Results","Coronavirus Infection","Drug: Colchicine|Drug: Usual Care","All","18 Years to 100 Years   (Adult, Older Adult)","Phase 2","21","July 31, 2020","Maimonides Medical Center, Brooklyn, New York, United States","https://ClinicalTrials.gov/show/NCT04363437"
78,"Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT)","Terminated","Has Results","Acute Lung Injury","Behavioral: intensive medical nutrition|Other: control","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","78","June 2013","Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01921101"
79,"Aerosolized Surfactant in Neonatal RDS","Completed","Has Results","Respiratory Distress Syndrome, Newborn","Drug: Surfactant","All","up to 24 Hours   (Child)","Phase 1|Phase 2","159","July 2020","Hutzel Women's Hospital, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT02294630"
80,"Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections","Completed","No Results Available","AKI|ARDS|COVID","Device: SCD","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","22","July 21, 2021","University of Kentucky, Lexington, Kentucky, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT04395911"
81,"SILtuximab in Viral ARds (SILVAR) Study","Terminated","No Results Available","Acute Respiratory Distress Syndrome|Lung Diseases|Pneumonia|Respiratory Tract Infections|Respiratory Tract Disease","Drug: Siltuximab|Other: Normal Saline","All","12 Years to 65 Years   (Child, Adult, Older Adult)","Phase 3","555","April 1, 2021","Sparrow Clinical Research Institute, Lansing, Michigan, United States|Atrium Health, Charlotte, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04616586"
82,"Study of Descartes-30 in Acute Respiratory Distress Syndrome","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Covid19","Biological: Descartes 30","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","30","May 2024","University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Maryland Medical Center Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04524962"
83,"The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19","Not yet recruiting","No Results Available","Covid19|Novel Coronavirus Pneumonia|Acute Respiratory Distress Syndrome","Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)|Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)|Drug: MSC-exosomes delivered intravenously every other day (8:8:8)","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","55","December 2024","Mission Community Hospital, Panorama City, California, United States","https://ClinicalTrials.gov/show/NCT04798716"
84,"Generating Evidence in ECMO Ventilation Strategies","Recruiting","No Results Available","ARDS|Acute Respiratory Failure","Other: Standard-Lung Protective Ventilation|Other: Ultra-Lung Protective Ventilation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","October 1, 2023","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT05708365"
85,"Use of UC-MSCs for COVID-19 Patients","Completed","Has Results","Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19","Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","24","October 31, 2020","Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT04355728"
86,"Short Term Outcomes of Children With Acute Respiratory Distress Syndrome","Completed","No Results Available","Acute Respiratory Distress Syndrome",,"All","0 Years to 18 Years   (Child, Adult)",,,"August 2005","Columbus Children's Hospital, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00142376"
87,"Stellate Ganglion Blockade in COVID-19 Positive Patients","Completed","No Results Available","COVID 19|ARDS","Procedure: Stellate Ganglion Block","All","19 Years to 85 Years   (Adult, Older Adult)","Not Applicable","1","November 1, 2021","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT04445337"
88,"Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)","Terminated","No Results Available","Respiratory Distress Syndrome, Newborn","Device: Surfactant administered via Laryngeal Mask Airway (LMA)|Other: standard of care (nasal CPAP and supplemental oxygen)","All","up to 72 Hours   (Child)","Not Applicable","380","December 2009","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00599651"
89,"Effects of Volume Guarantee With Pressure Supported vs. Synchronized Intermittent Mandatory Ventilation in VLBW Infants","Suspended","No Results Available","Respiratory Distress Syndrome","Procedure: PSV+VG mode versus SIMV+VG mode","All","72 Hours to 120 Hours   (Child)",,"16","September 2007","Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00295230"
90,"Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)","Completed","No Results Available","Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19","Biological: Mesenchymal Stromal Cells|Other: Supportive Care","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","28","January 11, 2023","Houston Methodist Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04345601"
91,"Amphetamine Induced Adult Respiratory Distress Syndrome","Completed","No Results Available","Burns|Acute Lung Injury|Acute Respiratory Distress Syndrome|Methamphetamine Abuse","Other: Difference in development of Acute Lung Injury in Amphetamine positive and negative patients","All","18 Years and older   (Adult, Older Adult)",,"49","January 1, 2020","Arrowhead Regional Medical Center, Colton, California, United States","https://ClinicalTrials.gov/show/NCT05611385"
92,"MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)","Recruiting","No Results Available","ARDS","Biological: MultiStem|Biological: Placebo","All","18 Years to 89 Years   (Adult, Older Adult)","Phase 2|Phase 3","400","December 2023","Athersys Investigational Site 107, Chicago, Illinois, United States|Athersys Investigational Site 103, Akron, Ohio, United States|Athersys Investigational Site 101, Cleveland, Ohio, United States|Athersys Investigational Site 102, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04367077"
93,"Prevention of COVID-19 Infection to Severe Pneumonia or ARDS","Unknown status","No Results Available","Covid19 Pneumonia","Drug: EC-18|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","60","November 2021","Lincoln Medical Center, Bronx, New York, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT04569227"
94,"Study of Energy Requirements in Critically Ill Newborns","Unknown status","No Results Available","Respiratory Distress Syndrome",,"All","24 Hours to 120 Hours   (Child)",,"60",,"Indiana University, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT00006274"
95,"A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19","Recruiting","No Results Available","Covid19","Biological: hMSC","All","18 Years and older   (Adult, Older Adult)","Phase 2","40","December 31, 2022","Providence Medical Foundation, Fullerton, California, United States|Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States","https://ClinicalTrials.gov/show/NCT04780685"
96,"Iloprost Effects on Gas Exchange and Pulmonary Mechanics","Completed","No Results Available","Acute Respiratory Distress Syndrome|Acute Lung Injury|Pulmonary Hypertension","Drug: Iloprost","All","18 Years and older   (Adult, Older Adult)","Phase 1","20","July 2012","OU Medical Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01274481"
97,"Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation","Withdrawn","No Results Available","Acute Lung Injury|Adult Respiratory Distress Syndrome|Kidney Injury","Device: Volume-Cycled Assist-Control (AC) mode|Device: Airway Pressure Release Ventilation (APRV) mode","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 2","0","November 2, 2020","James A. Tumlin, MD, Chattanooga, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00793013"
98,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS","Active, not recruiting","No Results Available","Pneumonia, Viral","Drug: Ibudilast|Drug: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","40","December 1, 2023","Denver Health and Hospital Authority, Denver, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04429555"
99,"Comparative Effectiveness Study of Bubble CPAP Devices in the NICU","Completed","Has Results","Respiratory Distress Syndrome","Device: Bubble CPAP- BabiPlus, Respiralogics|Device: Bubble CPAP- B&B Bubbler, B&B Medical devices","All","1 Day to 100 Days   (Child)","Not Applicable","43","August 2016","Cardinal Glennon Children's Hospital, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02392806"
100,"Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants","Completed","No Results Available","Respiratory Distress Syndrome",,"All","1 Hour to 28 Days   (Child)",,"21","October 2015","Dartmouth Hitchcock Medcial Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT02144363"
101,"Comparing Weaning of Nasal Continuous Positive Airway Pressure (CPAP) From Preterm Infants","Completed","No Results Available","Respiratory Distress Syndrome","Other: Gradual pressure wean","All","26 Weeks to 32 Weeks   (Child)","Not Applicable","70","December 2015","Maimonides medcial center, Brooklyn, New York, United States","https://ClinicalTrials.gov/show/NCT02126501"
102,"Comparing Bubble and Ventilator Nasal CPAP in Preterm Infants","Completed","No Results Available","Respiratory Distress Syndrome",,"All","2 Days to 3 Months   (Child)",,"18","October 2014","Maimonides Medical Center, Brooklyn, New York, United States","https://ClinicalTrials.gov/show/NCT02003846"
103,"Verification of Pulse Oximetry in Neonatal Population","Completed","No Results Available","Respiratory Distress Syndrome",,"All","1 Day to 30 Days   (Child)",,"25","September 2009","Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00751439"
104,"Premedication for Less Invasive Surfactant Administration Study (PRELISA)","Recruiting","No Results Available","Respiratory Distress Syndrome, Newborn","Drug: IV Atropine and Fentanyl Premedication Arm|Drug: IV Normal Saline Placebo Arm","All","0 Hours to 72 Hours   (Child)","Phase 4","58","May 2023","Parkland Health and Hospital System, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT05065424"
105,"Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)","Completed","No Results Available","Acute Respiratory Distress Syndrome (ARDS)","Drug: Inhaled Carbon Monoxide at 100ppm (4 participants)|Drug: Placebo for Inhaled Carbon Monoxide at 100ppm (2 participants)|Drug: Inhaled Carbon Monoxide at 200ppm (4 participants)|Drug: Placebo for Inhaled Carbon Monoxide at 200ppm (2 participants)","All","18 Years and older   (Adult, Older Adult)","Phase 1","12","August 2019","Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Weill Cornell Medical College/NewYork-Presbyterian, New York, New York, United States|Duke Univesity Hospital, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02425579"
106,"Comparison of Two Fetal Lung Maturity Tests","Withdrawn","No Results Available","Respiratory Distress Syndrome",,"Female","Child, Adult, Older Adult",,"0","May 2010","Oklahoma State University Medical Center, Tulsa, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT00613977"
107,"Fluid Restriction in Respiratory Distress of the Newborn","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Other: Fluid Management Intervention","All","up to 12 Hours   (Child)","Not Applicable","65","March 31, 2021","Icahn School of Medicine at Mount Sinai, New York, New York, United States|Comanche county Memorial hospital, Lawton, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT03120585"
108,"Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs","Unknown status","No Results Available","Respiratory Distress Syndrome in Premature Infant","Device: Nasal interface","All","up to 28 Days   (Child)","Not Applicable","20","June 30, 2020","Arkansas Children's Hospital, Little Rock, Arkansas, United States","https://ClinicalTrials.gov/show/NCT04326270"
109,"Physiological Changes With High-Flow Nasal Cannula","Completed","No Results Available","Respiratory Distress Syndrome in Premature Infant","Procedure: High flow nasal cannula|Procedure: Nasal CPAP","All","23 Weeks to 29 Weeks   (Child)","Not Applicable","80","February 14, 2022","Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT03700606"
110,"Pulmozyme to Improve COVID-19 ARDS Outcomes","Recruiting","No Results Available","COVID","Drug: Pulmozyme|Drug: Placebo","All","3 Years and older   (Child, Adult, Older Adult)","Phase 2","60","December 31, 2021","Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|South Shore Hospital, Weymouth, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04402944"
111,"A First-in-Human Study of AV-001 in Healthy Subjects","Completed","No Results Available","Covid19-associated ARDS|Covid19|ARDS","Drug: AV-001|Other: Placebo","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","48","March 10, 2021","Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04737486"
112,"Genetic Regulation of Surfactant Deficiency","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Drug: Nutrient","All","1 Day to 6 Months   (Child)",,"525","March 2013","St. Louis Children's Hospital, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00828243"
113,"The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Other: Heliox gas","All","1 Minute to 12 Hours   (Child)","Not Applicable","13","August 2011","Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States","https://ClinicalTrials.gov/show/NCT00739115"
114,"Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section","Terminated","No Results Available","Respiratory Distress Syndrome, Newborn","Drug: Betamethasone","Female","Child, Adult, Older Adult","Phase 2|Phase 3","67","September 2007","Emory University affiliated newborn intensive care units, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT00139256"
115,"Study to Evaluate ARD-101 in Adults With Obesity","Completed","No Results Available","Obesity","Drug: ARD-101|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","20","November 9, 2022","Altman Clinical and Translational Research Institute, University of California, San Diego, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT05121441"
116,"Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery","Active, not recruiting","No Results Available","Bariatric Surgery|Obesity|Weight Gain","Drug: ARD-101","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","12","April 30, 2023","Altman Clinical and Translational Research Institute, University of California, San Diego, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT05215847"
117,"Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury","Unknown status","No Results Available","Covid-19|ARDS, Human|Acute Lung Injury","Drug: Heparin|Drug: 0.9% Sodium-chloride","All","18 Years and older   (Adult, Older Adult)","Phase 4","50","December 31, 2021","Frederick Health Hospital, Frederick, Maryland, United States","https://ClinicalTrials.gov/show/NCT04397510"
118,"Assessment of Occult Lung Stress During Lung Protective Mechanical Ventilation","Not yet recruiting","No Results Available","Acute Respiratory Distress Syndrome","Other: Esophageal Catheter","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","April 1, 2024","Tisch Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05675696"
119,"Noninvasive Estimation of Work of Breathing","Terminated","No Results Available","Acute Respiratory Distress Syndrome","Other: changes in ventilator settings","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5","May 4, 2017","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02867228"
120,"Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome","Recruiting","No Results Available","COVID-19 Infection|COVID-19-Associated Acute Respiratory Distress Syndrome|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed","Other: Best Practice|Biological: Mesenchymal Stem Cell","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","70","April 30, 2024","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04565665"
121,"Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome","Active, not recruiting","No Results Available","Ventilator-Induced Lung Injury|Respiratory Distress Syndrome|Bronchopulmonary Dysplasia|Preterm Infant","Device: Mid frequency ventilation|Device: Standard frequency ventilation","All","1 Day to 3 Days   (Child)","Phase 2|Phase 3","60","October 31, 2024","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of South Alabama, Mobile, Alabama, United States","https://ClinicalTrials.gov/show/NCT03231735"
122,"Tenecteplase in Patients With COVID-19","Completed","Has Results","COVID-19|Respiratory Failure|ARDS","Drug: Tenecteplase|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","13","March 10, 2022","Mount Sinai Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04505592"
123,"Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient","Completed","No Results Available","Acute Respiratory Distress Syndrome","Other: Ventilation strategy","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","January 2011","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00538161"
124,"Observational Crossover Study Comparing Oxygenation and Ventilation Using SiPAP Versus CPAP in LBW Infants","Completed","No Results Available","Ventilation|Respiratory Distress Syndrome","Device: SiPAP","All","Child, Adult, Older Adult",,"20","May 2011","Childrens Hospital and Clinics of MN - St. Paul, St. Paul, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01053455"
125,"Post-Hospital Case Management to Improve Clinical Outcomes in Individuals Requiring Mechanical Ventilation","Completed","No Results Available","Acute Respiratory Distress Syndrome","Behavioral: Targeted Case Management|Behavioral: Usual care","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","600","February 2009","University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00149513"
126,"Carbon Monoxide to Prevent Lung Inflammation","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Procedure: Bronchoscopy|Procedure: Bronchoalveolar lavage|Drug: Endotoxin|Drug: Carbon Monoxide","All","18 Years to 40 Years   (Adult)","Phase 1","35","March 11, 2010","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00094406"
127,"Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation","Unknown status","No Results Available","Respiratory Failure|Acute Lung Injury (ALI)|Acute Respiratory Distress Syndrome (ARDS)","Device: Mechanical Ventilation","All","18 Years and older   (Adult, Older Adult)","Phase 2","246","June 2016","Intermountain Medical Center, Murray, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01339533"
128,"LISA in the Delivery Room for Extremely Preterm Infants","Recruiting","No Results Available","Extreme Prematurity|Respiratory Distress Syndrome","Procedure: LISA","All","5 Minutes to 20 Minutes   (Child)","Not Applicable","60","December 31, 2024","Venkatakrishna Kakkilaya, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT04715373"
129,"ETCare: Safety and Preliminary Efficacy Trial","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Other: #1 Respiratory Care Solution","All","Child, Adult, Older Adult","Early Phase 1","10","September 2005","McKay-Dee Hospital Center, Ogden, Utah, United States|LDS Hospital Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01688440"
130,"Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury","Completed","Has Results","Acute Respiratory Distress Syndrome|Acute Lung Injury","Procedure: Recruitment maneuver","All","1 Month to 18 Years   (Child, Adult)","Not Applicable","12","December 2012","Children's Hospital Boston, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00830284"
131,"Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants","Completed","Has Results","Respiratory Distress Syndrome|Bronchopulmonary Dysplasia","Device: CPAP and room air","All","up to 1 Year   (Child)","Not Applicable","50","September 2017","Oregon Health & Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02249143"
132,"Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis","Completed","No Results Available","Sepsis|Respiratory Distress Syndrome|Respiratory Distress Syndrome, Adult","Drug: vasoactive intestinal peptide","All","18 Years and older   (Adult, Older Adult)","Phase 1","18",,"Veterans Affairs Medical Center - Northport, Northport, New York, United States|State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00004494"
133,"A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation","Completed","Has Results","Apnea of Prematurity|Respiratory Distress Syndrome","Device: Discontinue NCPAP after weaning pressures|Device: Discontinue NCPAP without weaning pressures","All","Child, Adult, Older Adult","Not Applicable","66","March 31, 2019","The University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03292562"
134,"Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome","Completed","Has Results","Respiratory Distress Syndrome in Premature Infant|Bronchopulmonary Dysplasia","Drug: Half normal saline|Drug: Low Dose rhCC10|Drug: High dose rhCC10","All","24 Weeks to 29 Weeks   (Child)","Phase 2","88","August 25, 2017","Tufts Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01941745"
135,"Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation","Withdrawn","No Results Available","Respiratory Distress Syndrome, Adult|Pneumonia|Mechanical Ventilation","Device: High Frequency Percussive Ventilation","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","0","December 31, 2009","Parkland Health and Hospital System, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00308022"
136,"The Effects of Different Ventilator Strategies on Inflammation and Injury in Normal Lungs","Terminated","No Results Available","Acute Respiratory Distress Syndrome","Other: Ventilator settings","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","1","March 2010","UMDNJ/University Hospital, Newark, New Jersey, United States","https://ClinicalTrials.gov/show/NCT01003730"
137,"A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome","Recruiting","No Results Available","Prader-Willi Syndrome","Drug: ARD-101","All","17 Years to 65 Years   (Child, Adult, Older Adult)","Phase 2","12","May 31, 2023","Stanford University, Palo Alto, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT05153434"
138,"Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants","Completed","No Results Available","Prematurity, Respiratory Distress Syndrome,Hypoxemia","Drug: Inhaled nitric oxide|Drug: Placebo","All","4 Years to 6 Years   (Child)","Phase 3","160","September 2006","The University of Chicago, Comer Children's Hospital,, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00152542"
139,"Extubation Readiness Study in Very Low Birthweight Infants","Terminated","No Results Available","Respiratory Distress Syndrome","Other: spontaneous breathing trial","All","48 Hours to 14 Weeks   (Child)","Not Applicable","81","April 2016","The Hospital of the University of Pennsylvania, Phialdelphia, Pennsylvania, United States|Pennsylvania Hospital, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01471431"
140,"Restore Resilience in Critically Ill Children","Completed","No Results Available","Acute Respiratory Distress Syndrome","Other: R2 Bundle","All","6 Months to 17 Years   (Child)","Not Applicable","56","December 31, 2021","Johns Hopkins University - Charlotte Bloomberg Children's Center, Baltimore, Maryland, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04695392"
141,"Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide","Withdrawn","No Results Available","Low Tidal Volume Ventilation|Acute Respiratory Distress Syndrome","Other: HLR|Other: EHR","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","0","August 2014","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01927237"
142,"T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19","Recruiting","No Results Available","COVID-19 Acute Respiratory Distress Syndrome","Diagnostic Test: Agilent Seahorse XF Cell Mito Stress Test","All","18 Years and older   (Adult, Older Adult)",,"15","July 31, 2023","Christina Barkauskas, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT05798260"
143,"Long Term Follow up of Children Enrolled in the REDvent Study","Recruiting","No Results Available","Respiratory Distress Syndrome, Adult|Ventilator-Induced Lung Injury|Neurocognitive Dysfunction|Quality of Life|Respiration Disorders","Diagnostic Test: Ventilation Inhomogeneity|Diagnostic Test: Diaphragm Ultrasound|Diagnostic Test: Respiratory Inductance Plethysmography|Diagnostic Test: Spirometry|Diagnostic Test: Functional Residual Capacity|Diagnostic Test: MIP/MEP|Diagnostic Test: 6 minute walk test|Diagnostic Test: Neurocognitive Testing|Diagnostic Test: Emotional Health Assessment|Diagnostic Test: Health Related Quality of Life|Diagnostic Test: Functional Status|Diagnostic Test: Respiratory Status Questionnaire","All","1 Month to 18 Years   (Child, Adult)",,"240","March 1, 2024","Children's Hospital Los Angeles, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT03709199"
144,"Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA","Recruiting","No Results Available","Fetal Lung Maturity|Respiratory Distress Syndrome in Premature Infant","Other: blood draw","Female","18 Years to 40 Years   (Adult)",,"80","May 2022","Detroit Medical Ceter, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT03562182"
145,"Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates","Completed","No Results Available","Transient Tachypnea of the Newborn|TTN|Respiratory Distress Syndrome|RDS","Other: Respiratory Distress Group|Other: Control Group","All","28 Weeks and older   (Child, Adult, Older Adult)",,"36","June 2013","Icahn School of Medicine at Mount Sinai, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01517958"
146,"Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants","Terminated","Has Results","Prematurity|Respiratory Distress Syndrome|Patent Ductus Arteriosus","Drug: Survanta (beractant)|Drug: Curosurf (poractant)","All","up to 8 Hours   (Child)","Phase 4","52","January 2009","Boston Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00767039"
147,"Pragmatic Investigation of Volume Targeted Ventilation-1","Active, not recruiting","No Results Available","Respiratory Failure|Acute Respiratory Distress Syndrome (ARDS)|Ventilator Lung","Procedure: mode of mechanical ventilation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","139","December 2023","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03909854"
148,"Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?","Recruiting","No Results Available","PPROM|Respiratory Distress Syndrome in Premature Infants","Drug: Betamethasone|Drug: Placebo","Female","18 Years to 50 Years   (Adult)","Phase 2|Phase 3","98","November 30, 2023","University of Texas Medical Branch in Galveston, Galveston, Texas, United States","https://ClinicalTrials.gov/show/NCT02939742"
149,"Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System","Enrolling by invitation","No Results Available","Acute Respiratory Distress Syndrome|COVID-19","Device: V/Q System","All","18 Years and older   (Adult, Older Adult)","Not Applicable","36","December 2022","Emory University Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT04369599"
150,"Does Cricoid Pressure Reduce the Risk of Aspiration?","Completed","No Results Available","Microaspiration|Acute Respiratory Distress Syndrome (ARDS)|Hospital Acquired Pneumonia","Procedure: Cricoid pressure","All","18 Years and older   (Adult, Older Adult)","Not Applicable","95","October 2014","Mayo Clinic - Saint Mary's Campus, Rochester, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02058004"
151,"Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure","Completed","No Results Available","Respiratory Distress Syndrome|Cronic Lung Disease","Device: High Flow Nasal Cannula","All","72 Hours and older   (Child, Adult, Older Adult)","Phase 3","16","September 2007","Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00356668"
152,"Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome","Completed","Has Results","Acute Respiratory Distress Syndrome","Biological: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells","All","18 Years and older   (Adult, Older Adult)","Phase 1","9","February 2015","University of California San Francisco Medical Center, San Francisco, California, United States|Stanford University Medical Center, Stanford, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01775774"
153,"Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.","Completed","Has Results","Mechanical Ventilation|Acute Respiratory Distress Syndrome|Hypoxic Respiratory Failure",,"All","1 Day to 35 Years   (Child, Adult)",,"278","January 9, 2017","Boston Children's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02184208"
154,"Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns","Completed","No Results Available","Respiratory Distress Syndrome|Bronchopulmonary Dysplasia",,"All","0 Years and older   (Child, Adult, Older Adult)",,"200",,"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00006058"
155,"Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury","Terminated","No Results Available","Acute Lung Injury|Adult Respiratory Distress Syndrome","Drug: Nebulized hypertonic saline","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","13","November 6, 2018","Denver Health Medical Center, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT01667666"
156,"ED Lung Protective Ventilation to Reduce Complications","Completed","Has Results","Mechanical Ventilation|Ventilator-associated Conditions|ARDS","Procedure: lung protective ventilation","All","18 Years and older   (Adult, Older Adult)",,"1705","March 2016","Washinton University School of Medicine in St. Louis, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02543554"
157,"MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients","Recruiting","No Results Available","COVID-19|ARDS, Human|Stem Cells|Regeneration","Drug: MRG-001|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","40","July 1, 2022","Johns Hopkins Medicine, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04646603"
158,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).","Terminated","No Results Available","Acute Respiratory Distress Syndrome|Coronavirus|Hypoxic Respiratory Failure|Hypoxemic Respiratory Failure|Respiratory Complication|Respiratory Insufficiency|Cardiac Dysfunction|Pneumonia|Pulmonary Edema|Pulmonary Inflammation|Respiratory Failure|Cytokine Storm|COVID 19|SARS-CoV-2|Cardiac Event|Cardiac Complication|Cardiac Failure|Cardiac Infarct","Drug: Pemziviptadil (PB1046)|Drug: Low Dose (10 mg) Control","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 2","54","December 2, 2020","Baptist Health Research Institute, Jacksonville, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Adventist Healthcare White Oak Medical Center, Silver Spring, Maryland, United States","https://ClinicalTrials.gov/show/NCT04433546"
159,"Biomarkers of Lung Injury With Low Tidal Volume Ventilation Compared With Airway Pressure Release Ventilation","Terminated","No Results Available","Acute Lung Injury|Adult Respiratory Distress Syndrome","Other: low-tidal-volume ventilation|Other: APRV","All","18 Years and older   (Adult, Older Adult)","Not Applicable","3","September 2016","Boston Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01038531"
160,"Acute Lung Injury Ventilator Evaluation (ALIVE)","Terminated","No Results Available","Acute Lung Injury|Adult Respiratory Distress Syndrome","Other: Low-tidal-volume ventilation|Other: Airway Pressure Release Ventilation (APRV)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","4","October 2014","University of Wisconsin-Madison, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01901354"
161,"Genetic Variability and Biomarkers in Children With Acute Lung Injury","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome|Acute Lung Injury",,"All","2 Weeks to 18 Years   (Child, Adult)",,"0","June 2013","Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01048996"
162,"Pre-exposure Prophylaxis for SARS-Coronavirus-2","Completed","Has Results","COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome","Drug: Hydroxychloroquine|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 3","1483","July 13, 2020","Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04328467"
163,"Work of Breathing During Non-invasive Ventilation in Premature Neonates","Completed","No Results Available","Respiratory Distress Syndrome, Newborn|Bronchopulmonary Dysplasia","Other: Noninvasive neurally adjusted ventilatory assist (NIV NAVA)|Other: Nasal intermittent positive pressure ventilation (NIPPV)","All","up to 12 Months   (Child)","Not Applicable","15","June 2018","Arkansas Children's Hospital, Little Rock, Arkansas, United States","https://ClinicalTrials.gov/show/NCT02788110"
164,"Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury","Completed","No Results Available","Acute Lung Injury|Acute Respiratory Distress Syndrome","Procedure: Placement of an esophageal balloon measurements|Other: Low tidal volume ventilation|Other: Transpulmonary pressure-directed ventilation (EPVent)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","63","May 2010","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00127491"
165,"IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)","Terminated","No Results Available","COVID-19","Drug: PF-06650833|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","7","October 6, 2021","Yale New Haven Hospital, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04575610"
166,"Timing and Intensity of the Exposures and Attributable Burden of Acute Lung Injury","Completed","No Results Available","Acute Lung Injury|Acute Respiratory Distress Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"6600","December 2020","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00980915"
167,"Weaning From Mechanical Ventilation Using Permissive Hypercarbia","Terminated","No Results Available","Respiration, Artificial|Respiratory Distress Syndrome, Adult","Procedure: Permissive hypercarbia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","3","June 14, 2007","Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00357929"
168,"PAL to Improve Oral Feeding for Infants With Chronic Lung Disease","Recruiting","No Results Available","Chronic Lung Disease of Prematurity|Respiratory Distress Syndrome in Premature Infant|Bronchopulmonary Dysplasia|Preterm Birth","Device: Pacifier Activated Lullaby ®","All","1 Day to 33 Weeks   (Child)","Not Applicable","60","December 31, 2023","University of Missouri Healthcare, Columbia, Missouri, United States","https://ClinicalTrials.gov/show/NCT05446389"
169,"Macrophage Programing in Acute Lung Injury: MiniBAL","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Ventilator Associated Pneumonia","Other: Non-Bronchoscopic Mini Bronchoalveolar Lavage","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","56","December 30, 2023","Intermountain Health - St. Joseph's Hospital - National Jewish Health, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT05767671"
170,"Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation","Completed","Has Results","Respiratory Distress Syndrome in Premature Infants|Very Low Birth Weight Baby","Drug: iNO|Other: Nitrogen","All","1 Minute to 2 Minutes   (Child)","Not Applicable","33","May 1, 2017","University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|University of Oklahoma, Childrens Hospital, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01220687"
171,"Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome","Completed","No Results Available","Respiratory Distress Syndrome, Adult",,"All","18 Years and older   (Adult, Older Adult)",,"520","October 2012","University of Maryland Medical Center, Baltimore, Maryland, United States|Veterans Affairs Hospital, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Bayview Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00300248"
172,"Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)","Withdrawn","No Results Available","Acute Lung Injury|Adult Respiratory Distress Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"0","March 2016","Boston Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01083355"
173,"Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)","Completed","No Results Available","Respiratory Distress Syndrome in Premature Infant|Bronchopulmonary Dysplasia","Drug: recombinant human CC10 (rhCC10)|Drug: placebo","All","24 Weeks to 29 Weeks   (Child)","Phase 1|Phase 2","22","December 2003","Christiana HealthCare Systems, Wilmington, Delaware, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola, New York, United States","https://ClinicalTrials.gov/show/NCT01473264"
174,"CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure","Unknown status","No Results Available","Prematurity|Respiratory Distress Syndrome|Apnea of Prematurity","Other: continuous positive airway pressure|Other: nasal intermittent positive pressure ventilation","All","up to 6 Months   (Child)","Not Applicable","80","June 30, 2022","Women and Infants Hospital of Rhode Island, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT03670732"
175,"Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function","Recruiting","No Results Available","Neonatal|Premature Birth|Respiratory Distress Syndrome","Other: Additional 2 weeks of CPAP","All","1 Day to 12 Weeks   (Child)","Phase 2|Phase 3","130","December 31, 2023","Doernbecher Neonatal Care Center at Oregon Health & Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04295564"
176,"IC14 Antibodies to Treat Individuals With Acute Lung Injury","Terminated","No Results Available","Respiratory Distress Syndrome, Adult|Lung Diseases","Drug: IC14","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","13","June 2007","University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00233207"
177,"PECO Air Purification in Hospital Rooms to Improve Health Outcomes for Pediatric Respiratory Distress","Completed","No Results Available","Asthma|Pneumonia|Respiratory Distress Syndrome","Device: Photo Electrochemical Oxidation (PECO) for Air Purification","All","1 Year to 17 Years   (Child)","Not Applicable","274","December 31, 2018","Mercyhealth Hospital - Rockton Avenue, Rockford, Illinois, United States","https://ClinicalTrials.gov/show/NCT03647397"
178,"Antenatal Betamethasone Compared to Dexamethasone - ""BETACODE TRIAL""","Completed","No Results Available","Respiratory Distress Syndrome|Intraventricular Hemorrhage|Neonatal Mortality","Drug: Betamethasone(Celestone soluspan) and Dexamethasone","Female","18 Years to 45 Years   (Adult)","Not Applicable",,"April 2005","Stony Brook University Hospital, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00418353"
179,"Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Drug: agenT-797","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","20","June 2, 2022","Saint John's Cancer Institute, Santa Monica, California, United States|Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, United States|Weill Cornell Medicine New York Presbyterian, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04582201"
180,"Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room","Recruiting","No Results Available","Prematurity|BPD - Bronchopulmonary Dysplasia|Respiratory Distress Syndrome, Newborn","Device: Volume Targeted Ventilation (VTV) using the Philips Respironics NM3 monitor|Device: Tidal Volume Measurement using the Philips Respironics NM3 monitor","All","5 Minutes to 60 Minutes   (Child)","Not Applicable","40","December 31, 2023","Baystate Medical Center, Springfield, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03938532"
181,"Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support","Withdrawn","No Results Available","Respiratory Distress Syndrome|Prematurity","Device: Nasal CPAP|Device: Oscillatory NCPAP","All","up to 28 Days   (Child)","Not Applicable","0","April 2017","Valley Children's Healthcare, Madera, California, United States|Primary Children's Medical Center, Salt Lake City, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01277874"
182,"Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study","Completed","Has Results","Infant Respiratory Distress Syndrome|Respiratory Insufficiency|Apnea of Prematurity","Other: Nasal high frequency ventilation","All","7 Days to 3 Months   (Child)","Phase 1","14","February 2008","Children's Hospital of Iowa NICU, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT00296231"
183,"Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)","Terminated","Has Results","COVID-19","Drug: Prazosin|Other: Standard of care","All","45 Years to 85 Years   (Adult, Older Adult)","Phase 2","5","March 31, 2022","Johns Hopkins Hospital, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04365257"
184,"Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Acute Lung Injury|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Traumatic Brain Injury","Device: nVNS|Other: SOC","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","46","December 2025","AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04935697"
185,"REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia","Completed","No Results Available","COVID19|ARDS","Biological: CK0802|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1","45","October 22, 2021","Johns Hopkins Hospital, Baltimore, Maryland, United States|Columbia University, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Baylor College of Medicine, St Luke's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04468971"
186,"Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Drug: BIO-11006|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","38","June 15, 2020","University of Chicago Medicine, Chicago, Illinois, United States|University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Vanderbilt University, Div of Allergy, Pulmonary, Critical Care, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT03202394"
187,"Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS","Active, not recruiting","No Results Available","ARDS|Respiratory Failure|Lung Ultrasound","Diagnostic Test: Estimation of hospital-wide incidence of ARDS","All","18 Years and older   (Adult, Older Adult)",,"9999","October 15, 2023","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University Health Network, Toronto, Ontario, Canada|AOU Citta' della Salute e Della Scienza - Molinette, Torino, Italy|Ospedale San Giovanni Bosco, Torino, Italy","https://ClinicalTrials.gov/show/NCT03546699"
188,"Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)","Terminated","Has Results","Lung Injury, Acute (ALI)|Respiratory Distress Syndrome, Acute (ARDS)","Drug: 5% human albumin|Drug: 6% hetastarch","All","18 Years and older   (Adult, Older Adult)","Phase 3","31","November 2016","Grady Memorial Hospital, Atlanta, Georgia, United States|Emory Crawford Long Hospital, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00796419"
189,"Treatment of ARDS With Instilled T3","Recruiting","No Results Available","ARDS, Human|Lung, Wet|Thyroid|Pulmonary Edema|Lung Inflammation","Drug: Liothyronine Sodium (T3) (modified formulation)","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","68","October 10, 2023","Essentia Health - St. Mary's Medical Center, Duluth, Minnesota, United States|M Health Fairview Southdale Hospital, Edina, Minnesota, United States|East Bank Hospital - M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|M Health Fairview St. Joseph's Hospital, Saint Paul, Minnesota, United States|M Health Fairview Bethesda Hospital, Saint Paul, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04115514"
190,"Observational Cohort Study of Distribution of Ventilation in Pediatrics Requiring Mechanical Ventilation by Electrical Impedance Tomography","Completed","No Results Available","Respiratory Failure|Acute Respiratory Distress Syndrome|Acute Lung Injury",,"All","1 Day to 17 Years   (Child)",,"11","November 4, 2018","Boston Children's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02247700"
191,"Forced Oscillometry in Infants With Bronchopulmonary Dysplasia","Recruiting","No Results Available","Infant, Premature, Diseases|Bronchopulmonary Dysplasia|Respiratory Distress Syndrome","Device: Non-invasive forced airway oscillometry","All","Child, Adult, Older Adult",,"70","December 2024","Children's Mercy Hospital, Kansas City, Missouri, United States","https://ClinicalTrials.gov/show/NCT04270045"
192,"LIPS-B: Lung Injury Prevention Study With Budesonide and Beta","Completed","Has Results","Acute Respiratory Distress Syndrome (ARDS)","Drug: Budesonide|Drug: Placebo|Drug: Formoterol","All","18 Years and older   (Adult, Older Adult)","Phase 2","61","December 2015","University of Arizona, Tucson, Arizona, United States|Stanford University, Stanford, California, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Beth Israel Medical Center, Boston, Massachusetts, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01783821"
193,"The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU","Enrolling by invitation","No Results Available","Acute Respiratory Distress Syndrome|Acute Hypoxemic Respiratory Failure|Acute Hypercapnic Respiratory Failure","Other: Toning|Other: Ocean drum & SOK melody|Other: SOK|Behavioral: Process|Other: Holding Harmonic Container","All","18 Years and older   (Adult, Older Adult)","Not Applicable","178","September 2024","Mount Sinai West, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03642002"
194,"Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care","Terminated","No Results Available","Respiratory Distress Syndrome|Hyperoxia|Prematurity",,"All","up to 3 Months   (Child)",,"20","March 2013","Primary Children's Medical Center, Salt Lake City, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00887731"
195,"A Study Promoting Critical Illness Recovery in the Elderly","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Critical Illness|Critical Care","Device: cycle ergometry","All","55 Years and older   (Adult, Older Adult)","Not Applicable","42","August 2023","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02963558"
196,"Telehealth-Enhanced Patient-Oriented Recovery Trajectory After ICU","Completed","No Results Available","Critical Illness|Acute Respiratory Distress Syndrome|Septic Shock","Other: Telehealth","All","18 Years and older   (Adult, Older Adult)","Not Applicable","91","February 28, 2023","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT03926533"
197,"Lung Injury Prediction Study","Completed","No Results Available","Respiratory Distress|Acute Lung Injury",,"All","18 Years and older   (Adult, Older Adult)",,"300","February 2010","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00889772"
198,"Neotech RAM Cannula Versus Conventional Binasal Prong Continuous Positive Airway Pressure (CPAP) to Treat Respiratory Distress in Low Birth Weight Neonates","Terminated","No Results Available","Respiratory Distress Syndrome, Newborn|Continuous Positive Airway Pressure|Low Birth Weight Infants","Device: RAM Cannula|Device: Binasal Prong CPAP","All","Child, Adult, Older Adult","Not Applicable","8","February 2017","Children's Hospitals and Clinics of Minnesota, Saint Paul, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02168257"
199,"hCT-MSCs for COVID19 ARDS","Terminated","Has Results","COVID|Corona Virus Infection|COVID19","Biological: Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","12","February 16, 2022","Boca Raton Regional Hospital, Boca Raton, Florida, United States|Jackson Memorial Hospital, Miami, Florida, United States|University of Miami Hospital, Miami, Florida, United States|New York Medical College, Valhalla, New York, United States|Duke Hospital, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04399889"
200,"Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Procedure: High Frequency Oscillatory Ventilation-Hi|Procedure: High Frequency Oscillatory Ventilation-Lo","All","18 Years and older   (Adult, Older Adult)","Phase 2","100","June 2009","Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Ohio State University Medical Center, Columbus, Ohio, United States|Wilford Hall Medical Center, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00399581"
201,"Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19","Completed","No Results Available","COVID-19|ARDS|Withdrawal Syndrome|Iatrogenic Disease",,"All","18 Years to 90 Years   (Adult, Older Adult)",,"353","December 31, 2022","Wilkes University, Wilkes-Barre, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT05336656"
202,"Airway Pressure Release Ventilation in Acute Lung Injury","Terminated","Has Results","Acute Lung Injury|Acute Respiratory Distress Syndrome|Mechanical Ventilation","Device: APRV|Device: Conventional MV","All","18 Years and older   (Adult, Older Adult)","Not Applicable","2","October 15, 2008","Johns Hopkins Hospital Medical Intensive Care Unit, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00750204"
203,"Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS","Completed","Has Results","COVID-19|ARDS","Biological: ExoFlo|Other: Intravenous normal saline","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 2","102","May 22, 2021","Helen Keller Hospital, Sheffield, Alabama, United States|St. Joseph Heritage Healthcare, Anaheim, California, United States|Donald Guthrie Foundation/ Robert Packer Hospital, Sayre, Pennsylvania, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|Covenant Health System, Lubbock, Texas, United States|PRX Research, Mesquite, Texas, United States","https://ClinicalTrials.gov/show/NCT04493242"
204,"Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants","Recruiting","No Results Available","Premature Lungs|Respiratory Distress Syndrome|Surfactant Deficiency Syndrome Neonatal","Procedure: Less Invasive Surfactant Administration LISA|Procedure: Continuous Positive Airway Pressure CPAP","All","24 Weeks to 29 Weeks   (Child)","Not Applicable","180","June 2025","University of California, Irvine, Irvine, California, United States|Loma Linda Medical Center, Loma Linda, California, United States|Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT04209946"
205,"Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress","Completed","No Results Available","Respiratory Distress Syndrome, Newborn","Other: Extubation to Nasal IPPV","All","10 Minutes to 120 Minutes   (Child)","Phase 4","110","January 2009","Women's and Children's Hospital, Room l-919, 1240, N.Mission Road, Los Angeles, California, United States|Sharp Mary Birch Hospital for Women, San Diego, California, United States|Medical College of Georgia, Augusta, Georgia, United States|Children's Hospital, OUMC, Oklahoma, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT00486850"
206,"MICU Recovery Clinic","Recruiting","No Results Available","Critical Illness|Sepsis|Respiratory Failure|ARDS","Other: Questionnaires, Physical and Cognitive Function","All","Child, Adult, Older Adult",,"250","June 2024","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02560129"
207,"Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite","Withdrawn","No Results Available","COVID-19|Acute Respiratory Distress Syndrome|Acute Respiratory Failure","Drug: Sodium Nitrite|Drug: Normal Saline","All","18 Years and older   (Adult, Older Adult)","Phase 2","0","August 15, 2020","Participating Research Facility, Tampa, Florida, United States|Participating Research Facility, Fort Worth, Texas, United States","https://ClinicalTrials.gov/show/NCT04401527"
208,"COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111","Completed","Has Results","Respiratory Distress Syndrome, Adult","Drug: Veru-111","All","18 Years and older   (Adult, Older Adult)","Phase 2","39","August 13, 2021","HonorHealth, Scottsdale, Arizona, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Inspira Medical Center, Vineland, New Jersey, United States|Memorial Hermann Memorial City Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04388826"
209,"Airway Inflammatory Response During Illness in Children With Respiratory Failure","Withdrawn","No Results Available","Acute Respiratory Failure|Acute Respiratory Infection|Acute Respiratory Distress Syndrome",,"All","up to 17 Years   (Child)",,"0","August 2019","University of North Carolina Hospital at Chapel Hill, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02047877"
210,"Seattle-PAP Bubble Nasal CPAP and Work of Breathing","Completed","No Results Available","Respiratory Distress Syndrome In Premature Infants|Bronchopulmonary Dysplasia|Newborn Primary Sleep Apnea","Device: Seattle-PAP","All","6 Hours to 72 Hours   (Child)","Phase 1","40","October 2015","Texas Children's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02210026"
211,"SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.","Terminated","Has Results","Respiratory Distress Syndrome, Newborn|Premature Birth|Bronchopulmonary Dysplasia","Drug: Lucinactant 175 mg/kg|Drug: Lucinactant 90 mg/kg|Drug: Placebo","All","3 Days to 10 Days   (Child)","Phase 2","136","July 2006","Discovery Laboratories, Inc., Warrington, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00215540"
212,"Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials","Completed","No Results Available","Respiratory Distress Syndrome, Adult",,"All","18 Years and older   (Adult, Older Adult)",,"922","October 2014","University of Maryland Medical Center, Baltimore, Maryland, United States|Johns Hopkins University, Baltimore, Maryland, United States|Wake Forest University, Winston Salem, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|University of Washington/Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00719446"
213,"Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection","Unknown status","No Results Available","Respiratory Failure|Ventilatory Failure|COVID-19|Pneumonia|ARDS, Human","Device: AirGo Respiratory Monitor","All","18 Years and older   (Adult, Older Adult)",,"500","December 31, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04356443"
214,"Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|ARDS","Biological: ExoFlo|Other: Intravenous normal saline","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 3","320","August 3, 2024","Dignity Health, Chandler, Arizona, United States|Providence St. Jude Medical Center, Fullerton, California, United States|UC Irvine, Orange, California, United States|UC Davis Health, Sacramento, California, United States|JD Medical Group, LLC, Miami, Florida, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Guthrie Medical Group, PC, Sayre, Pennsylvania, United States|PRX Research, Mesquite, Texas, United States","https://ClinicalTrials.gov/show/NCT05354141"
215,"Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant","Completed","Has Results","Lung Injury, Acute|Respiratory Distress Syndrome, Adult|Bronchiolitis Obliterans","Drug: Etanercept","All","6 Years and older   (Child, Adult, Older Adult)","Phase 2","34","February 2009","The University of Michigan Cancer Center, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT00141726"
216,"Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation","Completed","No Results Available","Respiratory Distress Syndrome, Adult|Bronchiolitis Obliterans|Pneumonia","Drug: etanercept","All","12 Months and older   (Child, Adult, Older Adult)","Phase 1|Phase 2","15","September 2003","University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT00029328"
217,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19","Terminated","Has Results","Acute Respiratory Distress Syndrome|SARS-CoV-2","Drug: PLN-74809|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","6","August 2, 2021","Valleywise Health Medical Center, Phoenix, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|National Jewish Health, Denver, Colorado, United States|Advent Health, Orlando, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Atlantic Health System, Summit, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04565249"
218,"Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19","Active, not recruiting","No Results Available","Coronavirus Infections|Pneumonia, Viral|Acute Respiratory Distress Syndrome","Drug: Nitric Oxide","All","18 Years and older   (Adult, Older Adult)","Phase 2","70","April 2025","Providence HealthCare Network, Anchorage, Alaska, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04305457"
219,"Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)","Completed","Has Results","Respiratory Distress Syndrome, Adult","Biological: Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells|Biological: Plasma-Lyte A","All","18 Years and older   (Adult, Older Adult)","Phase 2","60","February 9, 2018","University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Minnesota Medical Center, Saint Paul, Minnesota, United States|Ohio State University, Columbus, Ohio, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02097641"
220,"Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients","Unknown status","No Results Available","Respiratory Distress Syndrome, Adult|Respiratory Syncytial Virus Infections|Pneumonia|Acute Lung Injury",,"All","1 Hour and older   (Child, Adult, Older Adult)",,"120","January 2009","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00429637"
221,"Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Sepsis","Drug: Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%)|Other: Inhaled Medical air","All","18 Years and older   (Adult, Older Adult)","Phase 1","36","September 2025","Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Washington University, Saint Louis, Missouri, United States|New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|Weill Cornell Medical College, New York, New York, United States|Duke University Hospital, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04870125"
222,"Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure","Completed","Has Results","Acute Respiratory Distress Syndrome|Shock|Ventilatory Failure|Cardiogenic Pulmonary Edema","Device: Non invasive ventilation using a helmet hyperbaric device|Other: Noninvasive ventilation via facemask","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","83","May 2016","University of Chicago Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01680783"
223,"The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial","Terminated","No Results Available","Acute Respiratory Distress Syndrome (ARDS)","Device: SensorMedics 3100B High Frequency Oscillatory Ventilator|Procedure: Lung Protective Ventilation","All","16 Years to 85 Years   (Child, Adult, Older Adult)","Phase 3","548","September 2012","Denver Health Medical Centre, Denver, Colorado, United States|Orlando Regional Medical Centre, Orlando, Florida, United States|University of Michigan, Ann Arbor, Michigan, United States|Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States|Hospital of the University ofPennsylvania, Philadelphia, Pennsylvania, United States|Parkland Memorial Hospital, Dallas, Texas, United States|University of Texas HSC, Houston, Texas, United States|Texas A&M HSC College of Medicine, Scott & White Hospital, Temple, Texas, United States|Peter Lougheed Centre/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta Medical Centre, Edmonton, Alberta, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Vancouver Island Health Research Centre, Victoria, British Columbia, Canada|Health Sciences Centre, Winnipeg, Winnipeg, Manitoba, Canada|Royal Victoria Hospital, Barrie, Ontario, Canada|St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|University of Western Ontario - University Hospital, London, Ontario, Canada|University of Western Ontario - Victoria Hospital, London, Ontario, Canada|Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Ottawa Hospital-General Campus, Ottawa, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|St Josephs, Toronto, Ontario, Canada|St Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|William Osler Health Centre, Toronto, Ontario, Canada|Maisonneuve Rosemont, Montreal, Quebec, Canada|Centre Hosptialier de liUniersite de Montreal - CHUM- Saint Luc, Montreal, Quebec, Canada|Patrick Bellemare, Montreal, Quebec, Canada|Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada|Hopital de l'Enfant-Jesus, Quebec, Canada|Clinica Las Lilas, Santiago, Chile|Pontificia Universidad Catolica de Chile, Santiago, Chile|Deenanath Mangeshkar Hospital & Research Centre, Pune, India|King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia|King Fahad National Guard Hospital, Riyadh, Saudi Arabia|Riyadh Armed Forces, Riyadh, Saudi Arabia","https://ClinicalTrials.gov/show/NCT01506401"
224,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)","Terminated","No Results Available","Severe to Critical COVID 19 With Associated ARDS","Drug: FP-025 100 mg|Drug: FP-025 300 mg|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","90","April 18, 2022","Velocity Chula Vista, Chula Vista, California, United States|Velocity San Diego, La Mesa, California, United States|Shady Grove Medical Center, Rockville, Maryland, United States|University of Nevada, Las Vegas (UNLV) School of Medicine, Las Vegas, Nevada, United States|Trinity Health Center, Minto, North Dakota, United States|Legacy Health, Portland, Oregon, United States|Houston Methodist, Houston, Texas, United States|United Medical Memorial Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04750278"
225,"Epidemiology of Surfactant Protein-B Deficiency","Recruiting","No Results Available","Lung Diseases|Respiratory Distress Syndrome, Newborn|Pulmonary Surfactant|Lung Diseases, Interstitial",,"All","up to 1 Year   (Child)",,"7000","June 30, 2024","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00014859"
226,"Trial of Therapeutic Hypothermia in Patients With ARDS","Recruiting","No Results Available","Respiratory Distress Syndrome, Adult","Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of care","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","340","June 30, 2024","Emory University, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Loyola University Chicago, Chicago, Illinois, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Cooper Health System, Camden, New Jersey, United States|Cleveland Clinc, Cleveland, Ohio, United States|University of Pennsylavia, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Intermountain Healthcare (Utah), Salt Lake City, Utah, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04545424"
227,"CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial","Completed","No Results Available","Infant, Newborn, Disease|Hypoxia|Respiratory Distress Syndrome|Bronchopulmonary Dysplasia","Procedure: Continuous positive airway pressure|Procedure: Nasal Cannula","All","Child, Adult, Older Adult","Not Applicable","38","March 29, 2023","UAB Hospital, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT04792099"
228,"Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients","Unknown status","No Results Available","Acute Respiratory Failure|Covid19","Device: Life2000® Ventilator","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","October 2020","Park Nicolette, Bloomington, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04581161"
229,"Add-on Reparixin in Adult Patients With ARDS","Recruiting","No Results Available","Acute Respiratory Distress Syndrome, Adult","Drug: Reparixin 600mg|Other: Matching Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","66","September 2023","The University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States|Banner - University Medical Center Phoenix, Phoenix, Arizona, United States|University of Southern California, Los Angeles, California, United States|University of California Irvine Health, Orange, California, United States|Unversity of California Davis Medical Center, Sacramento, California, United States|Denver Health, Denver, Colorado, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|Methodist Hospitals of Northwest Indiana, Merrillville, Indiana, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Baystate Health, Springfield, Massachusetts, United States|University of Michigan Hospital, Ann Arbor, Michigan, United States|Detroit Medical Center, Detroit, Michigan, United States|MyMichigan Medical Center Midland, Midland, Michigan, United States|New York University Langone Health, New York, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|University of Oklahoma Medical Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|University of Tennessee Medical Center, Knoxville, Tennessee, United States|Baptist Hospitals of Southeast Texas, Beaumont, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Marshfield Medical Center, Horicon, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Universitaetsklinikum Heidelberg, Heidelberg, Baden Wuerttemberg, Germany|Universitaetsmedizin Goettingen, Göttingen, Niedersachsen, Germany|Herzzentrum Muenster, Muenster, Nordrhein Westfalen, Germany|Universitaetsklinikum des Saarlandes, Homburg, Saarland, Germany|Berufsgenossenschaftliche Kliniken Bergmannstrost, Halle, Sachsen Anhalt, Germany|Universitaetsklinikum Leipzig, Leipzig, Sachsen, Germany|University Hospital of Schleswig-Holstein, Kiel, Schleswig Holstein, Germany|Ospedale San Raffaele, Milano, Lombardia, Italy","https://ClinicalTrials.gov/show/NCT05496868"
230,"Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study","Unknown status","No Results Available","Vascular Access Complication|Vascular Access Related Infection","Device: Arrow PICC with Chloragard Technology","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","September 2017","University of Kentucky Medical Center, Lexington, Kentucky, United States|Detroit Medical Center, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT03019302"
231,"Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)","Active, not recruiting","No Results Available","Acute Respiratory Distress Syndrome","Drug: Inhaled Carbon Monoxide at 200 ppm|Other: Inhaled Medical air","All","18 Years and older   (Adult, Older Adult)","Phase 2","32","December 2023","Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Washington University, Saint Louis, Missouri, United States|New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|Weill Cornell Medical College, New York, New York, United States|Duke Regional Hospital, Durham, North Carolina, United States|Duke University Hospital, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03799874"
232,"Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECMO","Not yet recruiting","No Results Available","ARDS","Device: Venovenous ECMO","All","18 Years and older   (Adult, Older Adult)","Not Applicable","72","December 2023","New York Presbyterian Hospital, New York, New York, United States|OHSU Hospital, Portland, Oregon, United States|University of Alberta Hospital, Edmonton, Alberta, Canada|London Health Sciences Centre, London, Ontario, Canada|University of Ottawa, Ottawa, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Unity Health, Toronto, Ontario, Canada|University Health Network - Toronto Western Hospital, Toronto, Ontario, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04832789"
233,"Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants","Active, not recruiting","No Results Available","Infant,Premature|Respiratory Failure|Respiratory Insufficiency|Respiratory Distress Syndrome in Premature Infant","Other: Nasal high-frequency jet ventilation (nHFJV)|Other: Nasal intermittent positive pressure ventilation (NIPPV)","All","up to 72 Hours   (Child)","Not Applicable","40","December 31, 2022","University of Utah, Salt Lake City, Utah, United States|Primary Children's Hospital, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03558737"
234,"Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure","Unknown status","No Results Available","Acute Respiratory Distress Syndrome|ARDS|Respiratory Distress Syndrome, Acute|Respiratory Insufficiency|Respiratory Distress Syndrome|Shock Lung|Severe Acute Respiratory Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"8000","December 2022","Colin Grissom, Murray, Utah, United States","https://ClinicalTrials.gov/show/NCT03225807"
235,"Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury","Completed","No Results Available","Respiratory Distress Syndrome, Adult",,"All","30 Days to 18 Years   (Child, Adult)",,"396","December 2016","Children's Hospital Central California, Fresno, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital & Research Center of Oakland, Oakland, California, United States|University of California, San Francisco, San Francisco, California, United States|American Family Children's Hospital, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00605527"
236,"SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS","Completed","Has Results","Lung Injury, Acute","Drug: SB-681323 Intravenous 3mg|Drug: SB-681323 Intravenous 7.5 mg|Drug: SB-681323 Intravenous 7.5mg|Drug: SB-681323 Intravenous 10mg|Other: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","77","February 9, 2013","GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Winston-Salem, North Carolina, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00996840"
237,"Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome","Recruiting","No Results Available","Acute Respiratory Distress Syndrome",,"All","44 Weeks to 17 Years   (Child)",,"500","December 2024","Arkansas Children's Hospital, Little Rock, Arkansas, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Variety Children's Hospital D/B/A Nicklaus Children's Hospital, Miami, Florida, United States|Children's Healthcare of Atlanta - Emory, Atlanta, Georgia, United States|Riley Children's at Indiana University Health, Indianapolis, Indiana, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Washington University, Saint Louis, Missouri, United States|Cooperman Barnabas Medical Center, Livingston, New Jersey, United States|Columbia University Medical Center, New York, New York, United States|Akron Children's Hospital, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Texas Children's Hospital / Baylor College of Medicine, Houston, Texas, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04113434"
238,"Severe ARDS: Generating Evidence","Completed","No Results Available","Acute Respiratory Distress Syndrome|Acute Respiratory Failure With Hypoxia|Acute Respiratory Failure",,"All","18 Years and older   (Adult, Older Adult)",,"2400","April 30, 2017","University of Arizona, Tucson, Arizona, United States|Los Angeles County + University of Southern California Medical Center, Los Angeles, California, United States|University of California, Los Angeles, Los Angeles, California, United States|Mayo Clinic, Jacksonville, Florida, United States|Emory University, Atlanta, Georgia, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Saint Agnes Hospital, Baltimore, Maryland, United States|Johns Hopkins University, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Saint Joseph Mercy Ann Arbor, Ypsilanti, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Montefiore Medical Center, Bronx, New York, United States|Northwell Health, Manhasset, New York, United States|Columbia University Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University Medical Center, Columbus, Ohio, United States|Oregan Health and Science University Hospital, Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03021824"
239,"Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection","Completed","Has Results","Severe Acute Respiratory Syndrome|Respiratory Failure|Acute Respiratory Distress Syndrome","Drug: Alteplase 50 MG [Activase]","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","50","September 30, 2021","Scripps Memorial Hospital La Jolla, La Jolla, California, United States|University of Colorado, Denver, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|National Jewish Health, Denver, Colorado, United States|St. Mary's Medical Center, West Palm Beach, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Long Island Jewish Medical Center, New York, New York, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|Ben Taub Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04357730"
240,"Feeding the Critically Ill During Phases of Altered Redox Status","Completed","No Results Available","Acute Respiratory Distress Syndrome|Oxidative Stress|Euthyroid Sick Syndromes|Systemic Inflammatory Response Syndrome","Other: Jevity 1.5","All","18 Years and older   (Adult, Older Adult)","Not Applicable","35","October 13, 2018","Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03085615"
241,"Zofin (Organicell Flow) for Patients With COVID-19","Active, not recruiting","No Results Available","Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome","Biological: Zofin|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","20","August 31, 2023","George C. Shapiro, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04384445"
242,"Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care","Completed","No Results Available","COPD|Congestive Heart Failure|Asthma|Respiratory Distress Syndrome, Adult|Pneumonia",,"All","18 Years and older   (Adult, Older Adult)",,"800","December 2009","Tufts Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00458926"
243,"Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)","Completed","No Results Available","Respiratory Distress Syndrome, Adult","Behavioral: Minimal (Trophic) Feeding|Behavioral: Full Feeding","All","13 Years and older   (Child, Adult, Older Adult)","Phase 3","1000","May 2011","University of San Francisco-Fresno Medical Center, Fresno, California, United States|University of California, Davis Medical Center, Sacramento, California, United States|University of California, San Francisco (UCSF)-Moffitt Hospital, San Francisco, California, United States|Centura St. Anthony Central Hospital, Denver, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|Washington Hospital Center, Washington DC, District of Columbia, United States|Baton Rouge General Hospital-Blue Bonnet, Baton Rouge, Louisiana, United States|Baton Rouge General Hospital-Midcity, Baton Rouge, Louisiana, United States|Earl K. Long Medical Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States|Medical Center of Louisiana, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Union Memorial Hospital, Baltimore, Maryland, United States|University of Maryland Shock Trauma Center, Baltimore, Maryland, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Rochester Methodist Hospital, Rochester, Minnesota, United States|St. Mary's Hospital, Mayo Clinic, Rochester, Minnesota, United States|Duke University Medical Center, Durham, North Carolina, United States|Durham Regional Medical Center, Durham, North Carolina, United States|Moses Cone Health System, Greensboro, North Carolina, United States|Wesley Long Community Hospital, Greensboro, North Carolina, United States|Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Virginia Medical Center, Charlottesville, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00883948"
244,"Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study","Completed","No Results Available","Influenza|Severe Acute Respiratory Distress Syndrome|Smallpox|Ebola|Unknown Respiratory Viruses","Drug: Poly-ICLC","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","57","December 16, 2009","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00646152"
245,"Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome","Active, not recruiting","No Results Available","Respiratory Distress Syndrome, Adult","Biological: Human Mesenchymal Stromal Cells|Biological: Cell Reconstitution Media","All","18 Years and older   (Adult, Older Adult)","Phase 2","120","July 1, 2024","University of California Davis Medical Center, Sacramento, California, United States|Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States|University of California San Francisco, San Francisco, California, United States|Oregon Health & Science University, Portland, Oregon, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Memorial Hermann Hospital - Texas Medical Center, Houston, Texas, United States|Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03818854"
246,"Sleep Intervention During Acute Lung Injury","Completed","No Results Available","Critical Illness|Sleep|Acute Lung Injury|Acute Respiratory Distress Syndrome","Drug: Dexmedetomidine|Drug: Midazolam and Fentanyl","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 4","90","January 2019","Southern Arizona VA Health Care System, Tucson, Arizona, United States|University Medical Center, Tucson, Arizona, United States","https://ClinicalTrials.gov/show/NCT01050699"
247,"Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19","Terminated","Has Results","COVID-19|Acute Respiratory Distress Syndrome|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections","Drug: Naltrexone|Drug: Ketamine|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","70","April 1, 2021","William Beaumont Hospital, Royal Oak, Michigan, United States","https://ClinicalTrials.gov/show/NCT04365985"
248,"Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)","Terminated","No Results Available","Respiratory Distress Syndrome, Adult","Behavioral: Minimal (Trophic) Feeding|Behavioral: Full Feeding|Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements|Dietary Supplement: Placebo","All","13 Years and older   (Child, Adult, Older Adult)","Phase 3","272","April 2009","University of San Francisco-Fresno Medical Center, Fresno, California, United States|University of California, Davis Medical Center, Sacramento, California, United States|UCSF-Moffitt Hospital, San Francisco, California, United States|UCSF-San Francisco General Hospital, San Francisco, California, United States|Centura St. Anthony Central Hospital, Denver, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|Washington Hospital Center, Washington DC, District of Columbia, United States|Baton Rouge General Hospital-Blue Bonnet, Baton Rouge, Louisiana, United States|Baton Rouge General Hospital-Midcity, Baton Rouge, Louisiana, United States|Earl K. Long Medical Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States|Medical Center of Louisiana, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|University of Maryland Shock Trauma Center, Baltimore, Maryland, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Rochester Methodist Hospital, Rochester, Minnesota, United States|St. Mary's Hospital, Mayo Clinic, Rochester, Minnesota, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Durham Regional Medical Center, Durham, North Carolina, United States|Moses Cone Health System, Greensboro, North Carolina, United States|Wesley Long Community Hospital, Greensboro, North Carolina, United States|Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Virginia Medical Center, Charlottesville, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00609180"
249,"A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)","Terminated","Has Results","Acute Respiratory Distress Syndrome|COVID-19","Drug: Brexanolone|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 3","29","July 1, 2021","Sage Investigational Site, Fresno, California, United States|Sage Investigational Site, Augusta, Georgia, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Burlington, Massachusetts, United States|Sage Investigational Site, Lansing, Michigan, United States|Sage Investigational Site, Las Vegas, Nevada, United States|Sage Investigational Site, Charlotte, North Carolina, United States|Sage Investigational Site, Richmond, Virginia, United States|Sage Investigational Site, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04537806"
250,"Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome","Completed","No Results Available","Acute Respiratory Distress Syndrome","Other: Sigh breaths","All","18 Years to 89 Years   (Adult, Older Adult)","Not Applicable","524","October 8, 2022","UCSF Fresno Community Regional Medical Center, Fresno, California, United States|University of Southern California (LA County), Los Angeles, California, United States|University of California Davis Medical Center, Sacramento, California, United States|UC San Diego Medical Center, San Diego, California, United States|Christiana Care Health System, Newark, Delaware, United States|University of Maryland Medical System Shock Trauma Center, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University Medical Center Brackenridge, Austin, Texas, United States|UT Southwestern (Parkland), Dallas, Texas, United States|University of Texas Medical School, Houston, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Medical College of Wisconsin, Wauwatosa, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02582957"
251,"Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury","Completed","No Results Available","Respiratory Distress Syndrome, Adult|Head Injuries, Closed|Shock|Shock, Traumatic","Drug: Hypertonic Saline-Dextran Solution|Drug: Lactated Ringer's Solution","All","18 Years and older   (Adult, Older Adult)","Not Applicable","209","March 2007","University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00113685"
252,"Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms","Active, not recruiting","No Results Available","COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)","Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies","All","18 Years and older   (Adult, Older Adult)","Not Applicable","21","December 1, 2023","AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|AHN West Penn Hospital, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04382391"
253,"A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)","Completed","Has Results","Respiratory Distress Syndrome, Newborn","Drug: CHF5633|Drug: Poractant alfa","All","1 Hour to 24 Hours   (Child)","Phase 2","123","May 24, 2018","University of South Alabama - USA Children's and Women's Hospital, Mobile, Alabama, United States|LAC + USC Medical Center, Keck School of Medicine, Los Angeles, California, United States|UC Irvine Medical Center, Orange, California, United States|Sharp Mary Birch Hospital, San Diego, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Plantation General Hospital (Sheridan Clinical Research, Inc.), Plantation, Florida, United States|Jatinder Bhatia, Augusta, Georgia, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|University of Louisville Research Foundation, Inc., Louisville, Kentucky, United States|Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts, United States|Baystate Children's Hospital / Baystate Medical Center, Springfield, Massachusetts, United States|Winthrop University Hospital, Mineola, New York, United States|Kings County Hospital Center, New York, New York, United States|Sergio G. Golombek, Valhalla, New York, United States|Martha Naylor, Greenville, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Krishnamurthy Sekar, Oklahoma City, Oklahoma, United States|Hahnemann University Hospital, Philadelphia, Pennsylvania, United States|Texas Tech University Health Sciences Center, El Paso, Texas, United States|MultiCare Institute for Research & Innovation, Tacoma, Washington, United States|West Virginia University, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT02452476"
254,"A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)","Terminated","No Results Available","Neonatal Respiratory Distress","Other: RAM Nasal Cannula","All","28 Weeks to 42 Weeks   (Child)","Not Applicable","14","July 8, 2021","Englewood Hospital and Medical Center, Englewood, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04096235"
255,"Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)","Recruiting","No Results Available","Covid 19",,"All","18 Years and older   (Adult, Older Adult)",,"400","October 19, 2023","Methodist Dallas Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT05595031"
256,"Oscillatory Versus Non-oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support","Withdrawn","No Results Available","Neonatal Respiratory Distress Related Conditions","Device: Regular Nasal CPAP using a conventional ventilator|Device: High Frequency Nasal CPAP","All","up to 4 Months   (Child)","Not Applicable","0","September 2026","UC Davis Health, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT03711565"
257,"A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19","Terminated","Has Results","Coronavirus|COVID|ARDS|Cytokine Storm|Cytokine Release Syndrome","Drug: SNDX-6352|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","1","July 13, 2020","HonorHealth, Scottsdale, Arizona, United States|Montefiore Medical Center, Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT04415073"
258,"Calfactant for Direct Acute Respiratory Distress Syndrome","Terminated","No Results Available","Respiratory Distress Syndrome, Adult","Drug: Calfactant|Drug: Room Air (placebo)","All","12 Years to 85 Years   (Child, Adult, Older Adult)","Phase 3","332","February 2011","University of Florida, Gainesville, Florida, United States|Florida Hospital and Florida Children's Hospital, Orlando, Florida, United States|Northwestern University-Chicago, Chicago, Illinois, United States|West Suburban Hospital Medical Center, Oak Park, Illinois, United States|Peoria Pulmonary Associates/OSF St. Francis Hospital, Peoria, Illinois, United States|Clarian Health, Inc/Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa, Iowa City, Iowa, United States|Creighton University, Omaha, Nebraska, United States|Omaha Children's Hospital, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Columbia Medical Center--Pediatrics, New York, New York, United States|The Oregon Clinic, Portland, Oregon, United States|Penn State University, Hershey, Pennsylvania, United States|Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, United States|Uthscsa/Stvah, San Antonio, Texas, United States|University of Virginia Health Science Center, Charlottesville, Virginia, United States|INOVA Fairfax Hospital, Fairfax, Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Royal Columbian Hospital, New Westminster, British Columbia, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Surrey Memorial Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Haemek Medical Center, Jerusalem, Israel|Rabin Medical Center, Jerusalem, Israel|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Auckland City Hospital, Auckland City, Auckland, New Zealand|Starship Children's Hospital, Auckland, New Zealand","https://ClinicalTrials.gov/show/NCT00682500"
259,"MSCs in COVID-19 ARDS","Terminated","No Results Available","Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID","Biological: Remestemcel-L|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 3","223","January 2, 2022","Dignity Health, Gilbert, Arizona, United States|University of Southern California, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|New York University Langone Health, New York, New York, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|WakeMed, Raleigh, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT04371393"
260,"Nebulised Heparin in Patients With Severe COVID-19","Recruiting","No Results Available","Covid19|Respiratory Failure","Drug: Nebulised unfractionated heparin (UFH)","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","300","June 2024","Frederick Health Hospital, Frederick, Maryland, United States","https://ClinicalTrials.gov/show/NCT04545541"
261,"Pre-hospital Ventilation Clinical Study","Enrolling by invitation","No Results Available","Altered Mental Status|Sepsis|Heart Failure|Hemorrhage|Respiratory Distress Syndrome, Adult|Cardiac Arrest","Device: 731 Series Ventilator","All","Child, Adult, Older Adult",,"500","June 30, 2024","East Baton Rouge EMS, Baton Rouge, Louisiana, United States","https://ClinicalTrials.gov/show/NCT05604430"
262,"Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection","Enrolling by invitation","No Results Available","Pulmonary Alveolar Proteinosis|COPD|Idiopathic Pulmonary Fibrosis|Viral Pneumonia|Coronavirus Infection|Interstitial Lung Disease","Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use","All","18 Years to 90 Years   (Adult, Older Adult)","Early Phase 1","10","January 31, 2024","Robert W. Alexander, MD, FICS, LLC, Stevensville, Montana, United States","https://ClinicalTrials.gov/show/NCT04326036"
263,"A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome","Completed","No Results Available","Acute Respiratory Distress Syndrome","Biological: MultiStem|Biological: Placebo","All","18 Years to 90 Years   (Adult, Older Adult)","Phase 1|Phase 2","36","July 2019","University Hospitals - Cleveland Medical Center, Cleveland, Ohio, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Queen Elizabeth Hospital, Birmingham, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|University College London Hospital, London, United Kingdom|St. Georges Hospital, London, United Kingdom|Manchester Royal Infirmary, Manchester, United Kingdom|Wythenshawe Hospital, Manchester, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom","https://ClinicalTrials.gov/show/NCT02611609"
264,"Implementation of Nudges to Promote Utilization of Low Tidal Volume Ventilation (INPUT) Study","Recruiting","No Results Available","ARDS|Critical Illness|Acute Respiratory Distress Syndrome|Acute Respiratory Failure","Behavioral: RT-targeted accountable justification|Behavioral: Default order set|Behavioral: physician-targeted accountable justification|Other: Standard of Care","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","15100","May 31, 2024","Princeton Medical Center, Plainsboro, New Jersey, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States|Pennsylvania Hospital, Philadelphia, Pennsylvania, United States|Chester County Hospital, West Chester, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04663802"
265,"INR-Triggered Transfusion In GI Bleeders From ER","Terminated","No Results Available","Respiratory Distress Syndrome, Adult|Gastrointestinal Hemorrhage|Liver Diseases|Transfusion Related Lung Injury","Other: Transfuse plasma to High INR target|Other: Transfuse plasma to Low INR target","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","50","August 2015","University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Hospitals, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT01461889"
266,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19","Unknown status","No Results Available","COVID-19|ARDS","Biological: SOC plus 15mg/kg EB05 IV|Other: SOC plus Placebo IV","All","18 Years and older   (Adult, Older Adult)","Phase 2","396","April 2021","UCSF Fresno, Fresno, California, United States|St. Jude Medical Center/ Providence, Fullerton, California, United States|St. Joseph Hospital, Orange - Providence, Orange, California, United States|University of Miami Hospital, Coral Gables, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Methodist Medical Center IL, Peoria, Illinois, United States|Norton Hospital, Louisville, Kentucky, United States|Norton Brownsboro Hospital, Louisville, Kentucky, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Providence Regional Medical Center - Everett, Everett, Washington, United States|UW Medicine Valley Medical Center, Renton, Washington, United States|West Virginia University Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States|Royal Alexandra Hospital, Edmonton, Alberta, Canada|Misericordia Community Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|University Hospital - LHSC, London, Ontario, Canada|Victoria Hospital - LHSC, London, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Hôpital Maisonneuve Rosemont, Montréal, Quebec, Canada|Hôpital Régional de Rimouski, Rimouski, Quebec, Canada|Clinica de las Americas, Medellín, Antioquia, Colombia|IPS de Universidad de Antioquia, Medellín, Antioquia, Colombia|FOSCAL, Bucaramanga, Santander, Colombia|Fund.Cardiovascular de Colombia-FCV, Bucaramanga, Santander, Colombia","https://ClinicalTrials.gov/show/NCT04401475"
267,"LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)","Completed","No Results Available","COVID|Severe Acute Respiratory Syndrome|Sars-CoV2|Acute Kidney Injury|Acute Respiratory Distress Syndrome","Drug: LSALT peptide|Drug: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","61","June 2, 2022","VA San Diego Healthcare System, San Diego, California, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|LSU Health Shreveport, Shreveport, Louisiana, United States|University of Calgary - Foothills Medical Centre, Calgary, Alberta, Canada|University of Calgary - Peter Lougheed Centre, Calgary, Alberta, Canada|Ankara City Hospital, Ankara, Turkey|Istanbul University Cerrahpasa, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT04402957"
268,"Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)","Terminated","No Results Available","Acute Respiratory Distress Syndrome","Drug: CUROSURF® (poractant alfa)","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","22","March 18, 2022","Henry Ford Health System, Detroit, Michigan, United States|Chiesi site # 14, Bologna, Italy|Chiesi site #13, Modena, Italy|UCLH and UCL 250 Euston Road, London, United Kingdom|Chiesi site #4, London, United Kingdom|Chiesi site # 12, Southampton, United Kingdom","https://ClinicalTrials.gov/show/NCT04502433"
269,"Biomarkers, Genomics, Physiology in Critically Ill and ECMO Patients","Active, not recruiting","No Results Available","Acute Respiratory Distress Syndrome|Cardiac Failure|Extracorporeal Membrane Oxygenation Complication|Respiratory Failure|Renal Failure|Critical Illness|Pulmonary Disease","Device: Ventilator","All","18 Years and older   (Adult, Older Adult)","Not Applicable","80","March 1, 2023","University of California San Diego Health, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT04669444"
270,"VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation","Completed","No Results Available","COVID-19","Drug: VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)","All","18 Years and older   (Adult, Older Adult)","Phase 2","11","June 29, 2021","Ohio State University, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT04452669"
271,"A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact","Recruiting","No Results Available","Respiratory Distress Syndrome in Premature Infant","Drug: AeroFact|Other: nCPAP","All","26 Weeks to 31 Weeks   (Child)","Phase 2","261","August 31, 2024","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Alta Bates Summit, Berkeley, California, United States|University of Colorado, Aurora, Colorado, United States|University of Florida Health, Jacksonville, Florida, United States|Wolfson Children's Hospital, Jacksonville, Florida, United States|South Miami Hospital, Miami, Florida, United States|Advent Health, Orlando, Florida, United States|Winnie Palmer Hospital, Orlando, Florida, United States|Northside Hospital Atlanta, Atlanta, Georgia, United States|University of Illinois, Chicago, Illinois, United States|Hospital of South Bend, South Bend, Indiana, United States|University of Kentucky, Louisville, Kentucky, United States|Barbara Bush Medical Center, Portland, Maine, United States|University of Maryland, Baltimore, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Children's and Women's (C & W) Mott Hospital, Ann Arbor, Michigan, United States|Children's Health Care d/b/a Children's Minnesota, Minneapolis, Minnesota, United States|University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi, Jackson, Mississippi, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Maimonides Hospital, Brooklyn, New York, United States|Mount Sinai Kravis Children's Hospital, New York, New York, United States|NY Presbyterian Morgan Stanley Children's Hospital-Columbia, New York, New York, United States|West Chester Medical Center-Maria Fareri Children's Hospital, Valhalla, New York, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Grant Hospital, Columbus, Ohio, United States|Texas Health-Methodist Harris, Fort Worth, Texas, United States|Women's Hospital of Texas, Houston, Texas, United States|Children's Hospital of San Antonio (CHofSA), San Antonio, Texas, United States|Methodist Children's Hospital, San Antonio, Texas, United States|North Central Baptist Hospital, San Antonio, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States|IWK Hospital, Halifax, Nova Scotia, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Mt. Sinai Hospital, Toronto, Ontario, Canada|CHU de Québec-Université Laval, Québec City, Quebec, Canada","https://ClinicalTrials.gov/show/NCT03969992"
272,"Tolerability and Efficacy of RJX in Patients With COVID-19","Active, not recruiting","No Results Available","COVID-19|Acute Respiratory Distress Syndrome|SARS-CoV-2|Hypoxemia","Drug: Rejuveinix (RJX) Active Comparator|Drug: Placebo Comparator","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","237","February 2023","Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|Memorial Hermann Southeast Hospital, Houston, Texas, United States|Christus Santa Rosa Hospital, New Braunfels, Texas, United States","https://ClinicalTrials.gov/show/NCT04708340"
273,"Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)","Terminated","Has Results","COVID-19","Drug: Placebo|Drug: Ruxolitinib","All","12 Years and older   (Child, Adult, Older Adult)","Phase 3","211","February 26, 2021","Honor Health Research Institute, Scottsdale, Arizona, United States|Sharp Memorial Hospital, San Diego, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|Teradan Clinical Trials, Brandon, Florida, United States|University of Florida, Gainesville, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|Northshore University Health System, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Indiana University Simon Cancer Center, Indianapolis, Indiana, United States|Indiana University Health Central Indiana Cancer Centers, Indianapolis, Indiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Johns Hopkins University, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Healthpartners Cancer Care Center - Regions Hospital, Saint Paul, Minnesota, United States|Mercy Research, Springfield, Missouri, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers Njms Clinical Research Unit, Newark, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|University of Rochester Medical Center, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|Kettering Cancer Care, Dayton, Ohio, United States|Jefferson University Hospitals, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|West Penn Hospital, Pittsburgh, Pennsylvania, United States|Allegheny Health Network, Wexford, Pennsylvania, United States|St David'S Medical Center, Austin, Texas, United States|University of Texas Health Science Center At Houston - McGovern Medical School, Houston, Texas, United States|University of Texas Health Science Cente, San Antonio, Texas, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States|Aurora Research Institute, Milwaukee, Wisconsin, United States|Sbih City Hospital 15, Saint Petersburg, Russian Federation","https://ClinicalTrials.gov/show/NCT04377620"
274,"Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)","Completed","No Results Available","Respiratory Distress Syndrome, Adult|Lung Diseases","Procedure: Low Tidal Volume Ventilation|Procedure: Positive End-Expiratory Pressure|Drug: Lysofylline|Drug: Methylprednisolone|Drug: Ketoconazole|Procedure: Fluid Management|Procedure: Pulmonary Artery Catheter","All","13 Years and older   (Child, Adult, Older Adult)","Phase 3",,"July 2004","University of California, San Francisco, California, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|University of Chicago, Chicago, Illinois, United States|Louisiana State University, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Mayo Foundation, Rochester, Minnesota, United States|Duke University, Durham, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas, San Antonio, Texas, United States|Latter Day Saints Hospital, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States|University of British Columbia, Vancouver, British Columbia, Canada","https://ClinicalTrials.gov/show/NCT00000579"
275,"The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age","Completed","Has Results","Respiratory Distress Syndrome","Drug: Lucinactant delivered via investigational delivery device|Drug: nCPAP","All","26 Weeks to 32 Weeks   (Child)","Phase 2","221","August 6, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States|Univ. of Arkansas Medical Center, Little Rock, Arkansas, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Children's Hospital of Orange County, Orange, California, United States|Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States|Christiana Care Health System, Newark, Delaware, United States|University of Miami Holtz Children's Hospital, Miami, Florida, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Albany Medical Center, Albany, New York, United States|Morgan Stanley Childrens Hospital of New York Presbyterian (CHONY), New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Brody School of Medicine at ECU, Greenville, North Carolina, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Case Western Reserve University (Rainbow Babies Hosp.), Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Women and Infants Hospital, Providence, Rhode Island, United States|Baylor University Medical Center, Dallas, Texas, United States|Cook Children's Hospital, Fort Worth, Texas, United States|Texas Health Harris Methodist Hospital, Fort Worth, Texas, United States|Foothills Medical Centre, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Montreal Children's Hospital, Montreal, Quebec, Canada|Sainte Justine Hospital, Montreal, Quebec, Canada|Hospital Dr Sotero Del Rio, Santiago, Region-MetropolitanadeSantiago, Chile|Hospital Clínico Regional de Concepción Dr Guillermo Grant Benavente, Concepción, Chile|Hospital San Jose, Santiago, Chile|Clinica Alamena de Santiago, Santiago, Chile|Hospital Santiago Oriente Dr Luis Tisné Brousse, Santiago, Chile|Hospital Clinico de la Pontificia Universidad Catolica de Chile, Santiago, Chile|Hospital San Juan de Dios, Santiago, Chile|Fundacion Hospitalaria San Vicente de Paul, Medellin, Antioquia, Colombia|Hospital General de Medellin, Medellin, Antioquia, Colombia|Fundacion Valle Del Lili, Cali, Valle Del Cauca, Colombia|Semmelweis Egyetem, Budapest, Hungary|Csolnoky Ferenc Korhaz, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Okato, Miskolc, Hungary|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Nyiregyhaza, Hungary|Cork University Hospital, Cork, Ireland|Mid-Western Regional Hospital Limerick, Limerick, Ireland|Erasmus Medical Center, Rotterdam, Netherlands|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw, Dolnoslaskie, Poland|S.U. nr2im. Dr. Jana Biziela Oddzial Kliniczny N. W. Z. Intensywna Terapia Noworodka wraz z Wgjazdowy m Zespolem N, Bydgoszcz, Kujawsko-pomorksie, Poland|Instytut Centrum Zdrowja Matki Polki Klinika Neonatologii, Lodz, Lodzkie, Poland|SP ZOZ Szpital Uniwersytecki w Krakowie, Oddzial Neonatologii, Krakow, Malopolskie, Poland|Szpital Kliniczny im. Ks, Anny Mazowieckiej Klinika Neonatologii, Warsaw, Mazowieckie, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, Pomorskie, Poland|Szpital Spegialistycszny nr 2 w Bytomia Oddzial Noworodkow Blok V, Bytom, Slaskie, Poland|Samodzielny Publiczny Specjalistczny Zaklad Opieki Zdrowotnej Zdroje, Szczecin, West Pomerania, Poland|Ginekologiczno-Polozniczy Szpital Klinicznym UM im. Karola Marcinkowskiego w Poznan i u Katedra Neonatologii, Poznan, Wielkopolskie, Poland","https://ClinicalTrials.gov/show/NCT02636868"
276,"A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19","Completed","Has Results","COVID|Covid-19|Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Ards|Acute Respiratory Distress Syndrome","Drug: APL-9|Other: Vehicle Control","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","72","February 13, 2021","University of California at San Francisco - Fresno, Fresno, California, United States|California Pacific Medical Center, San Francisco, California, United States|Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran Health Physicians, Fort Wayne, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Norton Audobon Hospital, Louisville, Kentucky, United States|Cambridge Medical Trials, Alexandria, Louisiana, United States|Ascension Providence Hospital, Southfield, Michigan, United States|Rutgers University - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|University at Buffalo, Buffalo, New York, United States|Columbia University, New York, New York, United States|Texas A&M College of Medicine - Scott and White, Temple, Texas, United States|Hospital Angelina Caron, Campina Grande Do Sul, Paraná, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Estadual Mario Covas, Santo André, Sao Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos LTDA EPP, São Bernardo Do Campo, Sao Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Sao Paulo, Brazil|Hospital Santa Marcelina, São Paulo, Sao Paulo, Brazil|UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - FMB/UNESP, Botucatu, São Paulo, Brazil","https://ClinicalTrials.gov/show/NCT04402060"
277,"A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration","Terminated","No Results Available","Respiratory Distress Syndrome, Newborn","Combination Product: LISA combination product (Curosurf+catheter CHF6440)|Drug: Curosurf through conventional administration (endotracheal tube)","All","30 Minutes to 24 Hours   (Child)","Phase 3","33","August 13, 2022","Chiesi Clinical Trial Site 84029, Little Rock, Arkansas, United States|Chiesi Clinical Trial Site 84001, Los Angeles, California, United States|Chiesi Clinical Trial Site 84002, Los Angeles, California, United States|Chiesi Clinical Trial Site 84013, Denver, Colorado, United States|Chiesi Clinical Trial Site 84026, New Britain, Connecticut, United States|Chiesi Clinical Trial Site 84003, Evanston, Illinois, United States|Chiesi Clinical Trial Site 84021, Peoria, Illinois, United States|Chiesi Clinical Trial Site 84023, Lexington, Kentucky, United States|Chiesi Clinical Trial Site 84028, Springfield, Massachusetts, United States|Chiesi Clinical Trial Site 84005, Worcester, Massachusetts, United States|Chiesi Clinical Trial Site 84008, Lansing, Michigan, United States|Chiesi Clinical Trial Site 84004, Saint Louis, Missouri, United States|Chiesi Clinical Trial Site 84012, Camden, New Jersey, United States|Chiesi Clinical Trial Site 84024, Manhasset, New York, United States|Chiesi Clinical Trial Site 84019, New Hyde Park, New York, United States|Chiesi Clinical Trial Site 84009, Valhalla, New York, United States|Chiesi Clinical Trial Site 84027, Greenville, North Carolina, United States|Chiesi Clinical Trial Site 84010, Wilmington, North Carolina, United States|Chiesi Clinical Trial Site 84025, Cincinnati, Ohio, United States|Chiesi Clinical Trial Site 84017, Oklahoma City, Oklahoma, United States|Chiesi Clinical Trial Site 84020, Hershey, Pennsylvania, United States|Chiesi Clinical Trial Site 84007, Nashville, Tennessee, United States|Chiesi Clinical Trial Site 84011, Lubbock, Texas, United States|Chiesi Clinical Trial Site 84006, Plano, Texas, United States|Chiesi Clinical Trial Site 84022, Temple, Texas, United States|Chiesi Clinical Trial Site 84015, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02772081"
278,"Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome","Completed","No Results Available","Sepsis|Acute Lung Injury|Acute Respiratory Distress Syndrome","Biological: TNX-832|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1","18","February 2008","University of Miami, Miami, Florida, United States|Beth Israel Deconess Medical Center, Boston, Massachusetts, United States|Washington University, St. Louis, Missouri, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Akron General Medical Center, Akron, Ohio, United States|Baylor School of Medicine, Houston, Texas, United States|Capital Health, Halifax, Nova Scotia, Canada","https://ClinicalTrials.gov/show/NCT01438853"
279,"Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform","Completed","No Results Available","Covid19|Influenza|Respiratory Tract Infections|Acute Respiratory Tract Infection|Acute Respiratory Distress Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"16000","December 8, 2021","Boston Children's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04663776"
280,"Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome","Completed","No Results Available","Sepsis|Acute Lung Injury|Acute Respiratory Distress Syndrome","Drug: ALT-836|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","150","January 2013","Los Angeles County and USC Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|Stanford University, Stanford, California, United States|Yale University, New Haven, Connecticut, United States|Northwestern University, Chicago, Illinois, United States|West Suburban Hospital Medical Center, Oak Park, Illinois, United States|Illinois Lung and Critical Care Institute, Peoria, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Kentucky Lung Clinic, Hazard, Kentucky, United States|University of Louisville-Division of Pulmonary and Critical Care, Louisville, Kentucky, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Saint Luke's Hospital, Kansas City, Missouri, United States|Saint Louis University, St. Louis, Missouri, United States|Mercy Hospital St. Louis, St. Louis, Missouri, United States|Mount Sinai Medical Center, New York City, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Carolinas Medical Center, Charlotte, North Carolina, United States|Piedmont Respiratory Research Foundation, Greensboro, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|University of Oklahoma, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT00879606"
281,"Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)","Recruiting","No Results Available","ARDS","Other: Respiratory Mechanics|Other: Standard Ventilation Strategy","All","18 Years and older   (Adult, Older Adult)","Not Applicable","740","November 2024","New York University Grossman School of Medicine, New York, New York, United States|Centro de Educación Médica e Investigaciones Clínicas Dr Norberto Quirno (CEMIC), Buenos Aires, Argentina|Complejo Médico Policía Federal Argentina Churruca Visca, Buenos Aires, Argentina|Hospital Británico de Buenos Aires, Buenos Aires, Argentina|Sanatorio Anchorena Recoleta, Buenos Aires, Argentina|Sanatorio Mater Dei, Buenos Aires, Argentina|Sanatorio Anchorena San Martín, San Martín, Argentina|St. Michael's Hospital, Toronto, Canada|Toronto General Hospital, Toronto, Canada|Toronto Western Hospital, Toronto, Canada|Pontificia Universidad Católica de Chile, Santiago de Chile, Chile|Centre hospitalier universitaire d'Angers, Angers, France|CH Victor Dupouy, Argenteuil, France|CH de Beauvais, Beauvais, France|CHU Bordeaux - Haut Leveque, Bordeaux, France|Hopital de la Cavale Blanche - CHRU Brest, Brest, France|CH de Cholet, Cholet, France|Hopital Intercommunal de Creteil, Creteil, France|CHU Grenoble-Alpes, Grenoble, France|Hopital Roger Salengro - CHU Lille, Lille, France|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Mulhouse, France|Hopital de l'Archet 1 - CHU de Nice, Nice, France|Hopital Europeen Georges-Pompidou, Paris, France|CHU de Poitiers - La Miletrie, Poitiers, France|CH Bretagne Atlantique Vannes-Auray, Vannes, France|HIA Robert Picque, Villenave-d'Ornon, France|Arcispedale Sant'Anna, Ferrara, Italy|University of Foggia, Foggia, Italy|Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy|L'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT03963622"
282,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19","Active, not recruiting","No Results Available","COVID|ARDS","Biological: PLX-PAD|Biological: Placebo","All","40 Years to 80 Years   (Adult, Older Adult)","Phase 2","66","February 2023","University of California Irvine, Irvine, California, United States|University of Southern California (USC) - Keck School of Medicine (KSOM), Los Angeles, California, United States|University Of California Davis,4860 Y Street, Sacramento, California, United States|Baptist Health Medical Center, Jacksonville, Florida, United States|Medical College of Georgia at Augusta University, Augusta, Georgia, United States|Sarah Cannon Research Institute, LLC (Mercer University School of Medicine), Macon, Georgia, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper Research Institute, Camden, New Jersey, United States|Holy Medical Center, Teaneck, New Jersey, United States|Montefiore Medical Center, New York, New York, United States|Maimonides Medical Center, New York, New York, United States|Mercy Medical Center, New York, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04389450"
283,"Plasma Adsorption in Patients With Confirmed COVID-19","Completed","No Results Available","Respiratory Failure|ARDS","Device: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","107","April 1, 2022","University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, United States|UNM Health Science Center, Albuquerque, New Mexico, United States|Providence Portland Medical Center, Portland, Oregon, United States|Reading Hospital, West Reading, Pennsylvania, United States|UT Southwestern/Clements Hospital, Dallas, Texas, United States|UTMB, Galveston, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT04358003"
284,"A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)","Completed","Has Results","Respiratory Distress Syndrome, Adult|Acute Lung Injury|Acute Respiratory Distress Syndrome","Drug: Fish oil (eicosapentaenoic acid and docosahexanoic acid)","All","18 Years and older   (Adult, Older Adult)","Phase 2","90","August 2009","St. Alphonsus Medical Center, Boise, Idaho, United States|Oregon Health Sciences University, Portland, Oregon, United States|University of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States|Harborview Medical Center, Seattle, Washington, United States|St. Michael's Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00351533"
285,"Post Acute Sequelae of COVID-19","Recruiting","No Results Available","Covid19|Sars-CoV-2 Infection|Dyspnea Caused by 2019-nCoV|COVID-19 Acute Respiratory Distress Syndrome|Pulmonary Fibrosis","Other: Cohort study","All","18 Years and older   (Adult, Older Adult)",,"500","May 2027","Vanderbilt_University MC, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04964115"
286,"Ventilation and Perfusion in the Respiratory System","Enrolling by invitation","No Results Available","Respiratory Failure|Respiratory Distress Syndrome, Adult|Critical Illness|Pulmonary Disease|Ventilator-Induced Lung Injury","Device: Electrical Impedance tomography|Other: Lung mechanics and gas exchange","All","18 Years and older   (Adult, Older Adult)",,"20","July 2024","University of California San Diego Health, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT05081895"
287,"Reevaluation Of Systemic Early Neuromuscular Blockade","Completed","Has Results","Acute Respiratory Distress Syndrome","Drug: Cisatracurium Besylate","All","18 Years and older   (Adult, Older Adult)","Phase 3","1008","April 4, 2019","UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University Hospital, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Indiana University Methodist Hospital, Indianapolis, Indiana, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center, Bronx, New York, United States|Mt. Sinai Hospital, New York, New York, United States|Wesley Long Hospital, Greensboro, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Summa Akron City Hospital, Akron, Ohio, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|University Hospital, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University or Virginia Health System, Charlottesville, Virginia, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Swedish Hospital Cherry Hill, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02509078"
288,"Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Viral or Bacterial Infections|Pneumonia|Pneumonia, Viral|Respiratory Infection|COVID-19 Acute Respiratory Distress Syndrome","Drug: AV-001 Injection|Drug: AV-001 Placebo Injection","All","18 Years and older   (Adult, Older Adult)","Phase 2","120","May 2023","University Medical Center of Southern Nevada, Las Vegas, Nevada, United States","https://ClinicalTrials.gov/show/NCT05123755"
289,"Losartan for Patients With COVID-19 Not Requiring Hospitalization","Completed","Has Results","Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection","Drug: Losartan|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","117","February 1, 2021","Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04311177"
290,"Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment","Completed","No Results Available","Acute Respiratory Failure|Encephalopathy|ARDS|Sepsis|Critical Illness","Device: Exersides","All","18 Years and older   (Adult, Older Adult)","Not Applicable","58","December 28, 2021","University of California San Diego, San Diego, California, United States|Johns Hopkins University, Baltimore, Maryland, United States|University of Vermont, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT04067622"
291,"Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection","Completed","Has Results","SARS-CoV Infection","Drug: Losartan","All","18 Years and older   (Adult, Older Adult)","Phase 4","31","June 13, 2020","Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT04340557"
292,"Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19","Terminated","No Results Available","2019 Novel Coronavirus Infection|COVID-19 Virus Infection|SARS Coronavirus 2 Infection|SARS-CoV-2 Infection|Respiratory Distress Syndrome, Adult|Adult Respiratory Distress Syndrome","Drug: USB002|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","21","May 10, 2022","The University of Arizona Health Sciences Center/ Banner Healthcare Systems Hospitals, Tucson, Arizona, United States","https://ClinicalTrials.gov/show/NCT04778059"
293,"Breethe Abiomed Recovery regisTry (BART)","Active, not recruiting","No Results Available","Cardiopulmonary Bypass|ARDS|Heart Failure","Device: Breethe Oxy-1 System","All","18 Years and older   (Adult, Older Adult)",,"1000","December 9, 2025","AdventHealth Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|University of Maryland, College Park, Maryland, United States|NYU School of Medicine, New York, New York, United States|UPenn Health System, Philadelphia, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05473130"
294,"Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates","Completed","Has Results","Respiratory Distress Syndrome","Device: Nasal continuous positive airway pressure (nCPAP)|Device: Laryngeal Mask Airway (LMA) to deliver surfactant|Drug: Surfactants, Pulmonary","All","up to 36 Hours   (Child)","Not Applicable","103","April 2015","Loma Linda University Medical Center, Loma Linda, California, United States|University of California- San Diego Medical Center, San Diego, California, United States|Maple Grove Hospital, Maple Grove, Minnesota, United States|University of Minnesota Children's Hospital, Minneapolis, Minnesota, United States|North Memorial Hospital, Robbinsdale, Minnesota, United States|St Paul Children's Hospital, St Paul, Minnesota, United States|University of Wisconsin- Madison, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01116921"
295,"Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients","Completed","No Results Available","Respiratory Distress Syndrome","Drug: Aerosolized Calfactant|Device: Solarys","All","1 Hour to 24 Hours   (Child)","Phase 3","477","July 31, 2018","USA Children's & Women's Hospital, Mobile, Alabama, United States|Banner - University Medical Center Phoenix, Phoenix, Arizona, United States|Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States|Baptist Hospital of Miami, Miami, Florida, United States|Adventist Healthcare System, Florida Hospital, Orlando, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|University of South Florida, Tampa general, Tampa, Florida, United States|Columbus Regional Hospital, Columbus, Georgia, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Kentucky Children's Hospital, University of Kentucky Medical Center, Lexington, Kentucky, United States|Children's Hospital and Clinics, Minneapolis, Minnesota, United States|Children's Hospital Minnesota, Saint Paul, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Sisters of Charity Hospital, Buffalo, New York, United States|Pitt County Memorial Hospital, Greenville, North Carolina, United States|The Medical University of South Carolina, Charleston, South Carolina, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|Vanderbilt university Medical Center, Nashville, Tennessee, United States|North central Baptist Hospital, San Antonio, Texas, United States|Timpanogos Regional Medical Center, Orem, Utah, United States|Utah Valley Hospital, Provo, Utah, United States|University of Virgina Medical Center, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT03058666"
296,"Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection","Recruiting","No Results Available","Prone Positioning|Covid19|Hypoxemic Respiratory Failure|ARDS|Non Invasive Ventilation|High Flow Nasal Cannulla","Other: Body position change","All","18 Years to 110 Years   (Adult, Older Adult)","Not Applicable","24","July 2023","Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04694638"
297,"EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures","Completed","No Results Available","Acute Respiratory Distress Syndrome","Other: Esophageal-pressure guided mechanical ventilation|Other: High PEEP mechanical ventilation","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","202","October 19, 2018","University of California at San Diego, La Jolla, California, United States|Stanford University Medical Center, Stanford, California, United States|Orlando Health, Orlando, Florida, United States|Shock-Trauma University of Maryland Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Massachusets Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Montefiore Medical Center, Bronx, New York, United States|Vancouver General Hospital, Vancouver, British Columbia, Canada|St Joseph's Healthcare, Hamilton, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Laval University, Quebec City, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01681225"
298,"Blood Volume Assessment in COVID-19 and Bacterial Sepsis","Recruiting","No Results Available","Covid19|Acute Respiratory Distress Syndrome|Bacterial Sepsis|Bacterial Infections","Device: BVA-100|Device: Transpulmonary Thermodilution (TPTD)|Device: Sublingual Microcirculation","All","18 Years to 95 Years   (Adult, Older Adult)",,"40","January 1, 2024","Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States|NYU Langone Health, New York, New York, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04517695"
299,"Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA","Terminated","Has Results","Respiratory Distress Syndrome","Combination Product: Lucinactant for inhalation|Device: nCPAP alone","All","26 Weeks to 28 Weeks   (Child)","Phase 2","48","August 11, 2017","Loma Linda University Medical Center, Loma Linda, California, United States|Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States|Christiana Care Health System, Newark, Delaware, United States|University of Miami, Miami, Florida, United States|University of Louisville, Louisville, Kentucky, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York, New York, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Women and Infants Hospital, Providence, Rhode Island, United States|Foothills Medical Centre, Calgary, Alberta, Canada|Royal Alexandria Hospital, Edmonton, Alberta, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Montreal Children's Hospital, Montreal, Quebec, Canada|Hospital Dr Sotero Del Rio, Santiago, Chile|Hospital San Juan de Dios, Santiago, Chile|S.U. nr2im. Dr. Jana Biziela Oddzial Kliniczny N. W. Z. Intensywna Terapia Noworodka wraz z Wgjazdowy m Zespolem N, Bydgoszcz, Kujawsko-pomorksie, Poland|Instytut Centrum Zdrowja Matki Polki Klinika Neonatologii, Lodz, Lodzkie, Poland|Szpital Kliniczny im. Ks, Anny Mazowieckiej Klinika Neonatologii, Warsaw, Mazowieckie, Poland|Ginekologiczno-Polozniczy Szpital Klinicznym UM im. Karola Marcinkowskiego w Poznan i u Katedra Neonatologii, Poznan, Wielkopolskie, Poland","https://ClinicalTrials.gov/show/NCT02528318"
300,"Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates","Completed","Has Results","Respiratory Distress Syndrome","Drug: Lucinactant for Inhalation|Device: nCPAP alone","All","29 Weeks to 34 Weeks   (Child)","Phase 2","80","November 2015","University of Alabama at Birmingham, Birmingham, Alabama, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States|Christiana Care Health System, Newark, Delaware, United States|University of Miami, Miami, Florida, United States|Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States|University of Louisville, Louisville, Kentucky, United States|Mid Atlantic Neonatology Associates, Morristown, New Jersey, United States|Duke University Medical Center, Durham, North Carolina, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02074059"
301,"External Nasal Dilator and Oxygen Therapy in Respiratory Failure","Completed","Has Results","Acute Respiratory Failure","Device: External nasal dilator (END)|Other: High flow nasal cannula (HFNC)","All","1 Day to 18 Years   (Child, Adult)","Not Applicable","55","June 15, 2016","LLUCH, Loma Linda, California, United States","https://ClinicalTrials.gov/show/NCT02662387"
302,"Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure","Completed","No Results Available","Acute Respiratory Failure","Other: Early ICU rehabilitation strategies|Other: Usual Care","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","August 2009","Wake Forest School of Medicine, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01707303"
303,"Activated Protein C to Treat Acute Lung Injuries","Terminated","No Results Available","Respiratory Distress Syndrome, Adult","Drug: Xigris","All","18 Years and older   (Adult, Older Adult)","Phase 2","90","February 2007","University of California San Francisco at Fresno, Fresno, California, United States|University of Southern California, Los Angeles, California, United States|San Francisco General Hospital, San Francisco, California, United States|University of California San Francisco, San Francisco, California, United States|Stanford University, Department of Pulmonary and Critical Care, Stanford, California, United States|Yale School of Medicine, Section of Pulmonary & Critical Care Medicine, New Haven, Connecticut, United States|Joseph M. Still Burn Center, Augusta, Georgia, United States|Bay State Medical Center, Springfield, Massachusetts, United States|Oregon Health Sciences University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT00112164"
304,"Variable Ventilation During Acute Respiratory Failure","Terminated","No Results Available","Acute Respiratory Failure","Device: variable ventilation|Other: Conventional ventilation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","7","December 23, 2016","Boston Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01083277"
305,"Standardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure","Completed","No Results Available","Acute Respiratory Failure","Other: Standardized Rehabilitation|Other: Usual Care","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","June 2015","Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00976833"
306,"The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)","Completed","No Results Available","COVID-19|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)","Drug: Lucinactant","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","20","March 16, 2022","University California San Diego - Jacobs Medical Center, La Jolla, California, United States|University of California San Diego - Medical Center, Hillcrest, San Diego, California, United States|Augusta University Health, Augusta, Georgia, United States|University of Kentucky, Lexington, Kentucky, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham and Womens, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|CEMIC - Centro de Educacion Medica e Investigaciones Clinicals, Buenos Aires, Argentina|Hospital Alemán, Buenos Aires, Argentina|Hospital Italiano, Buenos Aires, Argentina|Sanatorio Güemes, Buenos Aires, Argentina","https://ClinicalTrials.gov/show/NCT04389671"
307,"Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates","Unknown status","No Results Available","Respiratory Distress Syndrome In Premature Infants","Device: Babylog VN500 in HFOV Mode","All","23 Weeks to 30 Weeks   (Child)","Not Applicable","225","September 2020","Arkansas Children's Hospital, Little Rock, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States|St. Paul Children's Hospital, Saint Paul, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|North Central Baptist Hospital, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Health Science Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02445040"
308,"LIPS-A: Lung Injury Prevention Study With Aspirin","Completed","Has Results","Acute Respiratory Distress Syndrome","Drug: Aspirin|Drug: Lactose powder","All","18 Years and older   (Adult, Older Adult)","Phase 2","400","September 2015","Stanford Univeristy, Stanford, California, United States|Bridgeport Hospital, Bridgeport, Connecticut, United States|University of Florida, Gainsville, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|University of Illinois at Chicago, Chicago, Illinois, United States|University of Louisville Medical Center, Louisville, Kentucky, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Montefiore Medical Center, Bronx, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Medical Center, Winston Salem, North Carolina, United States|Temple University School of Medicine, Philadelphia, Pennsylvania, United States|Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01504867"
309,"PROSpect: Prone and Oscillation Pediatric Clinical Trial","Enrolling by invitation","No Results Available","Acute Respiratory Distress Syndrome in Children","Other: Either supine or prone positioning and either CMV or HFOV","All","2 Weeks to 20 Years   (Child, Adult)","Not Applicable","800","July 31, 2026","Children's of Alabama, Birmingham, Alabama, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Children's Hospital Orange County, Orange, California, United States|Stanford Children's Health, Palo Alto, California, United States|UCSF Benioff Children's, San Francisco, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Nemours Foundation, Wilmington, Delaware, United States|Holtz Children's Hospital, Miami, Florida, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Ann & Robert Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States|University of Iowa Stead Family Chlldren's Hospital, Iowa City, Iowa, United States|Norton Children's Hospital, Louisville, Kentucky, United States|University of Maryland Medical Center-Children's Hospital, Baltimore, Maryland, United States|Bloomberg Children's Center, Johns Hopkins University, Baltimore, Maryland, United States|CS Mott Children's Hospital, Ann Arbor, Michigan, United States|Children's Hospital and Medical Center, Omaha, Nebraska, United States|The Children's Hospital of Montefiore, Bronx, New York, United States|Cohen Children's Medical Center, Queens, New York, United States|Duke Children's Hospital, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital at Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|LeBonheur Children's Hospital, Memphis, Tennessee, United States|Medical City Dallas, Dallas, Texas, United States|Children's Health Dallas, Dallas, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Royal Children's Hospital, Melbourne, Victoria, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Children's Hospital at Westmead, Sydney, Australia|Sabara Hospital Infantil, Sao Paulo, Brazil|Alberta Children's Hospital, Calgary, Alberta, Canada|Centre Hospitalier Universitaire Sainte Justine, Montréal, Quebec, Canada|Guangzhou Women & Children's Hospital (Newtown), Guangzhou, Guangzhou, China|Guangzhou Women & Children's Hospital (Yuexiu), Guangzhou, China|Rainbow Children's Hospital, Hyderabad, India|Meyer Children's Hospital, Florence, Italy|Bambino Gesu Children's Hospital, Rome, Italy|University of Malaysia Medical Center, Kuala Lumpur, Malaysia|University Medical Center Groningen, Groningen, Netherlands|Starship Children's Hospital, Auckland, New Zealand|King Chulalongkorn Memorial Hospital, Bangkok, Thailand|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand|Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates|Birmingham Children's Hospital, Birmingham, UK, United Kingdom","https://ClinicalTrials.gov/show/NCT03896763"
310,"Open-Label Study of ARD-0403 in Testosterone Deficient Men","Completed","No Results Available","Hypogonadism","Drug: ARD-0403","Male","18 Years and older   (Adult, Older Adult)","Phase 3","150","February 2008","Medical Affiliated Research Center, Inc, Huntsville, Alabama, United States|Stanford University, Stanford, California, United States|Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, United States|Northwestern University, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|Oregon Health and Science University, Portland, Oregon, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Michael E. Debakey VAMC, Houston, Texas, United States|dgd Research, San Antonio, Texas, United States|VA Puget Sound Health Care System, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00448955"
311,"Open-Label Study of ARD-0403 in Testosterone Deficient Men","Terminated","No Results Available","Hypogonadism","Drug: ARD-0403","Male","18 Years and older   (Adult, Older Adult)","Phase 3","150","June 2008","Medical Affiliated Research Center, Inc, Huntsville, Alabama, United States|Stanford University, Stanford, California, United States|Harbor-UCLA Medical Center, Torrance, California, United States|Northwestern University, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|Oregon Health and Science University, Portland, Oregon, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|dgd Research, San Antonio, Texas, United States|VA Puget Sound Health Care System, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00562731"
312,"Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome","Completed","No Results Available","Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Bronchopulmonary Dysplasia","Drug: Exosurf|Drug: Survanta","All","up to 6 Hours   (Child)","Phase 2|Phase 3","617","January 1992","Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|George Washington University, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|University of Vermont, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT01203358"
313,"Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation","Completed","Has Results","Acute Respiratory Failure","Drug: Dexmedetomidine|Drug: Placebo","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 2","36","February 2013","Tufts Medical Center, Boston, Massachusetts, United States|Winchester Hospital, Winchester, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00871624"
314,"Strategies for Anticoagulation During Venovenous ECMO","Recruiting","No Results Available","Acute Hypoxemic Respiratory Failure|Anticoagulant-induced Bleeding|Thromboembolism","Other: Low intensity anticoagulation|Other: Moderate Intensity Anticoagulation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","15","May 12, 2023","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04997265"
315,"Clinical Decision Support Tool in PARDS Pilot Study","Recruiting","No Results Available","Ventilation Therapy; Complications|Ventilator-Induced Lung Injury|Ards","Other: Ventilator protocol","All","1 Month to 18 Years   (Child, Adult)","Not Applicable","180","June 2023","Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Penn State University, Hershey, Pennsylvania, United States|University of Utah, Salt Lake City, Utah, United States|University of Wisconsin-Madison, Madison, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|CHU Sainte-Justine, Montréal, Quebec, Canada|Ospedale Pediatrico Bambino Gesu, Roma, Italy","https://ClinicalTrials.gov/show/NCT04068012"
316,"Drug Study of Albuterol to Treat Acute Lung Injury","Terminated","Has Results","Respiratory Distress Syndrome, Adult","Drug: Albuterol Sulfate|Procedure: Mini-Bronchoalveolar Lavage (BAL)|Drug: Placebo","All","13 Years and older   (Child, Adult, Older Adult)","Phase 2|Phase 3","282","November 2008","University of San Francisco-Fresno Medical Center, Fresno, California, United States|University of California, Davis Medical Center, Sacramento, California, United States|UCSF-Moffitt Hospital, San Francisco, California, United States|UCSF-San Francisco General Hospital, San Francisco, California, United States|Centura St. Anthony Central Hospital, Denver, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|Washington Hospital Center, Washington DC, District of Columbia, United States|Baton Rouge General Hospital-Blue Bonnet, Baton Rouge, Louisiana, United States|Baton Rouge General Hospital-Midcity, Baton Rouge, Louisiana, United States|Earl K. Long Medical Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States|Medical Center of Louisiana, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|University of Maryland Shock Trauma Center, Baltimore, Maryland, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Rochester Methodist Hospital, Rochester, Minnesota, United States|St. Mary's Hospital, Mayo Clinic, Rochester, Minnesota, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Durham Regional Medical Center, Durham, North Carolina, United States|Moses Cone Health System, Greensboro, North Carolina, United States|Wesley Long Community Hospital, Greensboro, North Carolina, United States|Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|McKay-Dee Hospital, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Virginia Medical Center, Charlottesville, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00434993"
317,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)","Terminated","No Results Available","COVID-19|Acute Respiratory Distress Syndrome","Drug: Razuprotafib Subcutaneous Solution|Drug: Placebo Subcutaneous Solution","All","18 Years and older   (Adult, Older Adult)","Phase 2","31","February 26, 2021","University of Southern California, Los Angeles, California, United States|University of California- Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Snake River Research, Idaho Falls, Idaho, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Cincinnati, Cincinnati, Ohio, United States|Rhode Island Hospital, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT04511650"
318,"Pulmonary Function Using Non-invasive Forced Oscillometry","Recruiting","No Results Available","Infant, Premature, Diseases|Infant, Newborn, Diseases|Bronchopulmonary Dysplasia|Respiratory Distress Syndrome, Newborn|Meconium Aspiration Syndrome|Transient Tachypnea of the Newborn","Device: Non-invasive forced airway oscillometry","All","1 Day to 2 Years   (Child)","Not Applicable","1098","May 2026","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT03346343"
319,"Impact of Aerosol Box Use on Healthcare Provider Contamination","Completed","No Results Available","Coronavirus|Covid19|COVID-19 Acute Respiratory Distress Syndrome","Device: Aerosol Box (Splashguard)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","122","December 16, 2021","Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles, California, United States|KidSIM-ASPIRE Simulation Research Program Alberta Children's Hospital, Calgary, Alberta, Canada|Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada|Department of Pediatrics, CHU Sainte-Justine, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04880668"
320,"Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19","Recruiting","No Results Available","Lung Injury|ARDS|Acute Cardiac Event|Covid19|Ultrasound|Hypoxemia|Acute Respiratory Distress Syndrome","Diagnostic Test: Point of Care Ultrasound","All","18 Years and older   (Adult, Older Adult)",,"240","June 2022","UCLA-Ronald Reagan, Los Angeles, California, United States|Olive View-UCLA, Sylmar, California, United States|SUNY Downstate, New York, New York, United States|Temple University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT05228717"
321,"Vitamin D to Improve Outcomes by Leveraging Early Treatment","Completed","Has Results","Acute Respiratory Distress Syndrome|Vitamin D Deficiency|Critical Illness","Drug: Vitamin D3|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 3","1358","December 11, 2018","UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|St. Joseph Hospital, Del Norte, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center, Bronx, New York, United States|Mt. Sinai Hospital, New York, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Summa Akron City Hospital, Akron, Ohio, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|OSU Hospital East Campus, Columbus, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Swedish Hospital Cherry Hill, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03096314"
322,"A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)","Completed","Has Results","COVID-19","Drug: Gimsilumab|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","227","April 1, 2021","Banner University Medical Center, Phoenix, Arizona, United States|HonorHealth John C. Lincoln Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States|HonorHealth, Scottsdale, Arizona, United States|HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States|Banner University Medical Center, Tucson, Arizona, United States|UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|University of Florida, Gainesville, Florida, United States|Miami Cancer institute, Miami, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Emory University School of Medicine, Atlanta, Georgia, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Mount Sinai Beth Israel, New York, New York, United States|Mount Sinai West, New York, New York, United States|Mount Sinai Morningside, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor Jack & Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Memorial Hermann Hospital Affiliated with University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States|Baylor Scott & White Medical Center, Irving, Texas, United States|Baylor Scott & White Heart Hospital, Plano, Texas, United States|Baylor Scott & White Medical Center, Plano, Texas, United States|Baylor Scott & White Medical Center, Round Rock, Texas, United States|Baylor Scott & White Medical Center, Temple, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT04351243"
323,"Postoperative Respiratory Abnormalities","Unknown status","No Results Available","Respiratory Failure|Respiratory Arrest|Respiratory Distress Syndrome|Acute Respiratory Failure|Acute Respiratory Failure With Hypoxia|Acute Respiratory Failure With Hypercapnia|Acute Respiratory Failure Post Surgical|Acute Respiratory Failure Postprocedural|Acute Respiratory Failure Following Trauma and Surgery|Acute Respiratory Failure Requiring Reintubation|Acute Respiratory Failure Post Traumatic|Acute Respiratory Decompensation|Shock|Shock, Septic|Shock, Cardiogenic|Acute Cardiac Failure|Multi Organ Failure|Acute Kidney Failure","Other: Observational retrospective cohort to describe data validity; and Data reliability; and Completeness of the data","All","18 Years to 90 Years   (Adult, Older Adult)",,"50000","October 2020","Memorial Hermann Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04079829"
324,"Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm","Withdrawn","No Results Available","Acute Respiratory Distress Syndrome|Diaphragm Injury|Neuromuscular Blockade",,"All","19 Years and older   (Adult, Older Adult)",,"0","December 1, 2018","Brigham and Women's Health, Boston, Massachusetts, United States|Baystate Health, Springfield, Massachusetts, United States|Cleveland Clinic, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT03132896"
325,"Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury","Completed","Has Results","COVID-19 Pneumonia|Acute Lung Injury|ARDS","Drug: CERC-002|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","88","January 19, 2021","Hoag Memorial Hospital, Newport Beach, California, United States|Midway Immunology and Research Center, Fort Pierce, Florida, United States|Triple O Research Institute, P.A., West Palm Beach, Florida, United States|Parkview Research Center, Fort Wayne, Indiana, United States|MedPharmics, LLC, Metairie, Louisiana, United States|LSUHSC - Shreveport, Shreveport, Louisiana, United States|Carolina Institute for Clinical Research, LLC, Fayetteville, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|AnMed Health Medical Center, Anderson, South Carolina, United States|Lowcountry Infectious Diseases, P.A., Charleston, South Carolina, United States|BRCR Global Texas, McAllen, Texas, United States","https://ClinicalTrials.gov/show/NCT04412057"
326,"Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities","Withdrawn","No Results Available","Perinatal Death|Respiratory Distress Syndrome, Newborn|Hypoxic-Ischemic Encephalopathy|Neonatal Seizure|Meconium Aspiration Syndrome|Intracranial Hemorrhages|Neonatal Hypotension","Other: Room air","Female","18 Years to 55 Years   (Adult)","Not Applicable","0","December 30, 2022","Loma Linda University Children's Hospital, Loma Linda, California, United States","https://ClinicalTrials.gov/show/NCT03996317"
327,"Electrical Impedance Imaging of Patients on Mechanical Ventilation","Completed","No Results Available","Pneumothorax|Pulmonary Contusion|Pleural Effusion|Pulmonary Edema|Atelectasis|Hyperinflation|Emphysema|Acute Respiratory Distress Syndrome","Device: Mechanical Ventilation|Device: CT Scan","All","18 Years and older   (Adult, Older Adult)",,"2","August 2016","Medical Center of the Rockies, Loveland, Colorado, United States","https://ClinicalTrials.gov/show/NCT02232841"
328,"Peer Support for Post Intensive Care Syndrome Self-Management","Unknown status","No Results Available","Critical Illness|Sepsis|Shock, Septic|Shock|Respiratory Failure|Respiratory Distress Syndrome, Adult|Shock, Hypovolemic|Chronic Disease","Behavioral: Peer Support with Motivational Interviewing|Behavioral: Usual Care Group","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","January 27, 2021","Baylor Scott & White Health, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT03788096"
329,"Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors","Completed","No Results Available","Acute Respiratory Failure|Post-Intensive Care Syndrome","Behavioral: Mobile Critical Care Program|Behavioral: Attention Control","All","18 Years and older   (Adult, Older Adult)","Not Applicable","503","October 31, 2022","Eskenazi Hospital, Indianapolis, Indiana, United States|Methodist Hospital, Indianapolis, Indiana, United States|University Hospital, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT03053245"
330,"Predictors of Severe COVID-19 Outcomes","Active, not recruiting","No Results Available","Acute Respiratory Distress Syndrome|COVID-19",,"All","18 Years and older   (Adult, Older Adult)",,"494","October 2021","The University of Arizona, Tucson, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Weill Cornell Medical College, New York, New York, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Inova Health Care Services, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT04388813"
331,"SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19","No longer available","No Results Available","COVID-19|Pneumonia, Viral|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)","Biological: eculizumab","All","18 Years and older   (Adult, Older Adult)",,,,"Cedars-Sinai Medical Center, Los Angeles, California, United States|Boston Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Hôpital Henri Mondor, Creteil, France|Hôpital Garches Raymond Poincaré, Garches, France|Hôpital de Bicêtre, Le Kremlin Bicêtre, France|Hôpital Saint Louis, Paris, France|Hôpital Paul Brousse, Villejuif, France","https://ClinicalTrials.gov/show/NCT04355494"
332,"A Retrospective Study of COVID-19 Treatments","Recruiting","No Results Available","Covid19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Acute Bronchitis|COVID-19 Acute Respiratory Distress Syndrome|COVID-19 Lower Respiratory Infection|SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease","Other: No Intervention Used","All","18 Months and older   (Child, Adult, Older Adult)",,"300","July 31, 2022","Ginger Aurella, Ventura, California, United States","https://ClinicalTrials.gov/show/NCT04949230"
333,"Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia","Terminated","Has Results","COVID-19 Severe Pneumonia|Acute Lung Injury|Acute Respiratory Distress Syndrome|Pneumonia, Viral","Biological: Ravulizumab|Other: BSC","All","18 Years and older   (Adult, Older Adult)","Phase 3","202","April 8, 2021","Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States|LAC/USC Health Center, Los Angeles, California, United States|UC Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|University of Florida, Jacksonville, Florida, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Norton Healthcare, Louisville, Kentucky, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic Health System, Mankato, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYU Langone Health Center, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Westchester Medical Center, Valhalla, New York, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Baptist Memorial Hospital, Memphis, Tennessee, United States|Houston Methodist Hospital, Houston, Texas, United States|Mayo Clinic Health System in Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System, La Crosse, Wisconsin, United States|Hôpital Raymond Poincaré, Garches, Hauts De Seine, France|Hôpital Henri Mondor, Créteil, Val De Marne, France|Hôpital Bicêtre, Le Kremlin-Bicêtre cedex, Val De Marne, France|Medical Hospital, Tokyo Medical and Dental University, Bunkyō-Ku, Tokyo-To, Japan|Jikei University Hospital, Minato-Ku, Tokyo, Japan|Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo, Japan|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|King's College Hospital, London, Greater London, United Kingdom|Hammersmith Hospital, London, Greater London, United Kingdom|Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom|Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom|St James's University Hospital, Leeds, West Yorkshire, United Kingdom","https://ClinicalTrials.gov/show/NCT04369469"
334,"STIP: Statin Trial for Influenza Patients","Terminated","Has Results","Acute Respiratory Distress Syndrome|Influenza|H1N1 Influenza","Drug: Rosuvastatin (crestor)|Drug: Placebo","All","13 Years and older   (Child, Adult, Older Adult)","Not Applicable","7","July 2011","University of Arkansas, Little Rock, Alaska, United States|Maricopa Integrated Health System, Phoenix, Arizona, United States|Stanford, Stanford, California, United States|Northwestern University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Johns Hopkins Hospital, Baltiomore, Maryland, United States|Boston University, Boston, Massachusetts, United States|Baystate Medical Center, Springfiled, Massachusetts, United States|Columbia University, New York, New York, United States|Mt Sinai, New York, New York, United States|Moses H. Cone Memorial Hospital, Greensboro, North Carolina, United States|Metro Health, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|University of Oregon, Portland, Oregon, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Erlanger, Chattanooga, Tennessee, United States|Vanderbilt University, Nashville, Tennessee, United States|University of Texas, San Antonio, Texas, United States|Intermountain, Murray, Utah, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00970606"
335,"Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants","Recruiting","No Results Available","Infant, Premature|Neonatal Respiratory Distress|Oxygen Saturation|Bronchopulmonary Dysplasia","Device: Automated Control|Device: Manual Control","All","Child, Adult, Older Adult","Not Applicable","47","December 31, 2023","Children's National Hospital & Research Institute, Washington, District of Columbia, United States|University of Utah Hospital, Salt Lake City, Utah, United States|Seattle Children's Hospital, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT05030012"
336,"Universal Anti-Viral Vaccine for Healthy Elderly Adults","Completed","No Results Available","Virus Diseases|Pneumonia|COVID-19 Respiratory Infection|RSV Pneumonia|Influenza, Human|ARDS, Human","Drug: AlloStim","All","65 Years and older   (Older Adult)","Phase 1|Phase 2","40","April 1, 2023","Delray Physician Care Center, Delray Beach, Florida, United States|Coral Research Clinic & Coral Diagnostic, Miami, Florida, United States|Model Research, Tampa, Florida, United States|Florida Medical Clinic, LLC, Zephyrhills, Florida, United States","https://ClinicalTrials.gov/show/NCT04441047"
337,"Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide","Completed","Has Results","Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)|Bronchopulmonary Dysplasia","Drug: Infasurf (ONY Inc.)|Drug: Sham","All","7 Days to 14 Days   (Child)","Phase 3","85","December 2012","Alta Bates Summit Medical Center, Berkeley, California, United States|Children's Hospital Oakland, Oakland, California, United States|University of California, San Francisco, San Francisco, California, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Women and Children's Hospital of Buffalo, Buffalo, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Texas Children's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00569530"
338,"Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants","Terminated","No Results Available","Infant, Newborn|Respiratory Distress Syndrome|Respiratory Insufficiency","Drug: Early surfactant|Drug: Standard practice","All","up to 12 Hours   (Child)","Phase 3","61","July 2002","University of Alabama at Birmingham, Birmingham, Alabama, United States|Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00005774"
339,"Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury","Completed","No Results Available","Acute Lung Injury|Acute Respiratory Distress Syndrome",,"All","up to 18 Years   (Child, Adult)",,,"November 2007","Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital at Oakland, Oakland, California, United States|The Children's Hospital, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Miami Children's Hospital, Miami, Florida, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Kentucky Children's Hospital, Lexington, Kentucky, United States|UMAss Memorial Medical Center, Worchester, Massachusetts, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Children's Hospital, Omaha, Nebraska, United States|Nebraska Medical Center, Omaha, Nebraska, United States|Darmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|New York Presbyterian Hospital, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|The Children's hospital Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Austin, Austin, Texas, United States|Texas Childrens Hospital, Houston, Texas, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|Akademisches Lehrkrankenhaus, Feldkirch, Austria|Medical University of Vienna, Vienna, Austria|Paola Childrens Hospital, Antwerp, Belgium|Cliniques universitaires Saint-Luc, Brussels, Belgium|Hôpital SteJustine, Montreal, Quebec, Canada|Montreal Children' Hospital, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Stollery Children's Hospital, Edmonton, Canada|McMaster Children's Hospital, Hamilton, Canada|Children's Hospital of Western Ontario, London, Canada|Centre Hospitalier Universitaire de Quebec, Quebec, Canada|BC Children's Hospital, Vancouver, Canada|CHU Lille, Lille, France|CHU Nantes, Nantes, France|Hôpital Robert-Debré, Paris, France|Necker, Paris, France|CHU Pontchaillou, Rennes, France|University Clinic Frankfurt, Frankfurt, Germany|Universitätsklinikum Mannheim, Mannheim, Germany|Kinderzentrum im Klinikum Nürnberg, Nurnberg, Germany|Children's Hospital StAugustin, St Augustin, Germany|University Children's Hospital, Tuebringen, Germany|Ospedali riuniti di Bergamo, Bergamo, Italy|Padua University Hospital, Padova, Italy|Azienda Ospedaliera di Verona, Verona, Italy|The Wilhelmina Children's Hospital, Utrecht, Netherlands|Hospital Sant Joan de Déu-Hospital Clinic, Barcelona, Spain|Cruces Hospital, Bilbao, Spain|General University Hospital Gregorio Marañón, Madrid, Spain|Hospital Universitario Central de Asturias, Oveido, Spain|Hospital universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostella, Spain|Hospital Infantil La Fe, Valencia, Spain|The Queen Silvia Children's Hospital, Goteborg, Sweden|Astrid Lindgren Children's Hospital, Stockholm, Sweden|Children's Hospital, Geneva, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Bristol Children's Hospital, Bristol, United Kingdom","https://ClinicalTrials.gov/show/NCT00521625"
340,"Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure","Completed","No Results Available","Critical COVID-19 With Respiratory Failure|Acute Respiratory Distress Syndrome (ARDS)|Corona Virus Infection|Acute Lung Injury","Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care","All","18 Years to 100 Years   (Adult, Older Adult)","Phase 2|Phase 3","196","February 22, 2021","St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Heartland/Mosaic Health, Saint Joseph, Missouri, United States|Hendrick Health, Abilene, Texas, United States|Texas Health Harris Methodist Hospital, Fort Worth, Texas, United States|Texas Health Hospital Frisco, Frisco, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04311697"
341,"A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury","Completed","No Results Available","Respiratory Distress Syndrome, Adult|Acute Lung Injury","Drug: Sivelestat","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","600","December 2002","Birmingham, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Orange, California, United States|Sacramento, California, United States|San Diego, California, United States|Denver, Colorado, United States|Englewood, Colorado, United States|New Haven, Connecticut, United States|Washington, District of Columbia, United States|Bay Pines, Florida, United States|Clearwater, Florida, United States|Ft. Lauderdale, Florida, United States|Augusta, Georgia, United States|Austell, Georgia, United States|Chicago, Illinois, United States|Elk Grove Village, Illinois, United States|Maywood, Illinois, United States|North Chicago, Illinois, United States|Indianapolis, Indiana, United States|Des Moines, Iowa, United States|Kansas City, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Baton Rouge, Louisiana, United States|Lake Charles, Louisiana, United States|Shreveport, Louisiana, United States|Portland, Maine, United States|Baltimore, Maryland, United States|Silver Spring, Maryland, United States|Towson, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Kalamazoo, Michigan, United States|St. Louis, Missouri, United States|Camden, New Jersey, United States|Hackensack, New Jersey, United States|Holmdel, New Jersey, United States|Bronx, New York, United States|Buffalo, New York, United States|Elmhurst, New York, United States|Manhasset, New York, United States|Mineola, New York, United States|New York, New York, United States|Rochester, New York, United States|Greensboro, North Carolina, United States|Winston-Salem, North Carolina, United States|Akron, Ohio, United States|Cincinnati, Ohio, United States|Toledo, Ohio, United States|Portland, Oregon, United States|Allentown, Pennsylvania, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Providence, Rhode Island, United States|Sioux Falls, South Dakota, United States|Memphis, Tennessee, United States|Nashville, Tennessee, United States|Houston, Texas, United States|Irving, Texas, United States|Lubbock, Texas, United States|San Antonio, Texas, United States|Newport News, Virginia, United States|Morgantown, West Virginia, United States|Garran, Australian Capital Territory, Australia|Camperdown, New South Wales, Australia|Kingswood, New South Wales, Australia|Kogarah, New South Wales, Australia|St. Leonards, New South Wales, Australia|Wentworthville, New South Wales, Australia|SouthPort, Queensland, Australia|Adelaide, South Australia, Australia|Bedford Park, South Australia, Australia|Woodville, South Australia, Australia|Heidelberg, Victoria, Australia|Parkville, Victoria, Australia|Prahran, Victoria, Australia|Fremantle, Western Australia, Australia|Perth, Western Australia, Australia|Aaist, Belgium|Antwerpen, Belgium|Arion, Belgium|Braine L' Alleud, Belgium|Brugge, Belgium|Brussels, Belgium|Gent, Belgium|Liege, Belgium|Edmonton, Alberta, Canada|Vancouver, British Columbia, Canada|Winnipeg, Manitoba, Canada|Halifax, Nova Scotia, Canada|Hamilton, Ontario, Canada|Toronto, Ontario, Canada|Windsor, Ontario, Canada|Montreal, Quebec, Canada|Sherbrooke, Quebec, Canada|Christchurch, Canterbury, New Zealand|Auckland, New Zealand|Hastings, New Zealand|Wellington, New Zealand|Manresa, Barcelona, Spain|Sabadell, Barcelona, Spain|Getafe, Madrid, Spain|El Palmar, Murcia, Spain|Badajoz, Spain|Barcelona, Spain|Madrid, Spain|Murcia, Spain|Palma De Mallorca, Spain","https://ClinicalTrials.gov/show/NCT00036062"
342,"Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery","Terminated","No Results Available","COVID-19|Acute Respiratory Distress Syndrome","Device: LLLT Photobiomodulation","All","18 Years and older   (Adult, Older Adult)",,"5","November 21, 2022","MD at Bedside, Berkeley, California, United States|Health Atlast, Los Angeles, California, United States|Longevity, Santa Monica, California, United States|Wellness Junction, Millsboro, Delaware, United States|Diet MD, 'Ewa Beach, Hawaii, United States|Diet MD, Honolulu, Hawaii, United States|Healing Health Services, Brooklyn, New York, United States","https://ClinicalTrials.gov/show/NCT05258617"
343,"Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)","Completed","No Results Available","Critically Illness|Sedation|Invasive Mechanical Ventilation|Acute Respiratory Distress Syndrome","Drug: Intravenous sedation|Drug: Inhaled sedation","All","18 Years and older   (Adult, Older Adult)",,"203","April 30, 2021","Beth Israel Deaconess Medical Center, Inc., Boston, Massachusetts, United States|CHU, Brest, France|CHU, Clermont-Ferrand, France|Centre Hospitalier, Dunkerque, France|Pitié-Salpêtrière Hospital - APHP, Paris, France|CH Privé de la Loire, Saint-Étienne, France|Universitätsklinikum, Bochum, Germany|University Medical Center Schleswig-Holstein, Kiel, Germany|Universitätsklinikum, Oldenburg, Germany|Hospital Clínico Universitario de Valencia, Valencia, Spain|Cantonal Hospital, Münsterlingen, Switzerland|Universitätsspital, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT04383730"
344,"Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants","Completed","Has Results","Respiratory Compliance|Functional Residual Capacity|Pulmonary Function Testing","Drug: betamethasone|Drug: placebo","Female","15 Years and older   (Child, Adult, Older Adult)","Not Applicable","85","November 2009","Oregon Health & Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT00669383"
345,"Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)","Available","No Results Available","Neonatal Respiratory Distress","Combination Product: Infasurf Aero","All","up to 42 Weeks   (Child)",,,,"University of Mississippi Medical Center, Jackson, Mississippi, United States|Sisters of Charity Hospital, Buffalo, New York, United States|Pitt County Memorial Hospital, Greenville, North Carolina, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|Utah Valley Hospital, Provo, Utah, United States","https://ClinicalTrials.gov/show/NCT03582930"
346,"ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19","Terminated","Has Results","COVID-19","Drug: BI 764198|Drug: Placebo","All","50 Years and older   (Adult, Older Adult)","Phase 2","133","May 31, 2021","University of California Irvine, Orange, California, United States|Rapides Regional Medical Center, Alexandria, Louisiana, United States|St. Elizabeth's Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mercy Health St. Vincent Medical Center, Toledo, Ohio, United States|Providence Regional Medical Center, Everett, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|Hospital Luxemburgo, Belo Horizonte, Brazil|IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Brazil|Hospital Regional Hans Dieter Schmidt, Santa Catarina, Brazil|Hospital de Base - Fac Med de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil|Hospital Padre Alberto Hurtado, Santiago, Chile|Hospital Carlos Van Buren, Valparaiso, Chile|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|Hospital General de Culiacán ""Dr. Bernardo J. Gastellum"", Culiacán, Mexico|Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico|Hospital Auxilio Mutuo, Hato Rey, Puerto Rico|Hospital Municipal de San Juan, Rio Piedras, Puerto Rico|Hospital A Coruña, A Coruña, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Son Espases, Palma de Mallorca, Spain","https://ClinicalTrials.gov/show/NCT04604184"
347,"VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study","Completed","Has Results","SARS-CoV Infection","Drug: VERU-111","All","18 Years to 100 Years   (Adult, Older Adult)","Phase 3","204","July 6, 2022","Honor Health, Scottsdale, Arizona, United States|St. Bernard's Medical Center, Jonesboro, Arkansas, United States|Velocity Clinical Research, Chula Vista, California, United States|Velocity Clinical Research - San Diego, La Mesa, California, United States|Westchester General Hospital, Research Department, Miami, Florida, United States|James A. Haley Veterans Hospital, Tampa, Florida, United States|Wellstar Research Institute, Marietta, Georgia, United States|Benchmark Research, Covington, Louisiana, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States|Holy Name Medical Center, Institute for Clinical Research, Teaneck, New Jersey, United States|Inspira Medical Center, Vineland, New Jersey, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Atrium Health Carolinas Medical Center, Charlotte, North Carolina, United States|The Stern Cardiovascular Foundation, Inc., Germantown, Tennessee, United States|Regional One Health, Memphis, Tennessee, United States|North Knoxville Medical Center, Powell, Tennessee, United States|HD Research (Memorial Hermann - Memorial City Medical Center), Houston, Texas, United States|HD Research (Memorial Hermann Southeast Hospital), Houston, Texas, United States|Clinical Trial Network, Houston, Texas, United States|Hospital De Alta Compleijdad Cuenca Alta Nestor Kirchner, Buenos Aires, Argentina|Hospital del Bicentenario de Esteban Echeverría, Buenos Aires, Argentina|Center Sagrado Corazon, Buenos Aires, Argentina|Sanatorio Güemes, Buenos Aires, Argentina|Hospital De Infecciosas ""Dr. Francisco Javier Muniz"", Buenos Aires, Argentina|Fundacao Pio XII - Hospital de Amor de Barretos, Barretos, Sao Paulo, Brazil|Hospital PUC Campinas, Campinas, Sao Paulo, Brazil|Faculdade de Medicina de Botucatu - UNESP, Botucatu, Brazil|Hospital Universitário São Francisco na Providencia de Deus, Bragança Paulista, Brazil|IPECC (Instituto De Pesquisa Clínica de Campinas), Campinas, Brazil|Sociedade Hospital Angelina Caron, Campinas, Brazil|Santa Casa de Curitiba, Curitiba, Brazil|Complexo Hospitalar de Niteroi, Niteroi, Brazil|Hospital de Clínicas de Porto Alegre - Infectologia - Centro de Pesquisa Clínica, Porto Alegre, Brazil|Hospital Sao Luca Da PUCRS, Porto Alegre, Brazil|Hospital Universitario Cementino Fraga Filho, Rio De Janeiro, Brazil|IDOR - D'Or Institute for Research and Education, Sao Paulo, Brazil|Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, Sao Paulo, Brazil|Hospital Miguel Soeiro Sorocaba, Sorocaba, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São Paulo, Brazil|MHAT Blagoevgrad AD Department of Infectious Diseases, Blagoevgrad, Bulgaria|Multiprofile Hospital for Active Treatment - Haskovo, Department of Infectious Diseases, Haskovo, Bulgaria|Multiprofile Hospital for Active Treatment - Dr. Atanas Dafovski AD, Kardzhali, Department of Pneumology and Phthisiatry, Dept. of Pneumology & Phthisiatry, Kardzhali, Bulgaria|Specialized hospital for active treatment of pulmonary diseases -Pernik EOOD, Pernik, Pernik, Bulgaria|University Multiprofile Hospital for Active Treatment ""Pulmed"" OOD Plovid Rheumatology, Plovdiv, Bulgaria|MHAT Bratan Shukerov,Pulmonology Department, Smolyan,, Bulgaria|University Multiprofile Hospital for Active Treatment ""Tsaritsa Yoanna-ISUL"" EAD, Sofia,, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment and Emergency Medicine, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment ""Professor Doctor Stoyan Kirkovich"" AD, Stara Zagora, Clinic of Anaestheology and intensive care, Stara Zagora, Bulgaria|Fundación Hospital Universidad del Norte (Barranquilla), Atlántico, Colombia|Clinica de la Costa (Barranquilla), Barranquilla, Colombia|Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia|Centro Medico Imbanaco de Cali S.A, Cali, Colombia|Sociedad Medica Rionegro- Clínica Somer (Rionegro), Rionegro, Colombia|Unidad Médica para la Salud Integral (UMSI), San Nicolas de los Garza, Nuevo Leon, Mexico|Hospital General de Culiacán, Culiacán, Mexico|Hospital General de Occidente, Zapopan, Mexico","https://ClinicalTrials.gov/show/NCT04842747"
348,"Observational Study of Expected ARF Recovery","Completed","No Results Available","Acute Respiratory Failure|Post Intensive Care Syndrome",,"All","18 Years and older   (Adult, Older Adult)",,"180","December 1, 2021","Johns Hopkins University, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Vanderbilt University, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States","https://ClinicalTrials.gov/show/NCT03797313"
349,"Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)","Completed","No Results Available","Respiratory Insufficiency|Respiratory Distress Syndrome, Newborn|Lung Diseases","Behavioral: Team approach to sedation management|Behavioral: Usual approach to sedation management","All","2 Weeks to 18 Years   (Child, Adult)","Phase 3","2449","December 2013","Children's Hospital of Alabama, Birmingham, Alabama, United States|University Medical Center, The University of Arizona, Tucson, Arizona, United States|Children's Hospital and Research Center at Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, California, United States|University of California Davis Medical Center, Sacramento, California, United States|Children's Hospital at University of California San Francisco Medical Center, San Francisco, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale-New Haven Children's Hospital, New Haven, Connecticut, United States|Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States|Holtz Children's Hospital, Miami, Florida, United States|Florida Hospital for Children, Orlando, Florida, United States|Children's Memorial Hospital, Chicago, Chicago, Illinois, United States|Advocate Hope Children's Hospital, Oak Lawn, Illinois, United States|University of Maryland Hospital for Children, Baltimore, Maryland, United States|Johns Hopkins Children's Center, Baltimore, Maryland, United States|University of Massachusetts Memorial Children's Medical Center, Worcester, Massachusetts, United States|C. S. Mott Children's Hospital of the University of Michigan, Ann Arbor, Michigan, United States|Children's Mercy Hospital, Kansas City, Kansas City, Missouri, United States|St. Louis Children's Hospital, St. Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|The Children's Hospital at Montefiore, Bronx, New York, United States|Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Duke Children's Hospital and Health Center, Durham, North Carolina, United States|Doernbecher Children's Hospital, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Monroe Carell, Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Medical City Children's Hospital, Dallas, Texas, United States|Children's Medical Center Dallas, Dallas, Texas, United States|Primary Children's Medical Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00814099"
350,"The Budesonide in Babies (BiB) Trial","Recruiting","No Results Available","Bronchopulmonary Dysplasia (BPD)|Respiratory Distress Syndrome|Prematurity; Extreme|Neonatal","Drug: budesonide (Pulmicort nebulizing suspension).|Drug: surfactant (poractant alfa;Curosurf)","All","up to 48 Hours   (Child)","Phase 3","1160","September 30, 2027","University of Alabama, Birmingham, Alabama, United States|Stanford University, Palo Alto, California, United States|Emory University, Atlanta, Georgia, United States|University of Iowa, Iowa City, Iowa, United States|University of New Mexico, Albuquerque, New Mexico, United States|University of Rochester, Rochester, New York, United States|RTI International, Durham, North Carolina, United States|Duke University, Durham, North Carolina, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Brown University - Women and Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT04545866"
351,"Fostamatinib for Hospitalized Adults With COVID-19","Completed","Has Results","Coronavirus Disease 2019","Drug: Placebo|Drug: fostamatinib","All","18 Years and older   (Adult, Older Adult)","Phase 2","59","April 30, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States|INOVA Health Systems, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT04579393"
352,"Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial","Completed","Has Results","Pregnancy|Respiratory Distress Syndrome|Pregnancy Outcomes|Preterm Birth","Drug: Betamethasone|Drug: Placebo","Female","Child, Adult, Older Adult","Phase 3","2831","August 31, 2022","University of Alabama - Birmingham, Birmingham, Alabama, United States|Stanford University, Stanford, California, United States|University of Colorado, Denver, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Wayne State University, Detroit, Michigan, United States|Columbia University, New York, New York, United States|University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|Case Western Reserve University, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pittsburgh Magee Womens Hospital, Pittsburgh, Pennsylvania, United States|Brown University, Providence, Rhode Island, United States|University of Texas - Southwest, Dallas, Texas, United States|University of Texas - Galveston, Galveston, Texas, United States|University of Texas - Houston, Houston, Texas, United States|University of Utah Medical Center, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01222247"
353,"Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery","Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Critical Illness|Respiratory Failure|Sepsis","Drug: Intravenous Acetaminophen (room temperature)|Drug: Intravenous Vitamin C (refrigerated)|Drug: 5% Dextrose (room temperature)|Drug: 5% Dextrose refrigerated","All","18 Years and older   (Adult, Older Adult)","Phase 2","900","July 2023","University of Alabama Medical Center, Birmingham, Alabama, United States|University of Arizona, Tucson, Arizona, United States|UCSF Fresno, Fresno, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center-Weiler, Bronx, New York, United States|Montefiore Medical Center-Moses, Bronx, New York, United States|Mt. Sinai Hospital, New York, New York, United States|Carolinas Medical Center, Charlotte, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside/Magee, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Health Science Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Sentara/EVMS, Norfolk, Virginia, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04291508"
354,"Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors","Recruiting","No Results Available","COVID-19 Pneumonia|COVID-19|COVID-19 Respiratory Infection|COVID-19 Acute Respiratory Distress Syndrome|COVID-19 Lower Respiratory Infection|COVID-19 Acute Bronchitis|Coronavirus Disease 2019","Diagnostic Test: Cardiac MRI|Diagnostic Test: Echocardiogram|Diagnostic Test: 6-minute walk test|Diagnostic Test: Questionnaire","All","18 Years and older   (Adult, Older Adult)",,"510","July 30, 2026","New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn, New York, United States|New York Presbyterian Queens, New York, New York, United States|Weill Cornell Medicine/New-York Presbyterian Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05164744"
355,"Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure","Completed","Has Results","Acute Lung Injury|Acute Respiratory Distress Syndrome|Respiratory Failure","Drug: IV Ganciclovir|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","160","October 28, 2016","University of Colorado / National Jewish Health / Swedish Medical Center, Denver, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Baystate Critical Care Medicine / Tufts University School of Medicine, Springfield, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Wakeforest University, School of Medicine, Winston-Salem, North Carolina, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Medical Center, Columbus, Ohio, United States|The Oregon Clinic, Portland, Oregon, United States|University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|University of Vermont College of Medicine, Burlington, Vermont, United States|University of Virginia, Charlottesville, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center / Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01335932"
356,"Losartan for Patients With COVID-19 Requiring Hospitalization","Completed","Has Results","Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection","Drug: Losartan|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","205","February 1, 2021","University of Florida Health Gainesville, Gainesville, Florida, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Henry Ford Hospital, Detroit, Michigan, United States|M Health Fairview Ridges Hospital, Burnsville, Minnesota, United States|M Health Fairview Southdale Hospital, Edina, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|North Memorial Health Hospital, Robbinsdale, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper University Hospital, Camden, New Jersey, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04312009"
357,"Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19","Terminated","No Results Available","SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea","Drug: ZYESAMI™ (aviptadil acetate)|Drug: Placebo|Device: Nebulized administration of ZYESAMI™ or Placebo","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 2|Phase 3","144","December 31, 2021","St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|University of Miami Leonard M. Miller School of Medicine (UMMSM), Miami, Florida, United States|Advent Health Research Institute, Orlando, Florida, United States|Northwestern Medical Group, Winfield, Illinois, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Great Plains Health, North Platte, Nebraska, United States|University Medical Center, Las Vegas, Nevada, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Kettering Health Network, Kettering, Ohio, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|University of Texas San Antonio Medical Arts and Research Center, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04360096"
358,"Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants","Completed","No Results Available","Premature Neonate","Other: Higher permissive hypercapnia|Other: Lower Permissive Hypercapnia","All","7 Days to 14 Days   (Child)","Not Applicable","130","April 2021","UAB, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT02799875"
359,"Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)","Terminated","Has Results","Prematurity|Respiratory Insufficiency|Pulmonary Hypertension|Respiratory Distress Syndrome, Newborn","Drug: Aerosolized Normal Saline|Drug: Inhaled PGE1","All","up to 7 Days   (Child)","Phase 2","7","June 2012","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California - Los Angeles, Los Angeles, California, United States|Stanford University, Palo Alto, California, United States|University of Iowa, Iowa City, Iowa, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|University of Rochester, Rochester, New York, United States|Duke University, Durham, North Carolina, United States|Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01467076"
360,"Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.","Completed","Has Results","Diagnosis of Adult Growth Hormone Deficiency (AGDH)","Drug: AEZS-130 (formerly ARD-07)|Drug: L-ARG+GHRH","All","18 Years and older   (Adult, Older Adult)","Phase 3","101","July 2011","Celerion, Tempe, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Harbor-UCLA Medical Center, Torrance, California, United States|Northwestern University, Chicago, Illinois, United States|Radiant Research Inc., Chicago, Illinois, United States|John Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Celerion, Lincoln, Nebraska, United States|Celerion, Neptune, New Jersey, United States|Oregon Health & Science University, Portland, Oregon, United States|Baylor College of Medicine, Houston, Texas, United States|Cetero Research, San Antonio, Texas, United States|VA Puget Sound HCS University of Washington, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00448747"
361,"Trial II of Lung Protection With Azithromycin in the Preterm Infant","Completed","Has Results","Bronchopulmonary Dysplasia","Drug: Azithromycin|Drug: Placebo","All","up to 72 Hours   (Child)","Phase 2","220","June 2012","University of Kentucky Medical Center, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT00319956"
362,"Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias","Recruiting","No Results Available","COVID-19 Pneumonia|Viral Pneumonia","Biological: Allogeneic Mesenchymal Stromal Cells","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1","10","May 4, 2023","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT05286255"
363,"Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study","Unknown status","No Results Available","Respiratory Failure",,"All","18 Years and older   (Adult, Older Adult)",,"10","March 2019","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01806532"
364,"Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2","Completed","Has Results","Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections","Drug: Hydroxychloroquine|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 3","1312","May 20, 2020","Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Research Institute of the McGill University Heath Centre, Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04308668"
365,"Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial","Completed","No Results Available","Critical Illness|Acute Respiratory Failure","Behavioral: Early mobilization intervention","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1917","July 30, 2020","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States|Pennsylvania Hospital, Philadelphia, Pennsylvania, United States|Chester County Hospital, West Chester, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03863470"
366,"Betamethasone Dosing Interval - 12 or 24 Hours?","Completed","No Results Available","Preterm Delivery","Drug: dosing of Betamethasone","Female","16 Years to 45 Years   (Child, Adult)","Not Applicable","200","October 2009","Cooper University Hospital, Camden, New Jersey, United States|Atlanticare Regional Medical Center, Pomona, New Jersey, United States","https://ClinicalTrials.gov/show/NCT00453141"
367,"Tocilizumab for Patients With Cancer and COVID-19 Disease","Terminated","Has Results","Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed","Biological: Tocilizumab","All","2 Years and older   (Child, Adult, Older Adult)","Phase 2","1","January 14, 2021","National Cancer Institute, Rockville, Maryland, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Valley Medical Center, Renton, Washington, United States","https://ClinicalTrials.gov/show/NCT04370834"
368,"ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19","Completed","No Results Available","Covid19","Biological: Remdesivir|Drug: Remdesivir Placebo|Biological: Aviptadil|Drug: Aviptadil Placebo|Drug: Corticosteroid","All","18 Years and older   (Adult, Older Adult)","Phase 3","473","November 20, 2022","Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue, Tucson, Arizona, United States|UCSF Fresno (Site 203-005), 155 N. Fresno Street, Fresno, California, United States|VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda, California, United States|Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard, Los Angeles, California, United States|Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles, California, United States|UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St., San Francisco, California, United States|UCSF Medical Center (Site 203-001), Moffit-Long Hospital, 505 Parnassus Ave., San Francisco, California, United States|Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr., Stanford, California, United States|University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue, Aurora, Colorado, United States|Denver Health Medical Center (Site 204-004), 780 Delaware Street, Pavilion B, Denver, Colorado, United States|MedStar Health Research Institute (Site 009-021), 110 Irving St., NW., Washington, District of Columbia, United States|Washington DC VA Medical Center (Site 009-004), 50 Irving Street, NW., Washington, District of Columbia, United States|Emory University (Site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., NE., Atlanta, Georgia, United States|Massachusetts General Hospital (Site 202-002), 55 Fruit Street, Boston, Massachusetts, United States|Baystate Medical Center (Site 201-001), Critical Care Research, 759 Chestnut Street, Springfield, Massachusetts, United States|Montefiore Medical Center - Moses Hospital (Site 206-001), 111 E. 210th Street, Bronx, New York, United States|Montefiore Medical Center - Weiler campus (Site 206-003), 111 E. 210th Street, Bronx, New York, United States|Mount Sinai Medical Center (Site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, United States|Columbia University Irving Medical Center (Site 301-027), 177 Fort Washington Ave., New York, New York, United States|Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham, North Carolina, United States|Wake Forest Baptist Health (Site 210-001), Medical Center Blvd, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center (Site 207-003), 234 Goodman Street, ML 0740, Cincinnati, Ohio, United States|Cleveland Clinic Fairview Hosptial (Site 207-005), 18101 Lorain Ave., Cleveland, Ohio, United States|Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Ave., Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center (Site 207-004), 410 W. 10th Avenue, Columbus, Ohio, United States|Cleveland Clinic Marymount Campus (Site 207-006), 12300 McCracken Road, Garfield Heights, Ohio, United States|Cleveland Clinic Hillcrest Hospital (Site 207-007), 6780 Mayfield Road, Mayfield Heights, Ohio, United States|Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd., Portland, Oregon, United States|Medical University of South Carolina (Site 210-002), 96 Jonathan Lucas St., CSB 214, Charleston, South Carolina, United States|Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive, Nashville, Tennessee, United States|Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave., Dallas, Texas, United States|Houston Methodist Hospital (Site 301-028), 6565 Fannin Street, Houston, Texas, United States|Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266, Houston, Texas, United States|University of Texas Health Science Center (Site 203-006), 7000 Fannin St., Houston, Texas, United States|Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street, Murray, Utah, United States|University of Utah Hospital (Site 211-002), 50 North Medical Drive, Salt Lake City, Utah, United States|UVA School of Medicine (Site 210-003), University of Virginia Health System, University Hospital, 1215 Lee St., Charlottesville, Virginia, United States|Harborview Medical Center (Site 208-001), 325 9th Ave., Seattle, Washington, United States|Swedish Medical Center (Site 208-005), 747 Broadway, Seattle, Washington, United States|West Virginia University Medicine (Site 301-023), One Medical Center Drive, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT04843761"
369,"Synchronized Intermittent Mechanical Ventilation Versus Open Lung Ventilation With Spontaneous Respiration","Unknown status","No Results Available","Trauma",,"All","18 Years and older   (Adult, Older Adult)",,"198",,"University of New Mexico Hospital, Albuquerque, New Mexico, United States","https://ClinicalTrials.gov/show/NCT00891085"
370,"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","Completed","Has Results","Acute Lung Injury","Drug: Diuresis (furosemide) part I|Other: Fluid Bolus (crystalloid or albumin)|Drug: Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine)|Drug: Dobutamine|Other: Concentrate all drips and nutrition|Drug: Diuresis (furosemide) part II|Procedure: Dialysis","All","18 Years and older   (Adult, Older Adult)","Phase 2","33","January 2011","Kaiser Permanente Sunnyside, Clackamas, Oregon, United States|Legacy Good Samaritan, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT00624650"
371,"Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants","Completed","No Results Available","Patent Ductus Arteriosus","Drug: Ibuprofen","All","up to 6 Months   (Child)","Not Applicable","110","February 2012","John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01758913"
372,"Symphony IL-6 Study in Patients at Risk of Severe Sepsis","Recruiting","No Results Available","Severe Sepsis",,"All","22 Years and older   (Adult, Older Adult)",,"200","November 21, 2023","University of Michigan Medical Center, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT05665153"
373,"Description of Fluid Balance in Patients With Acute Respiratory Failure","Unknown status","No Results Available","Respiratory Insufficiency",,"All","18 Years and older   (Adult, Older Adult)",,"50","December 2015","University of Maryland Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02523872"
374,"Treatment of Critical Illness Polyneuromyopathy","Completed","Has Results","Acute Respiratory Failure","Procedure: intensive physical therapy|Procedure: control group","All","18 Years and older   (Adult, Older Adult)","Not Applicable","120","October 2015","Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Denver, Aurora, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States","https://ClinicalTrials.gov/show/NCT01058421"
375,"CLBS119 for Repair of COVID-19 Induced Pulmonary Damage","Withdrawn","No Results Available","Covid-19","Biological: CLBS119","All","18 Years and older   (Adult, Older Adult)","Phase 1","0","May 2021","NYU Langone Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04522817"
376,"Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure","Withdrawn","No Results Available","Infant, Newborn|Respiratory Insufficiency|Pulmonary Hypertension|Respiratory Distress Syndrome, Newborn|Streptococcal Infections","Drug: Inhaled Prostaglandin E1","All","up to 7 Days   (Child)","Phase 2","0","September 2008","University of Alabama at Birmingham, Birmingham, Alabama, United States|Stanford University, Palo Alto, California, United States|University of Iowa, Iowa City, Iowa, United States|Tufts Medical Center, Boston, Massachusetts, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|RTI International, Durham, North Carolina, United States|Duke University, Durham, North Carolina, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00598429"
377,"Predicting Lung Injury From Transfusion in Patients With Liver Disease","Terminated","No Results Available","Transfusion-related Acute Lung Injury|Chronic Liver Disease|Gastrointestinal Bleeding",,"All","18 Years to 85 Years   (Adult, Older Adult)",,"16","December 2016","University of Colorado Denver, Anshutz medical campus, Aurora, Colorado, United States|Denver Health and Hospital, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT01756690"
378,"High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation","Terminated","Has Results","Transient Tachypnea of the Newborn","Other: High Flow Nasal Cannula|Other: Bubble Nasal CPAP","All","up to 24 Hours   (Child)","Not Applicable","7","April 2012","Mount Sinai School of Medicine, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01270581"
379,"Fluid Management in Transient Tachypnea of the Newborn","Completed","Has Results","Transient Tachypnea of the Newborn","Other: Amount of total fluids","All","up to 24 Hours   (Child)","Not Applicable","64","September 2010","Mount Sinai School of Medicine, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01225029"
380,"Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial","Completed","No Results Available","Transient Tachypnea","Other: Prophylactic CPAP Administration","All","2 Minutes to 30 Minutes   (Child)","Not Applicable","138","April 2013","New York Hospital Queens, Flushing, New York, United States","https://ClinicalTrials.gov/show/NCT01082900"
381,"Effect of Supine or Prone Position After Caesarean Birth","Completed","No Results Available","Respiratory Distress|Transient Tachypnea of the Newborn|Delayed Transition of the Newborn|Persistent Pulmonary Hypertension","Procedure: prone positioning|Procedure: Supine","Female","Child, Adult, Older Adult","Not Applicable","65","February 2009","Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT01310153"
382,"Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis","Recruiting","No Results Available","Acute Respiratory Failure","Drug: IV Ganciclovir","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 3","500","August 31, 2027","University of Colorado Denver, Denver, Colorado, United States|Johns Hopkins University, Baltimore, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Washington University, Saint Louis, Missouri, United States|Montefioure Medical Center, Bronx, New York, United States|Duke University, Durham, North Carolina, United States|Wakeforest University, School of Medicine, Winston-Salem, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Medical Center, Columbus, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Medical College of South Carolina, Charleston, South Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|University of Vermont College of Medicine, Burlington, Vermont, United States|Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04706507"
383,"Early Inhaled Nitric Oxide for Respiratory Failure in Newborns","Terminated","No Results Available","Infant, Newborn|Hypertension, Pulmonary|Persistent Fetal Circulation Syndrome|Pneumonia, Aspiration|Respiratory Distress Syndrome, Newborn|Respiratory Insufficiency","Drug: Inhaled Nitric Oxide|Drug: Standard iNO therapy","All","up to 14 Days   (Child)","Phase 3","302","August 2003","University of Alabama at Birmingham, Birmingham, Alabama, United States|St. Joseph's Hospital, Phoenix, Arizona, United States|Stanford University, Palo Alto, California, United States|San Diego Children's Hospital, San Diego, California, United States|Yale University, New Haven, Connecticut, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Washington School of Medicine, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00005773"
384,"Inhaled Nitric Oxide Study for Respiratory Failure in Newborns","Terminated","No Results Available","Infant, Newborn|Hypertension, Pulmonary|Persistent Fetal Circulation Syndrome|Pneumonia, Aspiration|Respiratory Distress Syndrome, Newborn|Respiratory Insufficiency","Drug: Inhaled nitric oxide|Drug: Placebo","All","up to 14 Days   (Child)","Phase 3","235","May 1998","Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|George Washington University, Washington, D.C., District of Columbia, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|Texas Children's Hospital, Houston, Texas, United States|Foothills Hospital, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Health Sciences Center, Winnipeg, Manitoba, Canada|McMaster University, Hamilton, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Montreal Children's Hospital, Montreal, Quebec, Canada|Université de Sherbrooke,, Sherbrooke,, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00005776"
385,"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.","Not yet recruiting","No Results Available","Covid19","Drug: Selenium (as Selenious Acid)|Other: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","100","December 15, 2021","CHRISTUS Good Shepherd Medical Center, Longview, Texas, United States","https://ClinicalTrials.gov/show/NCT04869579"
386,"Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants","Completed","No Results Available","Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Bronchopulmonary Dysplasia|Respiration, Artificial|Respiratory Distress Syndrome, Newborn|Sepsis","Drug: Vitamin A|Other: Sham Procedure","All","24 Hours to 96 Hours   (Child)","Phase 1|Phase 2","807","July 1999","Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|George Washington University, Washington, D.C., District of Columbia, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01203488"
387,"Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)","Terminated","No Results Available","Bronchopulmonary Dysplasia|Respiratory Distress Syndrome|Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature","Procedure: Minimal mechanical ventilation management|Procedure: Routine mechanical ventilation management|Drug: Dexamethasone|Drug: Placebo","All","5 Minutes to 10 Days   (Child)","Phase 3","220","September 2002","University of Alabama at Birmingham, Birmingham, Alabama, United States|Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|RTI International, Durham, North Carolina, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00005777"
388,"Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)","Completed","No Results Available","Covid19","Drug: Enoxaparin|Drug: Rivaroxaban","All","18 Years to 100 Years   (Adult, Older Adult)","Phase 2","150","June 28, 2021","St. David's Medical Center, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT04640181"
389,"Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19","Active, not recruiting","No Results Available","Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2|Pneumonia|Pneumonia, Viral|Lung Diseases|Respiratory Tract Disease|Respiratory Tract Infections|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Virus Disease|Immunologic Disease|ARDS|Immunologic Factors|Physiological Effects of Drugs|Antiviral Agents|Anti-infective Agents|Analgesics|Antimetabolites, Antineoplastic","Biological: CYNK-001","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","86","June 30, 2022","UC Irvine, Irvine, California, United States|UC Davis Medical Center, Sacramento, California, United States|Scripps Health, San Diego, California, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Atlantic Health, Morristown, New Jersey, United States|Atlantic Health, Summit, New Jersey, United States|Multicare Health System, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT04365101"
390,"Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure","Terminated","No Results Available","Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Respiratory Distress Syndrome (RDS)|Sepsis|Pneumonia|Hypertension, Pulmonary","Drug: Inhaled nitric oxide|Drug: Placebo","All","up to 120 Hours   (Child)","Phase 3","420","May 2006","University of Alabama at Birmingham, Birmingham, Alabama, United States|Stanford University, Palo Alto, California, United States|University of California at San Diego, San Diego, California, United States|Yale University, New Haven, Connecticut, United States|University of Florida, Jacksonville, Florida, United States|University of Miami, Miami, Florida, United States|Northwestern University, Chicago, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of Rochester, Rochester, New York, United States|Wake Forest University, Charlotte, North Carolina, United States|RTI International, Durham, North Carolina, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00016523"
391,"Local Assessment of Ventilatory Management During General Anesthesia for Surgery","Completed","No Results Available","Surgery|Anaesthesia|Ventilator-Induced Lung Injury|Lung Injury|Pneumonia|Pneumothorax|Respiratory Distress Syndrome, Adult|Respiratory Insufficiency",,"All","18 Years and older   (Adult, Older Adult)",,"10690","November 2013","University of Colorado School of Medicine/University of Colorado Hospital, Aurora, Colorado, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|North Estonia Medical Center, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|University Hospital Carl Gustav Carus, Dresden University of Technonology, Department of Anesthesiology and Intensive Care Therapy, Dresden, Germany|Duesseldorf University Hospital, Duesseldorf, Germany|Diakoniekrankenhaus Friederikenstift, Hannover, Germany|Ospedale San Martino, Dipartimento di scienze chirurgiche e diagnostiche integrate, Genoa, Italy|Ospedale San Raffaele, Milano, Italy|Vilnius University Hospital - Institute of Oncology, Vilnius, Lithuania|Vilnius University Hospital - Santariskiu Clinics, Vilnius, Lithuania|Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands|VU University Medical Center, Amsterdam, Netherlands|MC Haaglanden, Den Haag, Netherlands|Haukeland University Hospital, Bergen, Norway|Førde Central Hospital /Førde Sentral Sykehus, Førde, Norway|Institute of Oncology Ljubljana, Ljubljana, Slovenia|University Medicine Centre Ljubljana, Ljubljana, Slovenia","https://ClinicalTrials.gov/show/NCT01601223"
392,"Physiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure","Not yet recruiting","No Results Available","Acute Hypoxemic Respiratory Failure","Device: HFNC only|Device: HFNC + CNEP10|Device: HFNC + CNEP20|Device: HFNC + CNEP30","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","December 30, 2024","Columbia University Irving Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05675345"
393,"Clazakizumab vs. Placebo - COVID-19 Infection","Unknown status","No Results Available","COVID-19 Infection","Drug: Clazakizumab|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","60","July 31, 2021","Houston Methodist Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04494724"
394,"Nasal Noninvasive NAVA in the Very Low Birth Weight Infant","Completed","Has Results","Inadequate; Pulmonary Ventilation, Newborn|Infant, Very Low Birth Weight","Device: Nasal NIV-NAVA","All","7 Days to 1 Year   (Child)","Not Applicable","40","December 31, 2018","Children's Hospital of Iowa NICU, Iowa City, Iowa, United States|University of Iowa, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT01785563"
395,"Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation","Completed","Has Results","COVID-19|Hypoxia","Drug: L-ascorbic acid","All","18 Years to 99 Years   (Adult, Older Adult)","Phase 1|Phase 2","20","October 13, 2020","Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT04357782"
396,"Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support","Recruiting","No Results Available","Invasive Mechanical Ventilation","Other: Artificial Intelligence-based Decision support","All","18 Years and older   (Adult, Older Adult)",,"318542","February 28, 2025","Cleveland Clinic Foundation, Cleveland, USA, Cleveland, Ohio, United States|University Hospital Carl Gustav Carus Dresden, Dresden, Germany|Institut Fur Angewandte Informatik (Infai) Ev, Leipzig, Germany|Institut Mihajlo Pupin, Belgrade, Serbia|Better Care Sl, Sabadell, Spain|Fundacio Parc Tauli, Sabadell, Spain|Fundacion Publica Andaluza Progreso Y Salud, Sevilla, Spain|Inselspital, Universitätsspital Bern, Bern, Switzerland","https://ClinicalTrials.gov/show/NCT05668637"
397,"Study of Varespladib in Patients Hospitalized With Severe COVID-19","Terminated","No Results Available","Coronavirus Disease 2019|Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2","Drug: Varespladib|Drug: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","18","November 22, 2022","Ventura Clinical Trials, Ventura, California, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Westchester Research Center at Westchester General Hospital, Miami, Florida, United States|Franciscan Alliance, Munster, Indiana, United States|The Brigham and Women's Hospital Emergency Medicine, Boston, Massachusetts, United States|Cooper University Hospital, Camden, New Jersey, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT04969991"
398,"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","Recruiting","No Results Available","COVID-19","Drug: Remdesivir|Drug: Imatinib Mesylate|Drug: Dexamethasone|Drug: Cenicriviroc|Drug: Icatibant|Drug: Apremilast|Biological: dornase alfa|Drug: Celecoxib|Drug: Famotidine|Biological: IC14|Drug: Aviptadil|Biological: narsoplimab|Drug: Cyproheptadine|Drug: Cyclosporine","All","18 Years and older   (Adult, Older Adult)","Phase 2","1500","November 1, 2023","University of Alabama at Birmingham, Birmingham, Alabama, United States|UC Davis Medical Center, Davis, California, United States|UC Irvine Medical Center, Irvine, California, United States|Long Beach Memorial Medical Center, Long Beach, California, United States|Kaiser LAMC, Los Angeles, California, United States|University of Southern California, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|University of Colorado, Aurora, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Georgetown University, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Emory University, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Spectrum Health, Grand Rapids, Michigan, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Logan Health Medical Center, Kalispell, Montana, United States|Montefiore Medical Center, Bronx, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University of Pennsylvania (U Penn), Philadelphia, Pennsylvania, United States|Lankenau Medical Center (Mainline Health), Wynnewood, Pennsylvania, United States|Main Line Health - Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Sanford Health, Sioux Falls, South Dakota, United States|DHR Health, Edinburg, Texas, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|WVU Medicine, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT04488081"
399,"The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury","Completed","Has Results","Lung Injury, Acute","Drug: Dose 1 GSK2586881|Drug: Dose 2 GSK2586881|Drug: Dose 3 GSK2586881|Drug: Dose 4 GSK2586881|Drug: Placebo (saline)","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","44","October 6, 2014","GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Springfield, Massachusetts, United States|GSK Investigational Site, Ann Arbor, Michigan, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Greensboro, North Carolina, United States|GSK Investigational Site, Winston-Salem, North Carolina, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Kingston, Ontario, Canada|GSK Investigational Site, Greenfield Park, Quebec, Canada|GSK Investigational Site, Sainte-Foy, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01597635"
400,"Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients","Recruiting","No Results Available","COVID-19","Drug: Niclosamide|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","436","December 2022","Helen Keller Hospital, Sheffield, Alabama, United States|University of California, Irvine, Irvine, California, United States|Baptist Health Research Institute, Jacksonville, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States|University of Missouri Health Care, Columbia, Missouri, United States|Caroline Institute for Clinical Research, Fayetteville, North Carolina, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|Memorial Hermann Southeast Hospital, Houston, Texas, United States|Providence Regional Medical Center Everett, Everett, Washington, United States","https://ClinicalTrials.gov/show/NCT04603924"
401,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19","Completed","Has Results","COVID-19","Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","2252","October 22, 2021","Regeneron Study Site, Birmingham, Alabama, United States|Regeneron Study Site, Chandler, Arizona, United States|Regeneron Study Site, Phoenix, Arizona, United States|Regeneron Study Site 1, Tucson, Arizona, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Mission Hills, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Pensacola, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Augusta, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Glenview, Illinois, United States|Regeneron Study Site, Urbana, Illinois, United States|Regeneron Study Site, Indianapolis, Indiana, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Grand Rapids, Michigan, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Chesterfield, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Omaha, Nebraska, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Englewood, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Pennington, New Jersey, United States|Regeneron Study Site, Summit, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Albuquerque, New Mexico, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site 1, Buffalo, New York, United States|Regeneron Study Site 2, Buffalo, New York, United States|Regeneron Study Site, Jamaica, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Rochester, New York, United States|Regeneron Study Site, Syracuse, New York, United States|Regeneron Study Site, West Islip, New York, United States|Regeneron Study Site, White Plains, New York, United States|Regeneron Study Site, Chapel Hill, North Carolina, United States|Regeneron Study Site, Greensboro, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site 1, Amarillo, Texas, United States|Regeneron Study Site 2, Amarillo, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Lubbock, Texas, United States|Regeneron Study Site, Sugar Land, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Salt Lake City, Utah, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site 1, Seattle, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Salvador, Bahia, Brazil|Regeneron Study Site, Fortaleza, Ceara, Brazil|Regeneron Study Site, Curitiba, Paraná, Brazil|Regeneron Study Site, Porto Alegre, Rio Grande Do Sul, Brazil|Regeneron Study Site, Passo Fundo, RS, Brazil|Regeneron Study Site, Chapeco, Santa Catarina, Brazil|Regeneron Study Site, Criciuma, Santa Catarina, Brazil|Regeneron Study Site, Botucatu, Sao Paolo, Brazil|Regeneron Study Site, Campinas, Sao Paolo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site 1, Las Condes, Santiago De Chile, Chile|Regeneron Study Site 2, Las Condes, Santiago De Chile, Chile|Regeneron Study Site, Vitacura, Santiago De Chile, Chile|Regeneron Study Site, Santiago de Chile, Chile|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Monterrey, Nuevo Leon, Mexico|Regeneron Study Site, Culiacán, Sinaloa, Mexico|Regeneron Study Site, Culiacan, Mexico|Regeneron Study Site, Monterrey, Mexico|Regeneron Study Site 1, Mérida, Mexico|Regeneron Study Site 2, Mérida, Mexico|Regeneron Study Site, Veracruz, Mexico|Regeneron Study Site, Zapopan, Mexico|Regeneron Study Site, Chisinau, Moldova, Republic of|Regeneron Study Site, Bucuresti, Romania","https://ClinicalTrials.gov/show/NCT04426695"
402,"Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19","Completed","No Results Available","SARS-CoV-2 (COVID-19) Severe Pneumonia","Drug: ATYR1923 1 mg/kg|Drug: ATYR1923 3 mg/kg|Drug: Placebo","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","32","December 21, 2020","University of Alabama at Birmingham, Birmingham, Alabama, United States|aTyr Investigative Site, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|University of Iowa, Iowa City, Iowa, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|aTyr Investigative Site, Vineland, New Jersey, United States|aTyr Investigative Site, Toledo, Ohio, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Alliance Medical Service, Cardio Pulmonary Research, Guaynabo, Puerto Rico|Manati Medical Center, Manatí, Puerto Rico","https://ClinicalTrials.gov/show/NCT04412668"
403,"TD-0903 for ALI Associated With COVID-19","Completed","Has Results","Acute Lung Injury (ALI) Associated With COVID-19|Lung Inflammation Associated With COVID-19","Drug: TD-0903|Drug: Placebo","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","235","April 21, 2021","Theravance Biopharma Investigational Site, Duarte, California, United States|Theravance Biopharma Investigational Site, Denver, Colorado, United States|Theravance Biopharma Investigational Site, Sebring, Florida, United States|Theravance Biopharma Investigational Site, Boston, Massachusetts, United States|Theravance Biopharma Investigational Site, Fall River, Massachusetts, United States|Theravance Biopharma Investigational Site, Kalispell, Montana, United States|Theravance Biopharma Investigational Site, Glens Falls, New York, United States|Theravance Biopharma, Hyde Park, New York, United States|Theravance Biopharma Investigational Site, Columbus, Ohio, United States|Theravance Biopharma Investigational Site, Allentown, Pennsylvania, United States|Theravance Biopharma Investigational Site, Bethlehem, Pennsylvania, United States|Theravance Biopharma Investigational Site, Wenatchee, Washington, United States|Theravance Biopharma Investigational Site, Bela Vista, Brazil|Theravance Biopharma Investigational Site, Botucatu, Brazil|Theravance Biopharma Investigational Site, Caxias Do Sul, Brazil|Theravance Biopharma Investigational Site, São José Do Rio Preto, Brazil|Theravance Biopharma Investigational Site, Helsinki, Finland|Theravance Biopharma Investigational Site, Turku, Finland|Theravance Biopharma Investigational Site, Chisinau, Moldova, Republic of|Theravance Biopharma Investigational Site, Bucharest, Romania|Theravance Biopharma Investigational Site, Brovary, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Ukraine|Theravance Biopharma Investigational Site, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT04402866"
404,"A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components","Completed","No Results Available","Transfusion Related Acute Lung Injury","Other: Standard of Care","All","Child, Adult, Older Adult",,"2291","May 2021","UCLA Medical Center, Los Angeles, California, United States|Stanford University, Palo Alto, California, United States|Yale-New Haven Hospital, New Haven, Connecticut, United States|Emory University, Atlanta, Georgia, United States|University of Maryland, Baltimore, Maryland, United States|Beth Israel, Boston, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|St. Louis Children's Hospital, Saint Louis, Missouri, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Memorial Sloan Kettering, New York, New York, United States|Strong Memorial Hospital, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University Hospital, Greenville, North Carolina, United States|TriHealth Cancer Institute, Cincinnati, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT02549222"
405,"Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen","Recruiting","No Results Available","Acute Respiratory Failure","Drug: Tozorakimab|Drug: Placebo","All","up to 18 Years   (Child, Adult)","Phase 3","2352","May 9, 2024","Research Site, Mobile, Alabama, United States|Research Site, Phoenix, Arizona, United States|Research Site, Chula Vista, California, United States|Research Site, Newport Beach, California, United States|Research Site, Torrance, California, United States|Research Site, Washington, District of Columbia, United States|Research Site, Bradenton, Florida, United States|Research Site, Bradenton, Florida, United States|Research Site, Saint Petersburg, Florida, United States|Research Site, Saint Petersburg, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Boise, Idaho, United States|Research Site, Chicago, Illinois, United States|Research Site, Elmhurst, Illinois, United States|Research Site, Evanston, Illinois, United States|Research Site, Fort Wayne, Indiana, United States|Research Site, Iowa City, Iowa, United States|Research Site, Shreveport, Louisiana, United States|Research Site, Annapolis, Maryland, United States|Research Site, Silver Spring, Maryland, United States|Research Site, Detroit, Michigan, United States|Research Site, Brooklyn, New York, United States|Research Site, New York, New York, United States|Research Site, Potsdam, New York, United States|Research Site, Chapel Hill, North Carolina, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Portland, Oregon, United States|Research Site, Providence, Rhode Island, United States|Research Site, Sioux Falls, South Dakota, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Charlottesville, Virginia, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Buenos Aires, Argentina|Research Site, Ciudad Autonoma de Buenos Aires, Argentina|Research Site, Ciudad Autonoma de Buenos Aires, Argentina|Research Site, Ciudad Autonoma de Buenos Aire, Argentina|Research Site, Ciudad Autónoma de Buenos Aires, Argentina|Research Site, La Plata, Argentina|Research Site, Mar del Plata, Argentina|Research Site, Rosario, Argentina|Research Site, Adelaide, Australia|Research Site, New Lambton Heights, Australia|Research Site, South Brisbane, Australia|Research Site, Ottignies, Belgium|Research Site, Belo Horizonte, Brazil|Research Site, Campinas, Brazil|Research Site, Caxias do Sul, Brazil|Research Site, Curitiba, Brazil|Research Site, Curitiba, Brazil|Research Site, Natal, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Rio de Janeiro, Brazil|Research Site, Sao Jose Do Rio Preto, Brazil|Research Site, Sao Paulo, Brazil|Research Site, São Paulo, Brazil|Research Site, Pernik, Bulgaria|Research Site, Pleven, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Calgary, Alberta, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Saskatoon, Saskatchewan, Canada|Research Site, Quebec, Canada|Research Site, Beijing, China|Research Site, Changsha, China|Research Site, Guangzhou, China|Research Site, Guangzhou, China|Research Site, Haikou, China|Research Site, Shenzhen, China|Research Site, Wuhan, China|Research Site, Yantai, China|Research Site, Bogota DC, Colombia|Research Site, Floridablanca, Colombia|Research Site, Medellin, Colombia|Research Site, Soledad, Colombia|Research Site, Villavicencio, Colombia|Research Site, Benesov, Czechia|Research Site, Brno, Czechia|Research Site, Kolin, Czechia|Research Site, Kyjov, Czechia|Research Site, Mlada Boleslav, Czechia|Research Site, Praha 10, Czechia|Research Site, Praha 5, Czechia|Research Site, Aalborg, Denmark|Research Site, Copenhagen Ø, Denmark|Research Site, Hvidovre, Denmark|Research Site, Kolding, Denmark|Research Site, København, Denmark|Research Site, Vejle, Denmark|Research Site, Amiens Cedex 1, France|Research Site, Angers, France|Research Site, Dijon, France|Research Site, Le Coudray Cedex, France|Research Site, Montpellier Cedex 5, France|Research Site, Nantes Cedex 1, France|Research Site, Orléans Cedex 2, France|Research Site, Strasbourg Cedex, France|Research Site, Strasbourg, France|Research Site, Tours, France|Research Site, Berlin, Germany|Research Site, Hannover, Germany|Research Site, Kiel, Germany|Research Site, Köln, Germany|Research Site, Leverkusen, Germany|Research Site, München, Germany|Research Site, Rostock, Germany|Research Site, Athens, Greece|Research Site, Hong Kong, Hong Kong|Research Site, Shatin, Hong Kong|Research Site, Balassagyarmat, Hungary|Research Site, Budapest, Hungary|Research Site, Budapest, Hungary|Research Site, Győr, Hungary|Research Site, Kistarcsa, Hungary|Research Site, Nyíregyháza, Hungary|Research Site, Pécs, Hungary|Research Site, Ahmedabad, India|Research Site, Ahmedabad, India|Research Site, Belagavi, India|Research Site, Chennai, India|Research Site, Gurgaon, India|Research Site, Gurugram, India|Research Site, Hyderabad, India|Research Site, Mumbai, India|Research Site, New Delhi, India|Research Site, Pune, India|Research Site, Thane, India|Research Site, Afula, Israel|Research Site, Beer Sheva, Israel|Research Site, Haifa, Israel|Research Site, Jerusalem, Israel|Research Site, Petah Tikva, Israel|Research Site, Ramat Gan, Israel|Research Site, Rehovot, Israel|Research Site, Arezzo, Italy|Research Site, Brescia, Italy|Research Site, Napoli, Italy|Research Site, Rozzano, Italy|Research Site, Torino, Italy|Research Site, Gifu-shi, Japan|Research Site, Izumisano-shi, Japan|Research Site, Kamakura-shi, Japan|Research Site, Kamogawa-shi, Japan|Research Site, Kasuga-shi, Japan|Research Site, Kusatsu-shi, Japan|Research Site, Kyoto-shi, Japan|Research Site, Maebashi-shi, Japan|Research Site, Okazaki-shi, Japan|Research Site, Shinjuku-ku, Japan|Research Site, Suita-shi, Japan|Research Site, Ureshino-shi, Japan|Research Site, Yokohama-shi, Japan|Research Site, Daegu, Korea, Republic of|Research Site, Jeonju, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Kuala Lumpur, Malaysia|Research Site, Kuantan, Malaysia|Research Site, Kubang Kerian, Malaysia|Research Site, Melaka, Malaysia|Research Site, Petaling Jaya, Malaysia|Research Site, Pulau Pinang, Malaysia|Research Site, Sarawak Miri, Malaysia|Research Site, Shah Alam, Malaysia|Research Site, Guadalajara, Mexico|Research Site, Monterrey, Mexico|Research Site, San Luis Potosi, Mexico|Research Site, Tlalpan, Mexico|Research Site, Cusco, Peru|Research Site, el Agustino, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Piura, Peru|Research Site, Cebu, Philippines|Research Site, Iloilo City, Philippines|Research Site, Manila, Philippines|Research Site, Quezon City, Philippines|Research Site, Quezon City, Philippines|Research Site, Chrzanów, Poland|Research Site, Rzeszów, Poland|Research Site, Warszawa, Poland|Research Site, Jeddah, Saudi Arabia|Research Site, Riyadh, Saudi Arabia|Research Site, Riyadh, Saudi Arabia|Research Site, Riyadh, Saudi Arabia|Research Site, Bratislava, Slovakia|Research Site, Košice, Slovakia|Research Site, Trnava, Slovakia|Research Site, Barcelona, Spain|Research Site, Madrid, Spain|Research Site, Malaga, Spain|Research Site, Palma de Mallorca, Spain|Research Site, Santander, Spain|Research Site, Lund, Sweden|Research Site, Stockholm, Sweden|Research Site, Umeå, Sweden|Research Site, Västerås, Sweden|Research Site, Kaohsiung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei, Taiwan|Research Site, Taipei, Taiwan|Research Site, Taipei, Taiwan|Research Site, Taoyuan City, Taiwan|Research Site, Taoyuan, Taiwan|Research Site, Bangkok, Thailand|Research Site, Bangkok, Thailand|Research Site, Chiang Mai, Thailand|Research Site, Khon-Kaen, Thailand|Research Site, Phutthamonthon, Thailand|Research Site, Ankara, Turkey|Research Site, Diyarbakir, Turkey|Research Site, Istambul, Turkey|Research Site, Istanbul, Turkey|Research Site, Izmir, Turkey|Research Site, Malatya, Turkey|Research Site, Bristol, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Hampshire, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Oxford, United Kingdom|Research Site, Prescot, United Kingdom|Research Site, Tyne And Wear, United Kingdom|Research Site, Wythenshawe, United Kingdom|Research Site, Hanoi, Vietnam|Research Site, Hochiminh city, Vietnam","https://ClinicalTrials.gov/show/NCT05624450"
406,"A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients","Terminated","No Results Available","COVID-19","Drug: OP-101|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2","28","August 12, 2022","Research Site, Loma Linda, California, United States|Research site, Fort Lauderdale, Florida, United States|Research site, Jacksonville, Florida, United States|Research Site, Atlanta, Georgia, United States|Research site, Baltimore, Maryland, United States|Research Site, Sioux Falls, South Dakota, United States|Research Site, Amarillo, Texas, United States|Research Site, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04458298"
407,"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19","Completed","Has Results","COVID-19","Drug: Sarilumab|Drug: Placebo","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","1912","September 2, 2020","Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Denver, Colorado, United States|Regeneron Study Site, New Haven, Connecticut, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Ann Arbor, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Edison, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Livingston, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, Elmhurst, New York, United States|Regeneron Study Site 1, Manhasset, New York, United States|Regeneron Study Site 2, Manhasset, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site 1, New York, New York, United States|Regeneron Study Site 2, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Stony Brook, New York, United States|Regeneron Study Site, Valhalla, New York, United States|Regeneron Study Site, Tulsa, Oklahoma, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Scranton, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Renton, Washington, United States","https://ClinicalTrials.gov/show/NCT04315298"
408,"Dexamethasone Therapy in VLBW Infants at Risk of CLD","Completed","No Results Available","Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Bronchopulmonary Dysplasia","Drug: Dexamethasone Early|Drug: Dexamethasone Late","All","13 Days to 15 Days   (Child)","Phase 3","371","April 1994","Stanford University, Palo Alto, California, United States|Yale University, New Haven, Connecticut, United States|George Washington University, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico, Albuquerque, New Mexico, United States|Cincinnati Children's Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States|University of Tennessee, Memphis, Tennessee, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00011362"
409,"Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine","Completed","Has Results","COVID-19","Drug: Hydroxychloroquine|Drug: Placebo oral tablet","All","18 Years and older   (Adult, Older Adult)","Phase 3","1360","January 9, 2021","Children's Hospital Colorado/University of Colorado Denver, Aurora, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|University of Florida Health Central Florida, Leesburg, Florida, United States|University of Miami Florida, Miami, Florida, United States|Advent Health, Orlando, Florida, United States|University of South Florida, Tampa, Florida, United States|Northwestern Medicine, Chicago, Illinois, United States|Rush University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Allina Health, Minneapolis, Minnesota, United States|Mayo Clinic Hospital Rochester, Rochester, Minnesota, United States|University of Missouri-Columbia, Columbia, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hospital for Special Surgery, New York, New York, United States|Columbia University, Irving Medical Center, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott & White Medical Center-Temple, Temple, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Marshfield Clinic Health System, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04334148"
